Topic ID: D1410_TRAIN | Citance Number: 10 | Citation Text: abundant solid cervical mir-24 up-regulated mirnas cancer cancers | Reference Offset: [457-696', 5101-5216', 5602-5791'] | Reference Text: species mirna sequencing mirnas abundant rna mir-21 library mir-24 small caski subset lesions demonstrate cervical significantly mirnas cancers total clones species mirna mirnas cloned abundant mir-21 mir-24 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 11 | Citation Text: breast differ patient-matched disseminated primary distant metastases tumors | Reference Offset: [33749-33901', 33568-33707', 34616-34762'] | Reference Text: breast detection itga5 patient-matched rdx primary distant metastases tumors rhoa breast patient-matched mir-31 primary distant metastases tumors breast patients mir-31 primary distant metastases tumors assessed | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 5 | Citation Text: kinase lats1 aurora-a s83 lats2/kpm cycle-dependent phosphorylated residue phosphorylation homologous | Reference Offset: [36157-36278', 15449-15535', 19040-19246'] | Reference Text: kinase lats2 aurora-a s83 centrosomal candidate residue phosphorylation kinases kinase lats2 aurora-a s83 figure vitro residue lats2 mouse aurora-a antibody peptide phosphorylated residue mice s83 confirm | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 9 | Citation Text: stem/progenitor regulating proliferation vitro tet2 differentiation myeloid suggested approaches recent | Reference Offset: [43625-43903', 1693-1890', 1904-2225'] | Reference Text: normal inhibition differentiation effects idh2 mutants stem/progenitor tet2 myeloid increase hematopoietic reduction stem/progenitor impaired marker tet2 differentiation idh1/2 hematopoietic suggesting finally mutant depletion hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 2 | Citation Text: lfa-1 molecule conformation affinity formation | Reference Offset: [1651-1922', 3816-3977', 476-609'] | Reference Text: limited interaction contact affinity sufficient ligands order tcr antigen tight low formation binds ligands area range cd2 adhesion participate molecule contact formation recognition antigen-presenting antigen requires formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 11 | Citation Text: chemokine immune trafficking play conditions critical 10 vitro fractalkine molecules adhesion molecule chemokines brain interactions | Reference Offset: [1727-2011', 2013-2244', 30664-30946'] | Reference Text: chemokine essential events trafficking molecular requires factors molecules adhesion chemotactic members processes work selective trafficking molecular subsets remain molecules adhesion chemokines functions complex chemokine class properties molecular cx3c represents nature fractalkine receptor molecules adhesion chemokines | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 8 | Citation Text: involves constitutively priming death bh3s mitochondrial | Reference Offset: [33038-33325', 6238-6433', 31748-31935'] | Reference Text: cellular demonstrate death assays mitochondrial signals electroporation transfected priming peptides bim treated 2b4 mcl-1 part reflect death show antiapoptotic models signaling family priming experimentally induced activator culture members additional permeabilization death signal mcl-1 mitochondrial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 17 | Citation Text: genes disseminated distant accumulation relapse eventual survival cancer extravasation | Reference Offset: [1201-1487', 2118-2569', 13505-13681'] | Reference Text: site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically complex neoplastic distant secondary tumors leads primary extravasation tissues tumor invasion-metastasis process cascade involving survival events suggested regulates observations lung viability initial and/or mir-31 survival early extravasation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 17 | Citation Text: mutations gatekeeper inhibitors ap24534 mutation structural recent kinase t315i point involved domain resistance bcr-abl inhibit mutant based | Reference Offset: [5924-6170', 2726-2843', 2966-3266'] | Reference Text: reveal structure acts gatekeeper mutation abl recent point kinase t315i domain x-ray mutant threonine kinase point involves mutations imatinib domain resistance binding bcr-abl inhibitor suggests treatment mutation potential abl clinically second-line clear present kinase patient identification imatinib domain active resistance bcr-abl inhibitor mutant therapy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 6 | Citation Text: patterns 2002 identify tumors subsets prognostic alizadeh multiple 2000 | Reference Offset: [5944-6313', 23455-23602', 44319-44486'] | Reference Text: microarrays single genes profiling leukemic determine 12 patients alizadeh utilized 1999 pediatric analyze prognostic approaches 2000 subtypes prognostic single collectively identify profiling selected prognostic classifiers genetic genes identify subgroups supervised | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 10 | Citation Text: mcf-7 assay renilla luciferase reporter plates transfected grown ng mutated | Reference Offset: [39855-39978', 21210-21297', 26626-26790'] | Reference Text: reporter constructs renilla relative calculated luciferase mcf-7 transfected expressing chimera vector transfected constructs luciferase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 12 | Citation Text: amino form common drugs inhibitors substitutions tyrosine kinase acid imatinib resistance cancer | Reference Offset: [5360-5637', 13222-13497', 30482-30707'] | Reference Text: residues mutations change substitutions 13 contact kinase imatinib domain required drug direct sites structure amino conformational include acid led binding based structure amino mutations potential abl confer kinase acid imatinib domain resistance mechanisms bound obtained amino defined evidence play substitutions mutants acid vitro imatinib resistance large | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 18 | Citation Text: kras mutations report tumor exert recent | Reference Offset: [26910-26993', 466-520', 522-707'] | Reference Text: dependency k-ras mutations tumor ras samples k-ras mutations epithelial occur frequently cancers k-ras shrnas mutations maintain lung viability pancreatic lines require cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 12 | Citation Text: analyze system ros accumulation transformation | Reference Offset: [31061-31379', 779-1050', 1898-2087'] | Reference Text: allowed direct rapidly inhibition differentiation induction effects ras demonstrating appears analyze system time oncogenic thyroid frtl-5 early activation cellular constitutively expressing differentiation origin established oncoprotein effects ras analyze generated thyroid active lines frtl-5 viral forms stably mutations progression common genes play tumor transformation malignant cancers oncogenic genetic alterations | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 11 | Citation Text: complex actin monomer baf53 baf product stimulation sequestering experiments atpase latrunculin required chromatin | Reference Offset: [29550-29676', 25955-26166', 25065-25218'] | Reference Text: product sequestering complex actin monomer atpase latrunculin baf natural activation detect complex demonstrate actin baf53 baf brg1 experiments vitro mediated interact directly interactions complex observation actin baf53 determine baf brg1 led subunits interact directly required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 5 | Citation Text: mcf-7 transfected hela t47d electroporation | Reference Offset: [16436-16565', 22460-22570', 45463-45604'] | Reference Text: cyclin mcf-7 d1 transfected wild-type mutant electroporation mcf-7 transfected vector construct electroporation mcf-7 hr transfected irradiated population electroporation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 14 | Citation Text: response termed h-rasv12 arrest oncogenes primary senescence stress premature growth | Reference Offset: [30597-30804', 33090-33236', 33238-33367'] | Reference Text: mutations induction ras transform program oncogenic primary senescence rodent premature demonstrate p53 association oncogenic primary senescence induction rodent ras premature response suppression signaling propose senescence induction mechanism tumor mitogenic premature | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 7 | Citation Text: chips oct4 obtained mouse differentiated profiling differentiation affymetrix murine 16 samples stages lineages 43 lines microarray early escs stembase carcinoma | Reference Offset: [7655-7863', 7865-8091', 590-800'] | Reference Text: basis 45 form set murine samples selected stem part stembase total set differentiated affymetrix embryonic adult derivatives variety samples biological stem oct4 essential lineage differentiation state embryonic factor adult implicated mediator stem homeodomain cancer transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 15 | Citation Text: flux ros insulin electron resistance | Reference Offset: [32765-32944', 13431-13645', 13765-13983'] | Reference Text: result flux ros alternative reduced chain transport electron pathways generation site reverse ros responsible generates ii flow acid electron occurring generation site ros rise absence electron subsequent block flow cytochrome produced | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 12 | Citation Text: processes series development neoplastic integrity normal tissue thought epigenetic accumulation transformation represent division vitro genetic alterations vivo occur | Reference Offset: [2207-2440', 3677-4023', 44531-44751'] | Reference Text: tumorigenesis evidence normal steps derivatives malignant transformation process genetic highly lines alterations reflect development normal tumor type cancers observations process models leads advantage analogous genetic cancer growth animal complex integrity normal tissue proteolysis signaling regulation molecules reflect | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 11 | Citation Text: rnai previous identify genes colon breast findings loss-of-function screens lines derived required multiple cancer | Reference Offset: [20414-20694', 26282-26649', 24046-24315'] | Reference Text: screen rnai essential proliferation genes developed collection consortium viability library lines part required shrna cancer large essential amplifications dependent made reminiscent egfr observations breast findings oncogenes lines oncogene bcr-abl cancer ikbke amplification genes induce possibility tumors transformation observations breast findings target lines cancer key ikbke | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 5 | Citation Text: essential domains promyelocytic pml 10 nuclear component oncogenic leukemia domain called bodies large | Reference Offset: [11551-11738', 794-977', 20278-20449'] | Reference Text: sites antibodies domains pml nuclear fail bodies antigen pml oncogenic domains part suggests structure complexity size pml led nuclear search large pod | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 13 | Citation Text: direct oct4 genes list 28 transcripts recently action investigated included published escs | Reference Offset: [13927-14151', 3942-4248', 6654-6899'] | Reference Text: direct oct4 pcr 28 transcriptional confirmed identification quantitative chromatin targets series oct4 revealed circuitry nanog recent transcriptional sox2 identification core escs targets cellular direct events developmental molecular outcome recently increase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 5 | Citation Text: sensor result functions removal tp53 dna component apoptosis induce damage mutation key | Reference Offset: [29051-29299', 25072-25206', 55050-55270'] | Reference Text: inactivation induce functional damage resulting apoptotic cancers product sensor removal p53 component dna cascade effector key response p53 proapoptotic dna apoptosis bax suppressor damage tumor systems member cycle apoptosis suppressor damage tumor response p53 arrest dna | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 12 | Citation Text: conditions mitochondria reports translocate endomembranes isoforms signal ras recent localized | Reference Offset: [18576-18681', 33260-33601', 1771-1879'] | Reference Text: endomembranes signal ras cycle trafficking isoforms signal ras regulates clear endomembrane pm golgi forms generated differential sequences isoforms part ras large distinct | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 7 | Citation Text: mutations pathway genes suppressor tumor accumulation selection process oncogenes experiments cancer mutated homologous | Reference Offset: [897-1026', 2202-2525', 2527-2800'] | Reference Text: rate-limiting oncogenes maintenance dependent highly context driver tumor continued kras mutations loss progression metastatic disease occurs acquisition suppressors intraepithelial tp53 cases activating subsequent tumor malignant pancreatic invasive oncogene early neoplasia kras mouse progression genes evidence suppressor tumor pdac models oncogenic genetically provided driver initiation major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 12 | Citation Text: p53kd generation | Reference Offset: [266-318', 320-411', 413-532'] | Reference Text: locus inactivated cancer p53 p16ink4a prb inhibit growth p14arf vectors analyze functions rna primary interference assays transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 7 | Citation Text: bcl-2 bak bax bh3-only inhibited | Reference Offset: [5432-5670', 397-552', 710-942'] | Reference Text: preventing bak complexes bcl-xl stable antiapoptotic mitochondrial comparison bcl-2 bax wild-type molecules bh3-only mutant 2001 members activation bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome bak characterized domains bh3 bad mitochondrial antiapoptotic resulting subset activate bcl-2 binds bax initiate displacement bik peptides directly | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 7 | Citation Text: cyclin interestingly 22 establish stability phosphorylated observations licensing stabilized replication recently cdc6 initiation phosphorylation key | Reference Offset: [1558-1674', 1780-1897', 10640-10798'] | Reference Text: p53 replication dna collectively cdc6 stability initiation regulated process licensing replication dna origins cdc6 plays key major critical licensing pre-rc ir replication dna cdc6 examined initiation factor formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 14 | Citation Text: subtypes serve lymphoblastic differentiation leukemic express stages resulting acute arrested t-cell t-all oncogenes subsequently classification leukemia developmentally thymocyte | Reference Offset: [31053-31237', 1806-2013', 16000-16133'] | Reference Text: subtypes defined development identify normal link molecular stages t-all oncogenes activation thymocyte subtypes lymphoblastic lineage line pathogenesis molecular research impact leukemias acute remain undefined largely leukemia t-all recognized differentiation profiles samples stages thymocyte | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 6 | Citation Text: cmv constructs mir-vec cloned vector dnd1 | Reference Offset: [42195-42329', 5596-5776', 13874-14062'] | Reference Text: promoter cmv mir-vec mirna pcr cloned genomic dna sequence downstream amplified region promoter cmv vector mir-vec marker vector resistance population growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 5 | Citation Text: cyclin-dependent suppressor phosphorylated tumor retinoblastoma substrate kinases product critical g1 phosphorylation early | Reference Offset: [1389-1486', 17016-17260', 19316-19611'] | Reference Text: genes suppressor class tumor retinoblastoma residues phosphorylated serine existence rb kinases phosphorylation threonine mutations functional tumor retinoblastoma rb suppression proposed directly phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 14 | Citation Text: cloned cd2-associated membrane cd2 domain cytoplasmic interacts natural | Reference Offset: [21415-21541', 41879-42054', 939-1154'] | Reference Text: residues 30 sequence cd2ap cd2 domain cytoplasmic interacts cloned mouse cd2 domain encoding pcr construct cytoplasmic produced cytoskeletal cd2 dependent domain interaction cytoplasmic required clustering | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 17 | Citation Text: work basis binding bh3-only structural specificities recent members antiapoptotic | Reference Offset: [7371-7545', 8080-8150', 4463-4757'] | Reference Text: domains determine bh3 assays antiapoptotic bcl-2 family binding bh3-only interactions members selective family binding bh3-only antiapoptotic members preventing oligomerization death domains bh3 interaction prevent bax/bak antiapoptotic sequestering upstream signaling family largely binding activator members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 13 | Citation Text: breast mir-126 recently leukemia metastasis cervical downregulated mirna suppressing cancer | Reference Offset: [1338-1652', 17489-17898', 4911-5099'] | Reference Text: normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer development mir-145 mir-143 mirna downregulated upregulation lesions mir-146a cervical suggesting case reduction downregulation cancer early tissues cervical mirna lines approaches cancer profile tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 7 | Citation Text: anchorage-independent targeting proliferation dependent transformed ras considered bj rna fibroblasts activated sv40 pten telomerase extracellular expressing matrix vectors p53 leading interference lines antigen knockdown survival small growth | Reference Offset: [2451-2823', 2113-2449', 3192-3288'] | Reference Text: telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth telomerase genes recombination ras transformation vectors altered apparent p53 prb pi3k rna ectopic recently pathways mutant viral homologous represents primary transformed st antigen small sv40 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 4 | Citation Text: mir-31 metastasis class suppressing suppress 50 | Reference Offset: [818-965', 967-1056', 1687-1768'] | Reference Text: breast patients mir-31 identify metastasis correlates microrna cancer breast mir-31 suppresses metastasis overexpression tumor findings mir-31 metastasis multiple mechanisms | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 12 | Citation Text: activating proposed kill bh3-only bax/bak directly drug considered | Reference Offset: [6957-7134', 26720-26893', 28140-28298'] | Reference Text: member bak responsible activating bh3 bax domain binding bh3-only directly bid bcl-2 activating initiate susceptibility bcl-xl predicted bh3-only require signal apoptotic cooperating activating pockets bh3-only members antiapoptotic intact include | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 4 | Citation Text: genes pitx1 factor endogenous ras transformation bj fibroblasts require regulated activation transcription | Reference Offset: [30639-30789', 400-535', 1276-1406'] | Reference Text: requirement deregulation fibroblasts primary genetically ras sole transformation subsets mutations activating tumorigenesis indicating ras activation occur frequently cancers affects rasal1 target pitx1 finally ras transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 6 | Citation Text: bak peptide synthetic mitochondria leads incubated bax membrane bim release activation cytochrome intact | Reference Offset: [11250-11438', 397-552', 554-708'] | Reference Text: bak hallmark tbid requires mitochondria native presence bax multidomain release 2000 cytochrome intact bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome bak oligomerization domains bh3 capable short bax peptides bim release bid find inducing cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 19 | Citation Text: 10 days transduction rasv12 assessed | Reference Offset: [2825-2977', 3909-4065', 4411-4526'] | Reference Text: model indispensable oncogenic resulted rasv12 transformed ras assay rasv12 representative vector overexpression selected days vector drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 3 | Citation Text: factors numerous metastasis tumor microenvironment outcome growth | Reference Offset: [7189-7357', 29718-30048', 46136-46333'] | Reference Text: stimulation generate normal tissue tumor microenvironment growth signals extracellular loss suppressor tumor signal ras signals signaling factors akt activated phosphatase survival intracellular pten body metastasis tumor mass initially primary invasion cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 17 | Citation Text: initially complex mammalian baf53 baf components swi/snf-like | Reference Offset: [17245-17438', 1098-1279', 3641-3823'] | Reference Text: cellular total complex mammalian baf53 antibodies determine baf components direct work complex swi/snf baf signals signaling membrane mammalian regulation chromatin complex complexes mechanism baf rise family mammalian remodeling group chromatin members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 10 | Citation Text: progression state established phosphorylation rb | Reference Offset: [6121-6466', 10034-10232', 14677-14866'] | Reference Text: cellular proliferation lymphocytes state induction phosphorylated investigate rb primary examined phosphorylation agents differentiation differentiate established effects rb chemical leukemia examined induced lines phosphorylation hr newly differentiation induction established continued 12 rb terminal synthesis phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 14 | Citation Text: responsible differentiation lauro differentiate lack tsh ras recent dose response signaling accepted di generally thyrocytes low | Reference Offset: [6197-6519', 14871-15015', 26802-27051'] | Reference Text: systems essential responsible maintenance differentiation induction understanding finally molecular ras factors oncogenic thyroid mechanisms inducible transcription level markers differentiation increase low ras loss differentiation show ras rat induces level oncogenic thyroid interference cultured low growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 10 | Citation Text: tumor-suppressor deregulation genes uncover inhibitors ras potentially suppressors describe primary fibroblasts pathways sole requirement defined pathway collectively inhibition strategy tumor transformation process p53 p16ink4a identification genetically approach regulate | Reference Offset: [20746-21000', 4659-4886', 6590-6758'] | Reference Text: requirement pathway inhibition ras resulting p53 presence p16ink4a prb additional oncogenes grow overexpression mutant model technology individual pathway neoplastic genes suppressor tumor transformation p53 p16ink4a prb rna combination contribution interference directly p14arf sufficient direct initially p53 prb primary fibroblasts inhibition examined lt transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 11 | Citation Text: preventing membranes oligomerization thymocytes bcl-xl conformational state preferential maintaining mitochondrial bax wild-type binding bh3-only sequestered translocation | Reference Offset: [5432-5670', 28392-28543', 3386-3632'] | Reference Text: preventing bak complexes bcl-xl stable antiapoptotic mitochondrial comparison bcl-2 bax wild-type molecules bh3-only mutant 2001 members activation bak bcl-xl preferential interaction assays antiapoptotic prior bcl-2 proapoptotic bax binding bim intact membranes death stimuli variety mitochondrial response inactive outer bax membrane located 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 14 | Citation Text: aberrant promoter enzymatic mutations deregulation genes lead metabolite tumors isocitrate 2-hydroxyglutarate production dehydrogenase idh2 resulting acute idh1 critical carrying family leukemia recently idh1/2 hypermethylated myeloid members phenotype epigenetic cancers inhibits tet2 tet | Reference Offset: [5121-5475', 5637-5936', 1904-2225'] | Reference Text: cellular enzymatic loss mutations metabolism normal tumors idh2 idh1 selected wild-type idh1/2 suggesting required relevant copy catalyzing enzymatic mutations common tumors idh2 neomorphic idh1 idh1/2 aml feature affecting reduction brain hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 11 | Citation Text: allowed potency inhibitors abl type residue date steric kinase atp advanced domain availability structure gatekeeper ii mutants t315i pocket wild-type target molecules imatinib-resistant inhibitor mutant bind clash design | Reference Offset: [5924-6170', 2966-3266', 3268-3527'] | Reference Text: reveal structure acts gatekeeper mutation abl recent point kinase t315i domain x-ray mutant threonine suggests treatment mutation potential abl clinically second-line clear present kinase patient identification imatinib domain active resistance bcr-abl inhibitor mutant therapy member multi-targeted nilotinib inhibitors abl date second-line dasatinib kinase achieved regulatory family imatinib inhibitor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 4 | Citation Text: t-all cases cortical display phenotype | Reference Offset: [5013-5161', 5563-5761', 5763-6077'] | Reference Text: transcriptional 1996 limited t-all generate remains maintain downstream understanding phenotype subset t-all cases strong receptor activated places reverse cases pediatric pcr translocations locus-specific samples transcriptase analyze t-all oncogene quantitative acting hypothesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 10 | Citation Text: site mutations effects dominant reduce affinity vicinity binding resistance multiple drug | Reference Offset: [5360-5637', 13499-13743', 14249-14438'] | Reference Text: residues mutations change substitutions 13 contact kinase imatinib domain required drug direct sites structure amino conformational include acid led binding based sites mutations contact imatinib atp binding affecting significantly group directly drug site hydrophobic pocket stabilized chain hydrogen atp binding formed group drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 12 | Citation Text: aurora-a lats centrosomal components required | Reference Offset: [1193-1377', 5293-5679', 5827-6018'] | Reference Text: lats2 aurora-a s83 basis localization centrosomal target plays phosphorylation observations aurora-a remains hela regulator mitotic biological component apparatus unclear recruiting required phosphorylation aurora-a additional centrosomal recruitment phosphorylation requires | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 13 | Citation Text: libraries tumor-suppressor genes large-scale screened clear loss-of-function mammalian recently plasmids reports identify establish retroviral involved proteasome screens group approaches shrna | Reference Offset: [726-921', 2451-2823', 3674-3907'] | Reference Text: tumor-suppressor constructs genes uncover absence ras screened transform oncogenic primary introduced library knockdown telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth assay pcr sequencing growing retroviral vector amplified shrna | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 10 | Citation Text: termed involves surface immune immunological receptors contact ligands area synapse multiple activation engagement presented | Reference Offset: [1156-1312', 2462-2800', 3816-3977'] | Reference Text: facilitate area cytoskeleton receptor cd2ap called adhesion receptors contact membranes cd2 interaction helps receptors ligands promote apc tcr cluster molecules dimensions tight central engagement nm binds ligands area range cd2 adhesion participate molecule contact formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 8 | Citation Text: complex isoforms ras signals mitochondria membrane golgi intracellular reticulum compartments endoplasmic | Reference Offset: [4249-4421', 747-1019', 1881-2010'] | Reference Text: membranes k-ras pkc rapid apparatus induced pm translocation golgi included intracellular reticulum endoplasmic region promotes k-ras membranes association bcl-xl show interacts rapid mitochondria polybasic kinase outer membrane pm intracellular phosphorylation methylation association membrane c-terminal isoforms proteolysis ras requires motif | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 8 | Citation Text: rip agents homotypic interaction inhibited motif caspase-8 response kinase binds cytokine interact | Reference Offset: [7798-7934', 1439-1604', 5781-6054'] | Reference Text: rip homotypic rip1 interact interaction rip3 motif essential virus innate rip3 response controls kinase initiating inflammatory cascade programmed necrosis infections rapidly tnf genes identify fadd-deficient jurkat screened response kinase rna undergo library programmed molecules interference necrosis small | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 19 | Citation Text: treatment rasv12 resulting response system stabilized p53 experiment activated alterations | Reference Offset: [22573-22780', 1687-1824', 6760-6899'] | Reference Text: pathway activates induce stress rasv12 response p53 oncogenic suggesting manner p14arf p53 prb genetic suppressor tumor pathways alterations cancers system p53 prb rna interfering suppress stably | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 1 | Citation Text: short designed previous oncogenes genes primary genetically suppressor tumor transformation | Reference Offset: [5446-5821', 12167-12374', 15048-15235'] | Reference Text: cellular anchorage-independent proliferation hallmark measured express transformation models oncogenes vitro subsequently recently primary acting viral culture pathway suppressor ii epithelial tumor type transformation transforming receptor growth screen genes suppressor candidate tumor transformation represent critical oncogenic negative pathways cancer regulators | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 14 | Citation Text: neoplastic uncover genes recently suppressor tumor assays transformation | Reference Offset: [12167-12374', 15048-15235', 33781-33944'] | Reference Text: pathway suppressor ii epithelial tumor type transformation transforming receptor growth screen genes suppressor candidate tumor transformation represent critical oncogenic negative pathways cancer regulators model actively genes context suppressor established tumor transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 16 | Citation Text: signaling activates apoptosis cascade genes downstream induction rip1 necrosis | Reference Offset: [815-1123', 3059-3251', 39311-39545'] | Reference Text: screen apoptosis set genes identify sirna rip1 necroptosis subset kinase involved and/or downstream act required genome-wide regulators regulate kinase apoptosis death induction rip1 receptors death rip1 mediating gaps involved signaling mediate downstream types multiple regulate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 8 | Citation Text: cloned duplexes vector sirna lentiviral | Reference Offset: [653-831', 6106-6278', 8457-8605'] | Reference Text: inactivation down-regulation vector mediated genes functional sirna show resulting targeted vector sirna synthetic survival profile transcript designed system test vector sequence target sirna synthetic psuper | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 2 | Citation Text: respiratory chain natural production mitochondrial represent | Reference Offset: [3121-3398', 8397-8547', 12437-12664'] | Reference Text: cellular evaluate ros oxidative stress production mitochondrial response major chain molecules manner stable energy mitochondrial cytochrome ros oxidative production mitochondria chain increase approach phosphorylation based cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 10 | Citation Text: kras oncogenic functional dependent mutant appears | Reference Offset: [1250-1525', 3569-3694', 9755-9913'] | Reference Text: c-raf therapeutic prevents dependent normal adult mice nsclc target k-ras-driven initiation information mediate signaling oncogenic pathways ras cancer erk single development erk2 erk1 observations process sufficient kinase nsclc signaling oncogenic initiate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 11 | Citation Text: plates grown pre-mirna repression ng 500 | Reference Offset: [42784-42972', 6456-6611', 10970-11100'] | Reference Text: product ng pcr 500 cases pre-mirna indicating detected mirnas accumulation screen presence grown absence rasv12 flow weeks | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 4 | Citation Text: subset mice host vitro pancreatic require lines survival cancer growth | Reference Offset: [522-707', 7162-7370', 11325-11564'] | Reference Text: k-ras shrnas mutations maintain lung viability pancreatic lines require cancer lung adenocarcinoma pancreatic lines significantly low suppressor regulator tumor related striking signaling pancreatic akt lines negative cancer pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 4 | Citation Text: gfpt1 rnai reduced vitro importantly blocked tumor knockdown vivo growth | Reference Offset: [15379-15605', 15607-15833', 21995-22378'] | Reference Text: tumor gfpt1 level reduced knockdown consistent tumor inhibited suppressed gfpt1 xenograft knockdown vivo growth flux suppresses enhanced dramatically glucose decreased importantly tumor knockdown reflect | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 20 | Citation Text: transcriptional regulatory genes circuitry microrna protein-coding group escs | Reference Offset: [933-1241', 2298-2418', 2792-2998'] | Reference Text: genes circuitry protein-coding mirna promoters sequencing transcriptional short regulatory identification transcripts describe chip-seq quantitative types es multiple based model regulatory generate genes circuitry protein-coding mirna es cellular development therapeutic differentiation circuitry potential understanding transcriptional regulatory es early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 12 | Citation Text: breast patient decreased reduced ovarian correlates inpp4b survival cancers | Reference Offset: [18245-18453', 19845-20070', 1429-1694'] | Reference Text: involvement loss decreased correlates inpp4b occurs cancers basal-like breast patient heterozygosity ovarian locus survival frequently decreased inpp4b cancers breast findings patient ovarian correlated investigated low survival based fraction lower majority suppressor finally tumor inpp4b cancers breast basal-like patient ovarian correlated suggesting locus survival find | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 3 | Citation Text: kras occupied gtp-bound genes resulted tumor rock finally rho-related striking surprisingly kinase involved signaling wild-type downstream gata2 active reduction pathways mutant knockdown rho | Reference Offset: [33212-33359', 35807-35950', 36319-36620'] | Reference Text: rho-related occupied signaling numerous gata2 pathways mutant wt striking lung gtp-bound gata2 mutant knockdown rho cancer triggered wt substrate suppressed lung signaling marker chain myosin downstream gata2 mutant knockdown phosphorylation rho cancer activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 24 | Citation Text: bj receptor primary fibroblasts ecotropic | Reference Offset: [7161-7453', 16366-16613', 28380-28575'] | Reference Text: virus ecotropic selected subsequently receptor vector fibroblasts encoding polyclonal drug population inhibition alter contrast level bj p16ink4a primary fibroblasts low growth p14arf obtained 10% 22 fcs skin dmem 5% bj fibroblasts primary | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 8 | Citation Text: pluripotent type differences fate distinct activate pluripotency underlying transcription cellular networks commitment properties molecular transcriptional models factors program stem mechanisms | Reference Offset: [6952-7314', 1591-1872', 7316-7608'] | Reference Text: sites mouse provide location mirna factor sequencing mirnas fate transcriptional regulatory start program primary quantitative types es mechanisms transcription cellular contributes model reveal differentiation normal circuitry mirna mirnas factors regulatory promote program es self-renewal targets key transcription cellular model post-transcriptional differentiation circuitry understanding mirnas molecular transcriptional regulatory mediated pluripotency regulation core es early produce | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 10 | Citation Text: apoptosis genes bh3 plays interacting regulates antiapoptotic bcl-2 mitochondria initiating p53 leading bax cascade domain bh release cytochrome | Reference Offset: [397-552', 6474-6629', 8919-9027'] | Reference Text: bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome targeting bh3 tbid wt comparison mitochondria domain required mutant release intact cytochrome peptide bcl-xl domain bh3 derived release antiapoptotic cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 9 | Citation Text: lats2 recently functional approaches mir-372 interactions cancer | Reference Offset: [32174-32393', 34136-34379', 33539-33771'] | Reference Text: lats2 expressing possibility p53kd wt investigate controls mir-373 vector cluster mutant mir-372 suppress processes direct lats2 proliferation effects point mir-373 tumorigenicity mediator mir-372 sites mcf-7 lats2 potent expressing inhibition luciferase mediated target significantly construct mir-372 mutated | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 9 | Citation Text: newly mouse essential development germ differentiation conserved protecting mitotic mirna-mediated arrest mrnas rna repression binding primordial dead zebrafish end regulate | Reference Offset: [1248-1543', 6041-6194', 1646-1748'] | Reference Text: sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding prohibits inhibition germ primordial show dead zebrafish end rbp mirna-mediated mrnas dnd1 repression protecting | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 2 | Citation Text: cycle modulate lats2 acts progression inhibiting transition g1/s | Reference Offset: [1345-1448', 2144-2206', 15014-15149'] | Reference Text: lats2 cycle ectopic demonstrated transition g1/s inhibited profile lats2 cycle suppressor transition tumor g1/s steady-state cycle lats2 inhibits virus transition g1/s | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 9 | Citation Text: bcl-2 apoptosis family outcome members signals | Reference Offset: [5720-5876', 48997-49246', 51056-51293'] | Reference Text: bcl-2 commitment apoptosis family momp bh3-only interact members antiapoptotic investigate model bak apoptosis exclusively inhibition interacting antiapoptotic present bcl-2 proapoptotic bax family bh3-only multidomain members preventing model bak apoptosis tbid antiapoptotic bcl-2 sequestering family activator inhibit consistent required activation members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 21 | Citation Text: cytotoxic cd4+ surface cd8+ cx3cr1 demonstrated monocytes nk | Reference Offset: [23900-23992', 38832-39047', 4906-5123'] | Reference Text: cd4+ cd8+ monocytes surface added assay express 5% fractalkine cd8+ receptor approximately nk migration functional leukocytes mediate fractalkine receptor identification report cx3cr1 adhesion directly monocytes nk high-affinity | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 4 | Citation Text: apl pod-associated | Reference Offset: [979-1108', 1110-1204', 1726-2086'] | Reference Text: pattern disrupted apl pod pml generate treatment pods triggers apl product retinoic acid receptor genes fusion chimeric translocation apl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 15 | Citation Text: inactivation ptpn12 likewise inhibitors suppressor tumors tumor frequent kinases tyrosine phosphatase derived multiple sensitive | Reference Offset: [1956-2297', 884-981', 1633-1885'] | Reference Text: ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer tyrosine screen ptpn12 genetic identify suppressor phosphatase tumor ptpn12 targeting provide collectively identify suppressor tumor cancers kinases tyrosine inactivated based profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 9 | Citation Text: cellular member functions ptpn12 selective numerous suppressor tumor diseases tyrosine dysregulation recently phosphatases regulate | Reference Offset: [884-981', 1633-1885', 4182-4396'] | Reference Text: tyrosine screen ptpn12 genetic identify suppressor phosphatase tumor ptpn12 targeting provide collectively identify suppressor tumor cancers kinases tyrosine inactivated based profile serve play tumor suppression tyrosine signaling phosphatases phosphorylation regulate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 16 | Citation Text: chemokine immune innate endothelial predominantly interacts membrane-bound fractalkine receptor activated cx3cr1 cognate killer natural | Reference Offset: [1183-1290', 37770-37989', 921-1181'] | Reference Text: migration fractalkine respond cx3cr1 adhesion killer express predominantly natural chemokine expressing capable fractalkine receptor mucin domain cognate adhesion consistent linked inducing termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 16 | Citation Text: ros source chain intracellular production major mitochondrial considered | Reference Offset: [3121-3398', 228-370', 8869-8995'] | Reference Text: cellular evaluate ros oxidative stress production mitochondrial response major postulates oxygen species theory production free intracellular reactive radical major aging sites ros superoxide pathways iii production major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 7 | Citation Text: complex association baf induces stimulation antigen swi/snf-like chromatin 2001 | Reference Offset: [506-609', 40884-41242', 6513-6690'] | Reference Text: complex signaling association receptor baf antigen chromatin rapid find induces complex complexes targeting observation baf stimulation 10 time receptor increase antigen required synthesis chromatin activation stably transcription stimulation 10 complex antibody receptor baf antigen nucleus | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 7 | Citation Text: cd2ap thought stabilize contacts | Reference Offset: [1924-2009', 4947-5212', 9143-9317'] | Reference Text: initiate mechanisms contact stabilize generate larger cd2 interaction contact stabilize tcr molecules plated dependent prior contacts stimulation t-cell receptor formed activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 6 | Citation Text: lats2 controls cycle lats1 progression apoptosis | Reference Offset: [1976-2141', 5828-5941', 6130-6297'] | Reference Text: cycle lats2 model lats1 proliferation finally regulating negatively propose mammalian combination lats2 cycle lats1 development roles play unclear tumor g2/m controls lats2 lats1 regulating negatively proliferation interestingly transition g1/s | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 14 | Citation Text: hyperphosphorylated mitosis newly previous rb presence late g1 fully dephosphorylated | Reference Offset: [16468-16630', 14677-14866', 14207-14372'] | Reference Text: treatment induced differentiate suggesting fully phosphorylation dephosphorylated rb hr newly differentiation induction established continued 12 rb terminal synthesis phosphorylation hr newly differentiation 16 synthesis decrease rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 3 | Citation Text: cyclin degradation essential skin proteolytic d1 present 286 presence require threonine phosphorylation | Reference Offset: [14491-14651', 3103-3229', 37123-37347'] | Reference Text: cyclin d1 leads 286 degradation pathway threonine phosphorylation activation cyclin ubiquitination d1 286 degradation nuclear triggers threonine cyclin newly genotoxic destruction stress rxxl motif requires signals d1 286 mediated phosphorylation threonine mitogenic | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 10 | Citation Text: promoter element mir-223 characterized lineage conserved preferential shows general distinct regulatory myeloid consistent | Reference Offset: [15059-15340', 622-782', 1371-1574'] | Reference Text: region sites promoter mir-223 constructs mir-126 induction made putative analyze involved order binding myeloid coding transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show mir-223 nfi-a crucial pathway lineage plays granulopoiesis molecular mediating point repression | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 3 | Citation Text: oct4 genes induce differentiation mirnas nanog resulting transcriptional sox2 mediated pluripotency regulation silencing ability | Reference Offset: [7316-7608', 24198-24465', 26197-26490'] | Reference Text: cellular model post-transcriptional differentiation circuitry understanding mirnas molecular transcriptional regulatory mediated pluripotency regulation core es early produce cellular oct4 occupied differentiation mirna tcf3 promoters mirnas nanog abundant sox2 es early silenced methylation oct4 genes maintain differentiation mirnas transcriptional dna pluripotency es | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 13 | Citation Text: support cases treatment larger prognosis distinct subsets genetic associations improvement correlated alterations confirm | Reference Offset: [34701-34953', 1281-1501', 5163-5400'] | Reference Text: result cases treatment studied patients additional profiles confirm lyl1 treatment tal1 prognosis response surprisingly findings importance significantly clinical activation strategies development drugs treatment thymocytes depend molecular tal1 effective t-all insights improvement developing oncoproteins pathways | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 2 | Citation Text: upregulation inpp4b prior akt loop negative knockdown suppress activation | Reference Offset: [16503-16596', 21716-22005', 772-1021'] | Reference Text: suppressed form akt inpp4b knockdown activation insulin play tumor inpp4b effects indicating enhanced response signaling pi3k suppressors phosphatases akt roles downstream knockdown activation pten 4-phosphatase anchorage-independent resulted ii epithelial inositol type enhanced polyphosphate knocking akt motility report knockdown activation growth pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 6 | Citation Text: critical degradation events subsequent differentiation induction apl formation | Reference Offset: [6760-7052', 979-1108', 1110-1204'] | Reference Text: suggests patterns localization treatment differentiation normal rara pml presence oncogenic fusion reversed atra therapy apl pattern disrupted apl pod pml generate treatment pods triggers apl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 4 | Citation Text: sufficient contrast response mitochondria previous hands momp prevent abt-737 formation observations | Reference Offset: [23082-23300', 23641-23830', 21611-21741'] | Reference Text: induce inhibition sufficient mitochondria bcl-2 peptides release note cytochrome bcl-2 mitochondria upstream oligomerization apoptosis bax inhibition bh3 bad abt-737 sufficient mitochondria apoptosis advanced due wt 12 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 13 | Citation Text: kras mutations common mediates effects tumor ras oncogenic ral pi3k effector active raf cancer formation | Reference Offset: [5249-5420', 44042-44219', 1685-1888'] | Reference Text: erk essential development mutations tumor kinases investigate mice carrying encoding raf end mek erk k-ras absence tumor kinases signaling mediate oncogenic suggesting raf phosphorylation appeared druggable k-ras development individual tumor contribute kinases signals cascade raf | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 14 | Citation Text: metastatic events effects steps invasion-metastasis colonization mir-31 cascade invasion local multiple early vivo | Reference Offset: [14197-14359', 19695-19883', 1201-1487'] | Reference Text: affects events metastatic effects influences colonization size mir-31 invasion local early affects mir-31 events metastatic ectopic invasion extended local demonstrating early colonization site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 17 | Citation Text: suggests mammalian profiling functionally validated targets genome-wide | Reference Offset: [25085-25419', 23833-24155', 1591-1872'] | Reference Text: promotes suggests contributes degradation development additionally mirna rapid transcripts family mrna mammalian zebrafish early direct reveal pluripotent development contribute mirnas mammalian group es targets key silenced cellular contributes model reveal differentiation normal circuitry mirna mirnas factors regulatory promote program es self-renewal targets key transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 10 | Citation Text: markers differentiated transition tumors poorly exhibited zeb1 undifferentiated increase consistent | Reference Offset: [27204-27481', 29090-29288', 27088-27202'] | Reference Text: k-ras genes differentiated differentiation state classified epithelial tumors predominantly ras demonstrating dependency findings consistent mutant culture signature model mouse differentiated tumors ductal integrin analyzed pancreatic k-ras-driven cancer dependency k-ras exhibited classified tumors low mutant ras | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 13 | Citation Text: nilotinib inhibitors interestingly class iii dasatinib receptor imatinib cluster kit | Reference Offset: [26575-26788', 32712-32907', 31580-31917'] | Reference Text: sensitivity chromosome related tyrosine kinase patients imatinib domain bcr-abl group kit assessed development status inhibitors mutation cml kinase selected patients imatinib undergo domain bcr-abl treated generation preventing mutations inhibitors abl conformation mutants kinase imatinib domain binding resistance bind 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 13 | Citation Text: lats2 lats1 anchorage-independent 36 25 inhibits 30 dramatically overexpression lines | Reference Offset: [26106-26272', 1151-1343', 1976-2141'] | Reference Text: lats2 cycle lats1 due possibility lines effects lats2 nude assay proliferation development suppresses tumors mice inhibits vitro ectopic cycle lats2 model lats1 proliferation finally regulating negatively propose mammalian combination | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 3 | Citation Text: implicated chromatin/nuclear mammalian baf53 matrix binding subunits | Reference Offset: [27246-27368', 812-943', 3573-3639'] | Reference Text: brg1 chromatin/nuclear actin association baf53 matrix stable induces actin-related complex peptide baf53 revealed subunits sequencing complex mammalian subunits families | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 1 | Citation Text: reveal therapeutic select genes lineage differentially differentiation predicted difficult stage differences leukemias reflect substantial targets portion | Reference Offset: [17082-17348', 33084-33194', 36875-37236'] | Reference Text: differentiation cd2 cortical upregulation tal1 stage contrast lck pattern late reflect appeared thymocyte oncogenes activated differentiation differences reflect stages thymocyte genes identify thymocytes differentiation normal leukemic developmental stage stages transformation subsets transcriptional arrest profiles directly linked reflect specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 13 | Citation Text: kras proliferation revealed lethal synthetic candidate recently screens lines knockdown mutant cancer suppress genome-wide shrna interactions appeared | Reference Offset: [5392-5584', 9164-9309', 4241-4507'] | Reference Text: suppression k-ras level reduced correlated h358 lines knockdown shrna growth classified due lines knockdown targets shrna k-ras requirement basis maintaining dependency sustained stratify viability features lines mutant large cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 5 | Citation Text: arrested t-all normal differentiation group leukemias acute stages heterogeneous | Reference Offset: [26151-26306', 16000-16133', 23911-24150'] | Reference Text: t-all normal comparable indicating low overexpressed group samples leukemias thymus t-all recognized differentiation profiles samples stages thymocyte development markers differentiation leukemias stages arrest bone myeloid consistent early marrow thymus | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 9 | Citation Text: myeloid-specific expected system mir-223 mouse characterized regulatory highly conserved suggesting | Reference Offset: [622-782', 19151-19380', 28036-28223'] | Reference Text: transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show mir-223 nfi-a sequences predicted factor related regulatory bind targets transcription mir-223 rnai nfi-a differentiation circuitry transcriptional factors order regulatory utilized | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 13 | Citation Text: necroptosis level crucial apoptosis rip3 appears | Reference Offset: [826-966', 4420-4544', 6315-6456'] | Reference Text: screen tnf crucial rna programmed induced infection virus activator interference necrosis rip3 kinase upstream crucial activating report programmed necrosis rip3 regulates level programmed sirna rip1 necrosis rip3 comparable | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 10 | Citation Text: represents development leading neoplastic genetic events emergence epigenetic phenotype tumorigenic | Reference Offset: [3182-3432', 3677-4023', 32947-33245'] | Reference Text: difficult transformation transform genetic introduced require cultured rodent tumorigenic development normal tumor type cancers observations process models leads advantage analogous genetic cancer growth animal essential development progression immortalized state potential tumor phenotype malignant acquired suggesting types culture vivo growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 2 | Citation Text: response cellular involves radiation p53 reduced cdc6 ionizing | Reference Offset: [5943-6080', 918-1028', 11378-11564'] | Reference Text: response radiation p53 pathway dna activated induced damage ionizing factor transcription response cellular p53 arrest genotoxic apoptosis stress suppressor tumor activation growth stabilization resulted higher damage line dose activate response 20 p53 down-regulation dna cdc6 required cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 14 | Citation Text: subset receptor mediates cx3cr1 binding chemotaxis | Reference Offset: [759-919', 6075-6271', 5713-5845'] | Reference Text: migratory functions fractalkine receptor identify mediates seven-transmembrane show high-affinity lymphocytes experiments fractalkine receptor respond binding monocytes experiments fractalkine receptor binding soluble | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 18 | Citation Text: sufficient p53 oncogenic overcome stress published p14arf | Reference Offset: [10186-10310', 18995-19163', 22573-22780'] | Reference Text: sufficient p53 loss oncogenic primary overcome ras-induced stress contrast single p16ink4a loss prb oncogenic overcome ras-induced stress p14arf pathway activates induce stress rasv12 response p53 oncogenic suggesting manner p14arf | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 8 | Citation Text: cytoskeletal cd2ap cytoplasm remodeling localized | Reference Offset: [774-937', 939-1154', 3090-3185'] | Reference Text: process demonstrate cytoskeletal cd2 ligand adhesion molecule engagement clustering cytoskeletal cd2 dependent domain interaction cytoplasmic required clustering critical area cytoskeletal polarity contact formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 9 | Citation Text: screen complex cyld scored genes sirna l929 hit necrosis knockdown required prevented formation | Reference Offset: [815-1123', 4029-4204', 5204-5317'] | Reference Text: screen apoptosis set genes identify sirna rip1 necroptosis subset kinase involved and/or downstream act required genome-wide regulators regulate screen genes functional sirna mechanism molecular necroptosis carrying required explored genome-wide necroptosis l929 scored genes required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 9 | Citation Text: complex baf53 baf | Reference Offset: [17245-17438', 22609-22688', 24247-24479'] | Reference Text: cellular total complex mammalian baf53 antibodies determine baf components brg1 complex presence association baf53 baf requires complex test assembly baf53 antibodies determine baf possibility brg1 transfected mediate vector | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 12 | Citation Text: kras acts agents mutation lethal kill recent gata2 mutant knockdown specifically | Reference Offset: [62289-62576', 3713-3872', 7126-7189'] | Reference Text: kras screen mutations lethal synthetic receptors recent lung earlier adenocarcinoma receptor mutant required multiple cancer specifically kras initial screens lethal synthetic mutant regulators shrna mitotic specifically kras nsclc gata2 require mutant survival specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 7 | Citation Text: characterized numerous metastasis tumor rhoa mirnas surprisingly downstream functionally invasion effectors relevant regulators | Reference Offset: [27501-27621', 588-816', 1201-1487'] | Reference Text: itga5 vitro rdx mir-31 functionally effectors rhoa relevant malignant fzd3 repress genes numerous metastasis tumor steps invasion-metastasis potentially micrornas cascade target capacity multiple regulate site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 5 | Citation Text: cd2 demonstrated enhanced contact leads signaling recently tcr clustering | Reference Offset: [4823-4945', 8749-8867', 9386-9533'] | Reference Text: serve recruit surface cd2 tcr contact clustering center cd2 demonstrated accumulation contact engagement basis cd2 domain determine cytoplasmic required molecular contact formation clustering | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 13 | Citation Text: alteration pathway pik3ca inpp4b frequency considered implicated regulatory pi3k phosphatases recently regulation subunits alterations pten | Reference Offset: [21716-22005', 25132-25392', 4481-4583'] | Reference Text: insulin play tumor inpp4b effects indicating enhanced response signaling pi3k suppressors phosphatases akt roles downstream knockdown activation pten result pathway inpp4b knocking findings pi3k senescence increase consistent knockdown pten model signaling roles downstream regulation class inpp4b indicating pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 11 | Citation Text: amplification mutation prevent occurs kinase patient relapse domain binding due fusion bcr-abl inhibitor | Reference Offset: [24084-24262', 1607-1748', 9967-10117'] | Reference Text: amplification evidence mutation kinase patient relapse domain bcr-abl based note amplification patients mutation resistance due bcr-abl clinical inhibitor small clones kinase independent time patient treatment imatinib domain mutation bcr-abl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 7 | Citation Text: rtk ptpn12 range epithelial observations led mammary increase knockdown phosphorylation | Reference Offset: [20990-21077', 983-1066', 4629-4747'] | Reference Text: her2 ptpn12 led increase depletion phosphorylation egfr ptpn12 proliferation suppresses mammary epithelial transformation leads ptpn12 loss mammary epithelial activation transformation malignant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 4 | Citation Text: rapidly phosphatases produces possibility inpp4b | Reference Offset: [6085-6199', 5940-6083', 8011-8152'] | Reference Text: systems epithelial possibility inpp4b knockdown retroviral investigate signaling pi3k suppressor possibility inpp4b tumor affecting vivo observations rapidly expressing directed inpp4b shrna pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 8 | Citation Text: libraries model targeting genes uncover change functional issue date rna suppressor tumor interference large | Reference Offset: [6605-6821', 15583-15681', 31490-31754'] | Reference Text: screen tumor-suppressor neoplastic genes inhibition ras assays transformation vitro oncogenic rna combination library interference prostate result evidence suppressor pitx1 tumor relevant cancer screen model identify evidence tumor transformation prostate suppressors fibroblasts susceptibility relevant cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 10 | Citation Text: region lymphoblastic promoter block chromosome stage acute resulting initially patients receptor leukemia cases pediatric adult places transcriptional t-all 30% translocation coding | Reference Offset: [3004-3148', 5563-5761', 1806-2013'] | Reference Text: lymphoblastic cases thymocytes pediatric leukemia adult disease malignant acute subset t-all cases strong receptor activated places subtypes lymphoblastic lineage line pathogenesis molecular research impact leukemias acute remain undefined largely leukemia | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 16 | Citation Text: knocking led reduced resulted suppressor overexpression epithelial suggesting inpp4b tumor growth | Reference Offset: [1023-1105', 1429-1694', 11791-11879'] | Reference Text: xenograft experiments reduced resulted overexpression inpp4b tumor growth fraction lower majority suppressor finally tumor inpp4b cancers breast basal-like patient ovarian correlated suggesting locus survival find model mouse xenograft reduced overexpression tumor inpp4b growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 13 | Citation Text: immune death genes revealed innate necrotic screens infections viral | Reference Offset: [571-813', 1125-1340', 4206-4477'] | Reference Text: termed activates death dependent rip1 receptors type apoptotic conditions necroptosis stimulation kinase necrotic systems cellular immune sensitivity genes innate show network subsets mediating necroptosis extensive signaling regulated cellular suggests pathway apoptosis innate potential disease necroptosis critical regulatory genetic necrotic profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 1 | Citation Text: plasma budding interestingly class particle hiv-1 event membrane recently vps topology utilize case viral formation | Reference Offset: [1266-1473', 3472-3647', 24653-24912'] | Reference Text: actively plasma gag assembly hiv-1 membrane enveloped viral cellular membranes budding virus create discrete event membrane enveloped viral p6 demonstrate pathway gag budding block particle hiv-1 experiments domain require components consistent viral release | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 13 | Citation Text: ptpn12 development mutations events impact potentially tyrosine involved dna phosphatase fusion driver cancer | Reference Offset: [884-981', 1956-2297', 4479-4627'] | Reference Text: tyrosine screen ptpn12 genetic identify suppressor phosphatase tumor ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer tyrosine screen ptpn12 suppressors functional phosphatase tumor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 3 | Citation Text: cd2 linked | Reference Offset: [12901-13076', 43996-44218', 774-937'] | Reference Text: processes suggests residues cd2 cytoplasmic t-cell 20 domain required linked clustering sensor residues chip peptide cd2 linked process demonstrate cytoskeletal cd2 ligand adhesion molecule engagement clustering | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 14 | Citation Text: sustained presence tumorigenicity proliferation oncogenic major signals | Reference Offset: [4958-5368', 15034-15195', 16440-16509'] | Reference Text: tissue sustained programmed invasion essential collectively death metastasis potential malignant signals alterations cancer growth mass proliferation tumor components carcinoma growth signals proliferation block mechanisms signals distinct | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 5 | Citation Text: reports p16ink4a remain senescence extended | Reference Offset: [21249-21466', 320-411', 742-903'] | Reference Text: resistant normal mutation ras-induced p53 p16ink4a fibroblasts report senescence premature p14arf p53 p16ink4a prb inhibit growth p14arf suppression contrast cellular p53 p16ink4a proliferation loss affect transformation growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 9 | Citation Text: development metastatic papillary response breast prostate implicated mir-146b and/or mir-146a thyroid pancreatic ovarian cervical proliferative binding cancer carcinoma | Reference Offset: [18627-18941', 22218-22290', 21822-22147'] | Reference Text: decreased papillary appears prostate level thyroid mir-146a lines lymphoma cancer carcinoma tissues mir-146b thyroid highly papillary carcinoma mir-223 targeting development apoptosis chronic mutation mir-155 implicated mir-146a leukemia cervical lymphocytic cancer regulate tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 4 | Citation Text: member intriguingly apoptosis death factor necroptosis bcl-2 proapoptotic family suggesting required members | Reference Offset: [1342-1444', 27683-27912', 36489-36603'] | Reference Text: member necroptosis bcl-2 family interestingly bh3-only required member importantly necroptosis bcl-2 family induced required necroptosis member bcl-2 family induced required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 1 | Citation Text: short designed previous oncogenes genes primary genetically suppressor tumor transformation | Reference Offset: [30639-30789', 1891-2111', 2451-2823'] | Reference Text: requirement deregulation fibroblasts primary genetically ras sole transformation system essential development vitro neoplastic tumorigenesis primary alterations transformation telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 14 | Citation Text: oncogenes suppressors demonstrated tumor act mirnas | Reference Offset: [5015-5142', 935-1177', 1316-1547'] | Reference Text: screen system model oncogenes genetic identify tumorigenesis functional act mirnas cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 provide development pathway evidence germ potential tumors mirnas testicular p53 presence oncogenes wild-type tumorigenic growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 5 | Citation Text: previous aspects analyses molecular | Reference Offset: [1371-1574', 2644-2779', 6034-6162'] | Reference Text: mir-223 nfi-a crucial pathway lineage plays granulopoiesis molecular mediating point repression systems differentiation molecular mechanisms formation point findings mir-223 nfi-a crucial circuitry granulopoiesis molecular | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 8 | Citation Text: subtypes classification profiling potential demonstrated clinically relevant recent | Reference Offset: [29059-29135', 37239-37389', 1503-1627'] | Reference Text: t-all subgroups profiling clinically t-all identify subgroups profiling relevant leukemia pathways profiles relevant transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 4 | Citation Text: analyzed primer nm | Reference Offset: [11336-11551', 11144-11334', 11704-11968'] | Reference Text: percentage analyzed measured line oncogene clones screening analyzed western quantitative positive ras individual establish oncoprotein ras clear oncogenes analyzed examined decrease elevated | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 8 | Citation Text: rgl family domains ralgef binding ras ralgds rgl2/rlf members | Reference Offset: [3161-3441', 6809-6935', 8284-8576'] | Reference Text: rgl family ralgef domain binding effectors ras rgl2/rlf ralgds members residues involved catalytic domain binding factor part ras ralgds exchange northern mouse pattern development absence family ralgef ralgds members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 7 | Citation Text: ablation development tumors h-ras ralgds reduced induced critically depends rac animal | Reference Offset: [11993-12188', 26721-26861', 528-640'] | Reference Text: mice development reduced reflected wild-type resistance tumor papillomas animal mice deficient p53 ablation tumors incidence ralgds affect mouse development ras-induced plays show ralgds substantial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 13 | Citation Text: k-ras outer membrane detected mitochondrial | Reference Offset: [4423-4576', 36352-36535', 747-1019'] | Reference Text: surprisingly k-ras membranes outer membrane bcl-xl phosphorylated included mitochondrial k-ras basis phosphorylated affinity mitochondrial presence outer membrane reflect region promotes k-ras membranes association bcl-xl show interacts rapid mitochondria polybasic kinase outer membrane pm intracellular phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 15 | Citation Text: previous genes suppressor class tumor suggested cancer | Reference Offset: [1429-1694', 1717-1978', 5940-6083'] | Reference Text: fraction lower majority suppressor finally tumor inpp4b cancers breast basal-like patient ovarian correlated suggesting locus survival find cellular aberrant proliferation progression apoptosis genes suppressor epithelial tumor tumors resulting oncogenes alterations generation multiple signaling pi3k suppressor possibility inpp4b tumor affecting vivo observations | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 2 | Citation Text: conformation mirnas close contrast fact factors pattern chromatin bound transcription | Reference Offset: [13557-13802', 1243-1436', 1591-1872'] | Reference Text: occupied set genes protein-coding promoters mirnas 20 factors mammalian bound key transcription factors set genes mirna promoters mirnas es find key transcription cellular contributes model reveal differentiation normal circuitry mirna mirnas factors regulatory promote program es self-renewal targets key transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 12 | Citation Text: sites termed mirna regions mrnas target binding silencing inhibit dead untranslated end | Reference Offset: [1248-1543', 833-984', 1125-1246'] | Reference Text: sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding mammals mrnas sequence seed inhibit nucleotides untranslated mirnas regions serve docking mrnas conserved mirna regions | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 4 | Citation Text: transiently lats2 centrosomes exogenous localized | Reference Offset: [909-1046', 27361-27668', 461-559'] | Reference Text: centrosomes transiently lats2 cycle aurora-a interacts lats2 reports aurora-a previous interphase mitotic localized centrosomes early mitosis lats2 lats1 apparatus phosphorylated mitotic localized | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 8 | Citation Text: cycle g1 required phase rb retinoblastoma | Reference Offset: [8850-8995', 16295-16466', 17559-17701'] | Reference Text: cycle loss phosphorylated phase primarily rb transiently cycle events late state phase phosphorylation early rb cycle typical late target phase occurs rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 1 | Citation Text: predict genes target mirna targetscan | Reference Offset: [6961-7319', 21274-21513', 632-862'] | Reference Text: identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions mouse defined set seed conserved targetscan mirna rat algorithm predict hypothesis targets region sites genes conserved mirna mirnas regulatory mrnas predict complementary target pairing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 19 | Citation Text: prs-gfp pmscv-gfp-st | Reference Offset: [391-540', 542-668', 670-777'] | Reference Text: mutations activating thyroid ras cancer carcinoma thyroid differentiated phenotype aggressive cancer likewise loss oncogenes thyroid differentiation frtl-5 viral ras rat | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 6 | Citation Text: cyclin complex machinery degraded stress anaphase-promoting rxxl proteolysis motif response d1 sequence located pest proteasome active binding case part | Reference Offset: [19253-19446', 14414-14490', 16307-16434'] | Reference Text: cyclin result degradation genotoxic stress rxxl motif sufficient response d1 mediate context cyclin d1 degradation genotoxic stress destruction rxxl requires motif cyclin d1 amino sequence g1 cyclins rxxl motif comparison | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 12 | Citation Text: cycle mutations ruley absence suppressor tumor ras variety induces arrest cooperating oncogenic ectopic senescence overexpression types | Reference Offset: [5146-5319', 11984-12174', 15677-15795'] | Reference Text: cellular demonstrate ras induces p53 arrest oncogenic senescence involving characterized suppressor induction tumor ras p53 arrest oncogenic induced g1 specifically arrest oncogenic identical senescence induced ras | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 3 | Citation Text: mutations exclusive redundant mechanism effects large-scale acute showed time mutually genomic tet2 leukemia involving functionally suggesting types | Reference Offset: [48354-48534', 1349-1571', 27892-27957'] | Reference Text: mutations exclusive redundant lesions mutually tet2 genetically idh1/2 aml suggesting large mutations exclusive epigenetic defects mutants enzyme mutually loss-of-function tet2 idh1/2 aml mutually mutations exclusive tet2 idh1/2 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 9 | Citation Text: microarrays recently global profile cancers | Reference Offset: [809-1015', 1212-1299', 4906-5249'] | Reference Text: microarrays genes pediatric profiling determine leukemic enhance analyze patients pattern unique based profile mll rearrangements patients recently leukemia similarly poor outcome subtype hematopoietic stem | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 15 | Citation Text: cycle senescent investigate p53 arrest induced senescence required depletion shrna | Reference Offset: [20286-20689', 534-623', 2686-2872'] | Reference Text: result overcome derivatives ras showed observations response arrest bj fibroblasts premature previous expressing ras-induced phenotype indicating defective arrested p53 prb senescence binding mutant inactivation p53 prb show required transformation mouse subsequent upregulated embryonic ras response arrest oncogenic primary fibroblasts required growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 2 | Citation Text: expected sensitivity cx3cr1 abolished chemotaxis triggered | Reference Offset: [9505-9711', 9428-9503', 11370-11541'] | Reference Text: v28 migration transfected fractalkine vector soluble chemotaxis fractalkine induction chemotaxis soluble transduction abolished signal indicating | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 6 | Citation Text: lats2 contributes aurora mitotic size centrosomes entry increase capacity recruiting | Reference Offset: [27361-27668', 461-559', 909-1046'] | Reference Text: lats2 reports aurora-a previous interphase mitotic localized centrosomes early mitosis lats2 lats1 apparatus phosphorylated mitotic localized centrosomes transiently lats2 cycle aurora-a interacts | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 13 | Citation Text: mammals complexes actin similarly state stimulation activate receptor suggesting remodeling required molecule chromatin large transcription | Reference Offset: [40884-41242', 4304-4577', 6101-6336'] | Reference Text: complex complexes targeting observation baf stimulation 10 time receptor increase antigen required synthesis chromatin activation stably transcription structure complexes clear factors vitro binding remodeling chromatin vivo major ability transcription complexes lymphocytes association rapid occurs receptor require regulated remodeling antigen chromatin engagement | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 12 | Citation Text: | Reference Offset: [547-643', 645-748', 750-933'] | Reference Text: conserved rnas endogenous small mechanisms regulate functionally mirnas functions expressing majority developed barcode mirnas vectors cloned dna genetic library screens | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 11 | Citation Text: protects licensing degradation origins apc late cdc6 g1 phosphorylation 12 | Reference Offset: [4100-4235', 17461-17605', 1780-1897'] | Reference Text: mediated recognition apc late g1 required activation substrate degradation ligase destruction rxxl n-terminal mediate apc cdc6 g1 motifs early process licensing replication dna origins cdc6 plays key major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 5 | Citation Text: bcl-2 findings proapoptotic bax family activated tbid bh3-only bim puma bind | Reference Offset: [397-552', 4033-4174', 28392-28543'] | Reference Text: bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome subset family bik molecules bh3-only bim puma bad bid include bak bcl-xl preferential interaction assays antiapoptotic prior bcl-2 proapoptotic bax binding bim intact | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 1 | Citation Text: drugs therapeutic issue potential synthetic lethal finally demonstrating recent models approved kras-driven gata2 clinical | Reference Offset: [6830-7115', 62289-62576', 65307-65555'] | Reference Text: causing kras loss therapeutic inhibitors inhibition strategy established finally clinically combined suppression nsclc gata2 pathways mutant kras screen mutations lethal synthetic receptors recent lung earlier adenocarcinoma receptor mutant required multiple cancer specifically serve functions therapeutic intriguing determine finally factor kinases kinase regulatory factors gata2 regulated phosphorylation targets transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 21 | Citation Text: t-all obtained cases global affymetrix cryopreserved lymphoblast 39 samples | Reference Offset: [11969-12186', 2015-2335', 5763-6077'] | Reference Text: sufficient microarrays analyze t-all patterns test rna global hypothesis 39 samples aberrant methods obtained genes rt-pcr disease rearrangements transforming dna event clinical hypothesis central key activation transcription support absence factor samples analyze t-all combination microarray chromosomal reverse cases pediatric pcr translocations locus-specific samples transcriptase analyze t-all oncogene quantitative acting hypothesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 6 | Citation Text: induced nanog epiblast stage escs represent | Reference Offset: [23468-23606', 31135-31226', 31468-31554'] | Reference Text: requirement essential initial maintenance pluripotency demonstrated nanog stage low nanog stage key fate functions crucial nanog stage fate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 22 | Citation Text: sites chemokine receptors express accumulation variety remain leading largely infection nk large | Reference Offset: [1444-1587', 3033-3169', 6273-6536'] | Reference Text: sites rapidly lymphocytes mature leukocytes infection tissues chemokine transmembrane leukocytes receptors date sites single lymphocytes revealed class receptors 30 pm binding monocytes 50 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 7 | Citation Text: ros complexes form iii dismutase mitochondrial respiratory superoxide chain hydrogen initial generated sod2 peroxide | Reference Offset: [35227-35420', 8869-8995', 34768-34887'] | Reference Text: complexes resulted demonstrated iii level respiratory chain components sites ros superoxide pathways iii production major complex respiratory component chain mutation iii mutant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 8 | Citation Text: chemokine expressing specificity leukocytes domain receptors n-terminal | Reference Offset: [609-757', 3033-3169', 37770-37989'] | Reference Text: migration chemokine transmembrane fractalkine leukocytes stalk mucin domain adhesion molecule induces chemokine transmembrane leukocytes receptors date chemokine expressing capable fractalkine receptor mucin domain cognate adhesion consistent linked inducing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 10 | Citation Text: serve plasma endomembranes pathway benefit therapeutic trafficking related additional membrane undergo retrograde specifically | Reference Offset: [33603-33823', 611-745', 2012-2218'] | Reference Text: involves trafficking intermediate demonstrating ras membrane pm retrograde golgi polybasic functions k-ras plasma membrane sequence region k-ras plasma targeting unique motif requires polybasic membrane | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 18 | Citation Text: proliferation resistant inhibitors agents domains mutation kinase time approved designed resistance clinical trials clones gatekeeper promising t315i called bcr-abl bind suppress mutated | Reference Offset: [11669-11888', 21295-21574', 2966-3266'] | Reference Text: assay status inhibitors tyrosine kinase bcr-abl clinical phosphorylation trials screen compound single resistant ap24534 subsequent mutation kinase confirmed domain resistance bcr-abl mutant nm profile suggests treatment mutation potential abl clinically second-line clear present kinase patient identification imatinib domain active resistance bcr-abl inhibitor mutant therapy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 10 | Citation Text: staining fixed | Reference Offset: [12094-12182', 38534-38666', 38289-38410'] | Reference Text: pml structure nuclear staining treated prepared fixed cultured fixed | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 14 | Citation Text: result understand pathway set inhibition egfr network include findings genetic activated alterations | Reference Offset: [16655-16969', 22943-23101', 35085-35360'] | Reference Text: rtk proliferation network egfr signaling component pathways survival central cancer her2 suppressed ptpn12 inhibition mek transformation egfr suggests her2 amplification ptpn12 model loss pathway tumorigenesis events functional genetic operate rtks consistent | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 11 | Citation Text: breast reports mir-126 subsequent cervical downregulated oncogene cancer targeted showed | Reference Offset: [1338-1652', 7905-7989', 9687-10279'] | Reference Text: normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer cervical mirna lines cancer profile tissues showed normal signal showed abundant mir-21 tissues population mir-145 mir-143 000 cervical lines low cancer based | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 3 | Citation Text: recognized loss prb play suppressor repression thought tumor cancers retinoblastoma | Reference Offset: [11659-11752', 37072-37258', 423-576'] | Reference Text: loss disruption tumor types occurs retinoblastoma rb systems model single individual genes resulted inhibition suppressor tumor cancers arrest oncogenes growth p53 suppressors tumor disrupted factor cancer regulators transcription retinoblastoma | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 14 | Citation Text: subtypes newly classifiers cases pediatric lineage assigned showed leading genetic subtype accuracy | Reference Offset: [7855-8044', 11884-12034', 14713-14824'] | Reference Text: subtypes cases assigned collection leukemias heterogeneous profile distinct t-all clusters cases lineage subtype low subtypes figure cases genetic b-all | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 9 | Citation Text: direct result apoptosis death sensitizes stimuli free level bik consistent members | Reference Offset: [1720-1888', 2033-2226', 3386-3632'] | Reference Text: activating death domains bh3 antiapoptotic selected proapoptotic initiate pockets peptides members subcellular result death induce signals activate mitochondria caspase effector release multiple activation cytochrome membranes death stimuli variety mitochondrial response inactive outer bax membrane located 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 4 | Citation Text: real analyze subsequently test generated insights specifically | Reference Offset: [809-1015', 1301-1435', 5944-6313'] | Reference Text: microarrays genes pediatric profiling determine leukemic enhance analyze patients pattern genes subgroups leukemia insights provided signatures microarrays single genes profiling leukemic determine 12 patients alizadeh utilized 1999 pediatric analyze prognostic approaches 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 8 | Citation Text: breast genetic screens oncogene amplified overexpressed survival cancer frequently cancers | Reference Offset: [1404-1570', 5867-6036', 19539-19725'] | Reference Text: reveal patient-derived tumors structural kinases breast lines analyses overexpressed amplified cancer ikbke acts percentage identify tumors breast kinase akt downstream oncogene amplified approaches ikbke substantial fraction tumors observations breast kinase transforming primary lines overexpressed amplified cancer substantial ikbke | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 2 | Citation Text: expressing differentiation inhibition chimeric demonstrated show phenotype ras stable oncogenic molecule | Reference Offset: [26802-27051', 28634-28900', 31061-31379'] | Reference Text: loss differentiation show ras rat induces level oncogenic thyroid interference cultured low growth ras-transformed observation loss previous expressing select differentiation tsh ras oncogenic frtl-5 consistent allowed direct rapidly inhibition differentiation induction effects ras demonstrating appears analyze system time oncogenic thyroid frtl-5 early activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 8 | Citation Text: networks genes nanog transcriptional critical earlier factors regulatory sox2 roles recently core discovery transcription | Reference Offset: [5798-5948', 19789-19986', 32898-33068'] | Reference Text: foxd3 essential sox2 factors pluripotency recently transcription endoderm markers visceral rt-pcr nanog showed northern factors analyses null transcription pluripotent crucial therapeutic genes understanding nanog critical regulatory identification early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 17 | Citation Text: genes mirna potential tumors properties testicular mir-373 oncogenic regulation proposed due oncogene note | Reference Offset: [1316-1547', 935-1177', 1865-1988'] | Reference Text: provide development pathway evidence germ potential tumors mirnas testicular p53 presence oncogenes wild-type tumorigenic growth cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 oncogenic potential cluster demonstrated | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 2 | Citation Text: fashion amino crucial gatekeeper subsequent revealed demonstrated abl interacts comparison kinase binds acid imatinib detailed domain binding modes x-ray | Reference Offset: [5924-6170', 6909-7152', 2726-2843'] | Reference Text: reveal structure acts gatekeeper mutation abl recent point kinase t315i domain x-ray mutant threonine complex ap24534 murine network contacts kinase binds confirmed imatinib domain x-ray kinase point involves mutations imatinib domain resistance binding bcr-abl inhibitor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 9 | Citation Text: development bortezomib bcl-xl bcl-2 implicated and/or overexpression resistance mcl-1 drug | Reference Offset: [23220-23396', 23582-23736', 37251-37350'] | Reference Text: limited level bcl-xl resistance overexpression inactivated mcl-1 targets abt-737 cytotoxic bcl-2 bcl-xl overexpression inactivated mcl-1 abt-737 bcl-2 bcl-xl overexpression drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 1 | Citation Text: g2/m lats2 arrest death subsequent induces apoptotic | Reference Offset: [7963-8393', 7291-7557', 35285-35552'] | Reference Text: cyclin lats2 nih3t3 mouse lats2/kpm apoptosis induce hela inhibition transition g2/m kinase e/cdk2 down-regulation tumorigenicity arrest inhibit g1/s cdc2 suppress cycle lats1 apoptosis inhibition enhanced caused g2/m kinase level arrest bax induced lines cdc2 lats2 cycle phosphorylated stages distinct arrest suggesting regulated g1/s multiple phase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 6 | Citation Text: spite potential represent lung examined resistance cancer vivo drug | Reference Offset: [57833-58055', 1700-2032', 16096-16193'] | Reference Text: animals extend tumor weeks 12 mice extensive lung combination treated vivo drug kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth lung xenograft examined tumor cancer ability alter growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 1 | Citation Text: mitosis lats2 nih3t3 involves interphase cytoplasmic mitotic localized kinase signaling cascade apparatus | Reference Offset: [1827-1974', 6577-6712', 22438-22610'] | Reference Text: lats2 mitosis nih3t3 interphase apparatus cytoplasmic mitotic localized lats2 mitosis interphase apparatus show finally cytoplasmic mitotic lats2 mitosis fraction localization apparatus cytoplasmic mitotic exogenous | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 5 | Citation Text: demonstrate oct4 markers pluripotency potential nanog | Reference Offset: [1372-1475', 6463-6636', 18281-18365'] | Reference Text: critical demonstrate pluripotency underlying factor nanog es independently pluripotency report nanog es endoderm loss pluripotency extraembryonic differentiation nanog null | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 5 | Citation Text: processes biological underlying signatures clinically relevant investigate | Reference Offset: [17308-17482', 1301-1435', 4562-4661'] | Reference Text: hyperdiploid cases underlying pathogenesis molecular clinically distinct genes subgroups leukemia insights provided signatures cytotoxic response subtypes lesions drugs genetic leukemia underlying | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 8 | Citation Text: potent deregulation suppressor epithelial tumors malignant transformation cancers breast lung rest small | Reference Offset: [39252-39523', 12167-12374', 15641-15800'] | Reference Text: additionally profiling display distinct cancers prostate lung phenotypes rest microarray downregulation small pathway suppressor ii epithelial tumor type transformation transforming receptor growth implicated potent regulating proliferation pathway vitro oncogenic epithelial inhibitor transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 13 | Citation Text: upstream mir-223 mir-1 sequence interact elements | Reference Offset: [12198-12468', 14044-14246', 32417-32589'] | Reference Text: region sites promoter mir-223 putative upstream sequence encoding binding region promoter mir-223 sequence relative end region promoter mir-223 induction mirna time start correlated binding interact required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 8 | Citation Text: rabbit anti-pml antibody polyclonal | Reference Offset: [9809-9996', 14042-14274', 19895-20133'] | Reference Text: residues rabbit endogenous pml pattern directed polyclonal nucleus rabbit antibody primary murine rabbit anti-pml localization antibody receptor primary | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 12 | Citation Text: methods information protocol marson description detailed chip-seq sequencing | Reference Offset: [32081-32172', 35810-35889', 933-1241'] | Reference Text: methods description detailed methods information detailed sequences primer genes circuitry protein-coding mirna promoters sequencing transcriptional short regulatory identification transcripts describe chip-seq quantitative types es multiple based | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 9 | Citation Text: mir-142 mirna hematopoietic tissues | Reference Offset: [3034-3275', 4142-4371', 4533-4832'] | Reference Text: mir-223 differentially mirnas cloned analyses hematopoietic tissues site leukemia highly hematopoietic translocation aggressive tissues functions complex individual differentially suggested adult express mirnas hematopoiesis differential largely bone hematopoietic types marrow thymus tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 4 | Citation Text: p53 45 mammalian dependent cdc6 manner regulated stressed | Reference Offset: [1558-1674', 6706-6780', 13668-13770'] | Reference Text: p53 replication dna collectively cdc6 stability initiation regulated p53 interestingly dependent cdc6 destruction ir level p53 dependent cdc6 investigated decrease | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 21 | Citation Text: prs-gfp pmscv-gfp-st | Reference Offset: [10872-11136', 12302-12437', 26592-26802'] | Reference Text: prs-gfp constructs hela transient sirna retroviral assays produced vectors cloned p16ink4a active prs-hyg viral p14arf prs-gfp cellular constructs p16ink4a phenotypes uncover primary knockdown p14arf growth pcr generated pmscv-gfp-st antigen small sv40 large | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 18 | Citation Text: double-negative lyl1 expressing differentiation cortical stage stages samples prior arrested arrest late oncogene early thymocyte | Reference Offset: [14622-14866', 17082-17348', 16000-16133'] | Reference Text: cases genes normal differentiation cortical stage showed undergoing pattern early thymocyte differentiation cd2 cortical upregulation tal1 stage contrast lck pattern late reflect appeared thymocyte t-all recognized differentiation profiles samples stages thymocyte | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 8 | Citation Text: p6 budding mechanism recruit vps4 enveloped domain tsg101 interactions members formation involves pathway gag helps mvb factors hiv-1 late downstream viruses | Reference Offset: [35810-35974', 40097-40281', 3649-3839'] | Reference Text: suggests cellular pathway common domains receptors recruit factors primary late downstream vps viral cellular pathway common sequences receptors steps initially hiv-1 late downstream domain bind cellular machinery budding process recruit hiv-1 membrane enveloped viruses | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 15 | Citation Text: replication propose necrotic death induced plays early apoptotic | Reference Offset: [571-813', 2336-2533', 4944-5050'] | Reference Text: termed activates death dependent rip1 receptors type apoptotic conditions necroptosis stimulation kinase necrotic pathway fadd death caspases receptors induces apoptotic caspase-8 upstream family recruitment activation death treatment induced | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 15 | Citation Text: reactions bcl-2 displacement family target binding bh3-only multidomain relevant interactions | Reference Offset: [7371-7545', 2401-2687', 8152-8303'] | Reference Text: domains determine bh3 assays antiapoptotic bcl-2 family binding bh3-only interactions members regions antiapoptotic bcl-2 proapoptotic family bh3-only multidomain based bcl-2 family domains bh3 bh3-only interactions antiapoptotic nm | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 11 | Citation Text: gfp mir-vec mir-1 predicted g6pd wt luciferase system sequence complementary target examined suppress | Reference Offset: [33820-34057', 1119-1226', 12684-12896'] | Reference Text: expressing mir-1 hela mirna line predicted examined relevant stably targets reporter system hela experimentally predicted targets standard shuffled sequence mirna predicted mirnas targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 15 | Citation Text: cloned widely cd2ap highly library brain tissues | Reference Offset: [16894-17024', 42718-42912', 14385-14471'] | Reference Text: northern analyze tissue detected brain tissues total murine lysates lung kidney prepared brain thymus tissues mouse domain encoding library embryo partial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 3 | Citation Text: difference work system mouse mir-223 previous regulation mechanism | Reference Offset: [35243-35458', 622-782', 784-1003'] | Reference Text: mir-223 nfi-a mirna findings regulation produces activator hypothesis low transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show retinoic mir-223 nfi-a differentiation -induced factors acid binding low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 11 | Citation Text: suppression ptpn12 crucial oncogenic importantly roles play | Reference Offset: [14463-14746', 17191-17477', 60314-60489'] | Reference Text: cellular ptpn12 loss play plays phosphorylated transformation signaling experiments roles highly due suggesting depletion ptpn12 progression play potential interaction receptors egfr related breast critical regulatory receptor family roles initiation cancer ptpn12 tumorigenesis roles play types suppressing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 10 | Citation Text: total actin-related complex atpase baf activities remodeling contribute | Reference Offset: [611-810', 3641-3823', 5704-5989'] | Reference Text: complex complexes baf stimuli related sufficient vitro pip2 target remodeling regulated chromatin activation complex complexes mechanism baf rise family mammalian remodeling group chromatin members extracellular complex model induce baf mechanism signals striking system search underlying remodeling investigated mechanisms chromatin genome-wide activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 4 | Citation Text: involvement proliferation metabolism metastasis transition mirna extensive dysregulation cancer | Reference Offset: [8416-8569', 935-1177', 2232-2376'] | Reference Text: detection proliferation additionally made mirna effects microarray cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 functions screening identify approach mirna mirnas small stresses | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 19 | Citation Text: modulate complex actin 2002 evidence matrix baf nuclear atpase mammalian binding suggesting chromatin | Reference Offset: [10695-10781', 12975-13227', 28735-28835'] | Reference Text: sufficient enhance complexes nuclear pip2 matrix binding baf chromatin complex matrix baf possibility jurkat investigate transfected nuclear incubated chromatin bound stably brg1 complex nuclear actin association matrix subunits baf required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 8 | Citation Text: kras a549 h23 independent nsclc lines explored growth | Reference Offset: [11110-11323', 5016-5251', 8564-8750'] | Reference Text: a549 k-ras sensitivity inhibitors similarly inhibition h358 revealed kinases dependency nsclc lines mek a549 k-ras ablation harbor mutations proliferation activating h358 effects initially lung viability lines assessed independent k-ras experimentally classified lines derived based | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 2 | Citation Text: g2/m lats2 mitosis activated roles onset transition plays cultured phosphorylation | Reference Offset: [1193-1377', 1395-1512', 7963-8393'] | Reference Text: lats2 aurora-a s83 basis localization centrosomal target plays phosphorylation observations mitosis dephosphorylation numerous onset regulated phosphorylation cyclin lats2 nih3t3 mouse lats2/kpm apoptosis induce hela inhibition transition g2/m kinase e/cdk2 down-regulation tumorigenicity arrest inhibit g1/s cdc2 suppress | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 3 | Citation Text: lung kras-driven essential recently onset non-small cancer | Reference Offset: [423-577', 891-964', 1540-1683'] | Reference Text: lung k-ras oncogene-driven individual cascade onset investigated non-small members raf/mek/erk carcinoma c-raf essential nsclc onset lung k-ras implicated oncogenes tumors non-small prognosis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 5 | Citation Text: anti-hiv therapeutics complex essential budding develop research major targeted | Reference Offset: [5576-5704', 12463-12559', 30393-30577'] | Reference Text: essential budding plays retroviral poorly ubiquitin 2000 cellular systems requirement hiv-1 test budding tsg101 develop functions essential pathway budding trafficking indicating stage hiv-1 late inhibiting endosomal tsg101 vps viral release | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 7 | Citation Text: arginine site state transition finger gaps stabilizing introduced cognate active rho | Reference Offset: [13192-13436', 15167-15353', 16085-16236'] | Reference Text: site stabilization state transition effective gaps catalysis active molecule arginine site state transition finger called negative arginine catalytic conserved mechanism finger ras rho | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 4 | Citation Text: belonged location genes mirna mirnas recently features positive transcription scored markers epigenetic comparable include targeted studied factors promoter mouse marson peak putative algorithm experiments conservation mir-21 chip previous assigned predicted promoters general variety combined dataset cluster chip-seq core negative | Reference Offset: [14494-14769', 1243-1436', 2016-2296'] | Reference Text: mouse genes set functional mirna factor promoters factors core suggesting occupancy es bound key transcription factors set genes mirna promoters mirnas es find key transcription marson state mirna promoters sequencing short factors promote identification program transcripts describe chip-seq quantitative types es multiple key transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 7 | Citation Text: cellular protective inhibition rasv12 pitx1 efficiently suppressing transformation p53-p16ink4a induced overexpression mechanisms growth | Reference Offset: [8468-8646', 10312-10509', 742-903'] | Reference Text: response cellular oncogenic primary stress rasv12 requires transformation sufficient htert prb inhibition primary rasv12 st required transformation suppression contrast cellular p53 p16ink4a proliferation loss affect transformation growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 15 | Citation Text: direct complex swi/snf interaction matrix/chromatin targeted fact nuclear family pip2 chromatin | Reference Offset: [1098-1279', 13745-13872', 38894-39123'] | Reference Text: direct work complex swi/snf baf signals signaling membrane mammalian regulation chromatin complex pip2 baf interaction interacts enhanced chromatin complex association matrix signals regulating nuclear component receptor pip2 antigen remodeling chromatin regulate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 4 | Citation Text: detect previous lymphocytes failed cx3cr1 | Reference Offset: [1444-1587', 1589-1725', 2656-2832'] | Reference Text: sites rapidly lymphocytes mature leukocytes infection tissues migratory defense host essential lymphocytes leukocytes immunological properties chemokine targeting lymphocytes exhibit extent molecules | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 3 | Citation Text: present experiments report | Reference Offset: [2031-2142', 28074-28274', 30878-31143'] | Reference Text: patients pediatric profiling report leukemic large experiments determined prediction group accuracy percentage secondary random prediction indicating experiments determined aml accuracy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 16 | Citation Text: methylation aberrant promoter believed loss tet2 aml regions | Reference Offset: [45207-45475', 45477-45795', 6471-6602'] | Reference Text: hypermethylation subtypes aberrant methylation extensive promoter demonstrate dna aml feature aberrant methylation promoter affects unique genes global display indicating epigenetic putative roles increase aml hypermethylated signature methylation promoter defined patterns clusters importantly aml distinct | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 5 | Citation Text: recently suppressor oncogene tumor rest | Reference Offset: [1478-1640', 29369-29484', 944-1088'] | Reference Text: provide development genes suppressor approach tumor candidate rest suppress cancer support provide strong suppressor tumor rest hypothesis transcriptional suppressor tumor neuronal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 9 | Citation Text: cyclin radiation genotoxic treatment stability proteolysis p53-independent caused d1 arrest stresses pathway demonstrated ionizing rapid fact leading g1 regulated p27kip1 decrease | Reference Offset: [484-599', 982-1224', 35212-35318'] | Reference Text: cyclin d1 arrest dna damage g1 show proteolysis p53-independent rapid caused cyclin maintenance induction damage stability proteolysis p53-independent resulting response d1 p53 arrest dna mediated g1 initiation cyclin d1 ir treatment stability decrease caused | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 6 | Citation Text: arginine gaps stabilization catalytic alternative interaction finger | Reference Offset: [16085-16236', 17070-17280', 34509-34596'] | Reference Text: arginine catalytic conserved mechanism finger ras rho stabilization machinery catalytic cases residue gaps catalysis contribution arginine typical catalytic activities finger required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 5 | Citation Text: pathway form inhibitors caspases rip1 inhibited rip3 conditions necroptosis physiological initiate programmed necrosis viral infections | Reference Offset: [18606-18759', 21068-21251', 1439-1604'] | Reference Text: physiological programmed caspases necrosis inhibited viral infections cellular machinery apoptosis death inhibitors programmed mechanism necrosis show inhibited viral essential virus innate rip3 response controls kinase initiating inflammatory cascade programmed necrosis infections | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 1 | Citation Text: previous antibodies pcr show flow differences related mrna binding cx3cr1 cytometry quantitative assessed | Reference Offset: [5426-5711', 7591-7642', 26761-26943'] | Reference Text: form previous receptors binding phosphatase quantitative chemokines bind ability specifically binding show surface antibodies flow fractalkine soluble | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 5 | Citation Text: member effectively dependent tumors abt-737 cytotoxic bcl-2 family recently inhibit mcl-1 | Reference Offset: [1420-1594', 3990-4372', 13383-13649'] | Reference Text: bcl-2 agents tumors mcl-1 low abt-737 combined damaged member pathway mutations apoptosis induction tumors bcl-2 p53 family capacity bh3-only puma overexpressed promotes degradation regard bad abt-737 cytotoxic coexpression recently action mcl-1 targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 15 | Citation Text: induction line ras stable presence thyroid ectopic examined frtl-5 oncogene depends | Reference Offset: [1052-1275', 2619-2877', 5704-5902'] | Reference Text: ras-transformed obtained loss genes differentiation measured pcr thyroid-specific ras clear presence oncogene frtl-5 loss differentiation contribute partial ras cancers prognosis observations oncogenic thyroid depends aggressive selective absence differentiated phenotype ras transformation selection dual designed presence oncogenic thyroid interference | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 10 | Citation Text: genes factor nanog network include transcriptional sox2 dna domain core targets | Reference Offset: [1372-1475', 11508-11604', 11887-12000'] | Reference Text: critical demonstrate pluripotency underlying factor nanog es search revealed domain predicted nanog family domain conserved nanog | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 11 | Citation Text: promotes k-ras association organelle modifications suggested stable mitochondrial outer membrane recruitment correlate phosphorylation | Reference Offset: [747-1019', 4423-4576', 16334-16494'] | Reference Text: region promotes k-ras membranes association bcl-xl show interacts rapid mitochondria polybasic kinase outer membrane pm intracellular phosphorylation surprisingly k-ras membranes outer membrane bcl-xl phosphorylated included mitochondrial mitochondria red pattern outer localization membrane suggested mitochondrial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 3 | Citation Text: tyrosine ptpn12 lost phosphatase find cancers | Reference Offset: [884-981', 1633-1885', 1956-2297'] | Reference Text: tyrosine screen ptpn12 genetic identify suppressor phosphatase tumor ptpn12 targeting provide collectively identify suppressor tumor cancers kinases tyrosine inactivated based profile ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 6 | Citation Text: breast prostate prognostic loss ovarian poor inpp4b factor cancers | Reference Offset: [18245-18453', 1429-1694', 19158-19271'] | Reference Text: involvement loss decreased correlates inpp4b occurs cancers basal-like breast patient heterozygosity ovarian locus survival frequently fraction lower majority suppressor finally tumor inpp4b cancers breast basal-like patient ovarian correlated suggesting locus survival find breast patient loss poor tumor inpp4b outcome tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 7 | Citation Text: series checkpoints cycle lost tumorigenesis g2/m process arrested altered factors regulatory g1/s activities phase | Reference Offset: [5895-6063', 1392-1519', 1920-2073'] | Reference Text: arrested cycle ir result g1 effects irradiated treated phase cyclin cycle progression g1 cyclins types phase major cyclin cycle progression active transition cyclins g1/s appears prior | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 3 | Citation Text: obtained vector bamhi construct | Reference Offset: [37207-37283', 7022-7362', 21381-21711'] | Reference Text: cloned site vector construct bamhi cellular clones site constructs expressing retroviral ras cloned transfected oncogenes vector activated encoding frtl-5 bamhi viral clones obtained expressing chimeric reporter transiently transfected oncogenes wild-type domain encoding fusion construct homeodomain activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 3 | Citation Text: sites catalytic common 2002 mutation conserved abl cml kinases gorre t315i tyrosine patients relapse imatinib highly resistance therapy 2001 | Reference Offset: [3513-3710', 27275-27482', 1750-1952'] | Reference Text: 2002 cml 60% continued patients relapse respond imatinib approximately therapy blast mutations cml short acquisition initiating time patients relapse imatinib crisis therapy mutations frequency disease cml stages present kinase patients imatinib domain resistance bcr-abl develop | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 1 | Citation Text: terminal arrest mammalian differentiation differentiated poorly cancer growth | Reference Offset: [12080-12220', 13646-13860', 14677-14866'] | Reference Text: u937 terminal pathway differentiation cellular arrest differentiated hypophosphorylated rb hr newly differentiation induction established continued 12 rb terminal synthesis phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 3 | Citation Text: oct4 essential development nanog factors sox2 undifferentiated roles required es culture early transcription | Reference Offset: [5798-5948', 5040-5173', 11083-11232'] | Reference Text: foxd3 essential sox2 factors pluripotency recently transcription independently essential factors pluripotency transcription independently pathway undifferentiated state demonstrated nanog es | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 13 | Citation Text: direct bak bcl-xl truncated mitochondrial outer bax displacement membrane activated binding proposed bim bh3-only require mcl-1 bid activation | Reference Offset: [5432-5670', 6957-7134', 28392-28543'] | Reference Text: preventing bak complexes bcl-xl stable antiapoptotic mitochondrial comparison bcl-2 bax wild-type molecules bh3-only mutant 2001 members activation member bak responsible activating bh3 bax domain binding bh3-only directly bid bak bcl-xl preferential interaction assays antiapoptotic prior bcl-2 proapoptotic bax binding bim intact | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 26 | Citation Text: proliferation protective mechanism continued suppression p53 presence p16ink4a tumorigenicity leading oncogenic event primary pathways | Reference Offset: [742-903', 17495-17627', 25051-25171'] | Reference Text: suppression contrast cellular p53 p16ink4a proliferation loss affect transformation growth cellular inactivation p53 p16ink4a pathway proliferation primary fibroblasts inhibitor key p53 p16ink4a oncogenic primary transformation growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 15 | Citation Text: factors gtpase guanine activating nucleotide critically regulated small exchange | Reference Offset: [487-668', 1830-1978', 5822-5937'] | Reference Text: cellular functions gtpase-activating factors guanine nucleotide-binding nucleotide small exchange regulate subset level provide additional guanine inhibitors small gaps regulated molecular small mechanisms gefs | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 6 | Citation Text: transform nih3t3 arrest primary activated established lines ras growth | Reference Offset: [1548-1681', 4638-4811', 570-681'] | Reference Text: transform oncogenic immortal primary efficiently lines rodent ras established murine transformed ras lacking p53 oncogenic immortal primary fibroblasts lines arrest oncogenic primary g1 show rodent ras | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 6 | Citation Text: region pluripotent development progression apoptosis mirnas complementary induced processes repress cycle metabolism differentiation demonstrated variety hematopoiesis biological involved mrnas target stem large | Reference Offset: [18133-18475', 18477-18765', 21014-21207'] | Reference Text: complex proliferation development apoptosis commitment events lineage differentiation controlled maturation molecular process stem/progenitor lineages hematopoietic stem regulate mouse development lineage evidence differentially differentiation class mirnas alter represent hematopoiesis solid lineages mammalian molecules hematopoietic vivo regulate work direct processes set genes list mirnas hematopoiesis critical mrnas target pairing silencing act | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 12 | Citation Text: libraries practical remain mammalian sirna large-scale shrna | Reference Offset: [2451-2823', 3674-3907', 7422-7628'] | Reference Text: telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth assay pcr sequencing growing retroviral vector amplified shrna functional pcr retroviral subsequently identification sequence vector amplified shrna | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 10 | Citation Text: serve stabilizing structure gtpase-activating state proposed transition | Reference Offset: [14080-14138', 13192-13436', 13719-13892'] | Reference Text: state transition hydrolysis gtp site stabilization state transition effective gaps catalysis active molecule state hydrolysis transition gtp | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 8 | Citation Text: region nilotinib proven location mutation difficult residue dasatinib critical imatinib atp topology inhibit required high-affinity site gatekeeper interaction t315i pocket hydrogen binding mutant | Reference Offset: [32496-32806', 39188-39369', 38597-38753'] | Reference Text: position site revealed conformation motif enzyme binds pocket imatinib atp loop binding active bcr-abl activation loss remains steric t315i hydrogen imatinib binding due case mutant clash mutation positions imatinib helix binding facilitates required energy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 16 | Citation Text: potent vitro magnitude bh3 peptides release cytochrome | Reference Offset: [13930-14013', 13234-13448', 13017-13232'] | Reference Text: bh3 peptides release 100 induces cytochrome induce higher bh3 figure peptides significantly release confirm cytochrome mouse test bh3 mitochondria system peptides bim bid release cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 7 | Citation Text: exposure result loss differentiation chronic demonstrated ras event activated induced oncogene activation early | Reference Offset: [49971-50122', 1052-1275', 4735-5104'] | Reference Text: 20 proliferation loss thyroid normal differentiation epithelial oncogene ras activation induces 2000 ras-transformed obtained loss genes differentiation measured pcr thyroid-specific ras clear presence oncogene frtl-5 cellular pathway experimental demonstrated ras transcriptional transiently h-rasv12 activated recently effector domain approach oncogene frtl-5 inhibit pathways mutant multiple | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 21 | Citation Text: cyclin lats2 proliferation inhibition transition g2/m kinase e/cdk2 blocking inhibits down-regulation arrest g1/s cdc2 inducing | Reference Offset: [11219-11280', 16652-16734', 18061-18211'] | Reference Text: lats2 inhibits blocking proliferation transition g1/s cyclin lats2 kinase e/cdk2 transition g1/s regulates cyclin kinase lats2 e/cdk2 negatively transition g1/s directly regulates | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 4 | Citation Text: libraries enabled repressing shrnas therapeutic potential capable transformation genetic oncogenic screens genome-wide stably targets availability | Reference Offset: [4689-4856', 13995-14133', 33641-33779'] | Reference Text: model defined identify genes epithelial transformation mammary oncogenic genetic approach utilized suppress transforming targeting order shrnas potential candidate putative regions targets assessed genetic oncogenic genes identify approach epithelial suppressing transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 12 | Citation Text: believed proliferation generally regulator 13 rb 12 | Reference Offset: [2741-2856', 6121-6466', 14677-14866'] | Reference Text: dna chromosome 13 rb cellular proliferation lymphocytes state induction phosphorylated investigate rb primary examined phosphorylation hr newly differentiation induction established continued 12 rb terminal synthesis phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 12 | Citation Text: mice mir-223 development granulocyte regulate | Reference Offset: [37764-38019', 622-782', 784-1003'] | Reference Text: processes development therapeutic differentiation understanding possibility molecular leukemia granulocyte approaches required transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show retinoic mir-223 nfi-a differentiation -induced factors acid binding low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 2 | Citation Text: kras rnai essential proliferation genes factor 000 screened biological nsclc carrying viability oncogenic library wild-type gata2 lines mutant transcription | Reference Offset: [7392-7618', 681-770', 1700-2032'] | Reference Text: kras factors led viability loss apoptosis increase gata2 factor mutant decrease transcription nsclc depend gata2 show factor mutant transcription kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 4 | Citation Text: vector sirna hairpin psuper construct based | Reference Offset: [8457-8605', 520-651', 653-831'] | Reference Text: transcript designed system test vector sequence target sirna synthetic psuper system vector mammalian report rnas psuper interfering synthesis small inactivation down-regulation vector mediated genes functional sirna show resulting targeted | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 7 | Citation Text: work spectrum therapeutic understanding isoforms properties ras biological signaling regulating membrane types approaches mechanisms compartments | Reference Offset: [1881-2010', 1771-1879', 14490-14560'] | Reference Text: methylation association membrane c-terminal isoforms proteolysis ras requires motif generated differential sequences isoforms part ras large distinct k-ras signaling ras phosphorylation induces | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 4 | Citation Text: kinase cyclin-dependent mcl-1 inhibitor | Reference Offset: [32515-32745', 39784-40148', 32747-33005'] | Reference Text: cyclin-dependent ii production kinase blocking mrna recently clinical mcl-1 act inhibitor phase trials cyclin-dependent thought tumors kinase rna clinical synthesis key trials ii rapid breast lung mrna target mcl-1 inhibitor phase cancer hela abt-737 reduced action mcl-1 synthesis inhibitor carcinoma | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 4 | Citation Text: cyclin inactivation contributes proliferation deregulation pathway mechanism tumors point suggesting components | Reference Offset: [2999-3101', 3231-3360', 10526-10627'] | Reference Text: cyclin d1 pathway proteolysis activate cyclin kinase d1 pathway inhibit mitogenic stabilize signals cyclin d1 genotoxic examined stress underlying mechanism decrease rapid | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 6 | Citation Text: ring icam-1 form lfa-1 cd2 larger contact localized center tcr molecules dimensions central | Reference Offset: [32547-32702', 2462-2800', 4947-5212'] | Reference Text: center lfa-1 cd2 tcr molecules contact localized membranes cd2 interaction helps receptors ligands promote apc tcr cluster molecules dimensions tight central engagement nm generate larger cd2 interaction contact stabilize tcr molecules | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 20 | Citation Text: pretrosuper generated replacing pmscv-blast prs-hyg | Reference Offset: [26451-26590', 26036-26216', 26327-26449'] | Reference Text: generated resistance replacing pmscv-blast pretrosuper generated resistance replacing prs-hygro prs-gfp sequence generated replacing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 9 | Citation Text: conditions k-ras oncogenic intriguing factor act survival mitochondrial observations | Reference Offset: [1021-1120', 1228-1368', 2220-2439'] | Reference Text: k-ras promote apoptosis oncogenic manner transformed pkc k-ras fashion vitro oncogenic transformed inhibited pkc vivo growth k-ras class cytoplasmic polybasic pm act | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 11 | Citation Text: lats2 plk1 aurora-a factors similarly roles centrosomal maturation required multiple | Reference Offset: [39428-39688', 39690-39933', 1193-1377'] | Reference Text: cyclin lats2 complex aurora-a localization issue centrosomal maturation centrosomes s83 promote recruitment phosphorylation rapidly lats2 plk1 centrosomal efficiently maturation kinases kinase order components cdc2 lats2 aurora-a s83 basis localization centrosomal target plays phosphorylation observations | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 5 | Citation Text: nilotinib development majority higher leukemic affinity include observations dasatinib patients led binding due bcr-abl imatinib-resistant modes generation suppress | Reference Offset: [866-1118', 4743-5029', 6172-6498'] | Reference Text: nilotinib mutations attributable inhibition chronic lead switch second-line induces dasatinib kinase patients relapse imatinib leukemia domain resistance myeloid bcr-abl therapy development mutation cml t315i patients advanced molecules due clinical phase therapy targeting nilotinib abl dasatinib ligands designed imatinib modes form interaction native chain hydrogen binding inhibitor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 18 | Citation Text: functions complex complexes actin association baf brg1 presence nuclear component interest mammalian tight discovery | Reference Offset: [28735-28835', 39562-39815', 22609-22688'] | Reference Text: brg1 complex nuclear actin association matrix subunits baf required complex targeting observation actin association baf53 baf matrix/chromatin brg1 nuclear subunits required brg1 complex presence association baf53 baf requires | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 3 | Citation Text: necroptosis reports induced rip1 rip3 | Reference Offset: [826-966', 968-1021', 1023-1224'] | Reference Text: screen tnf crucial rna programmed induced infection virus activator interference necrosis rip3 rip1 rip3 regulates phosphorylation complex species oxygen association activates rip1 rip3 production kinase downstream triggers reactive phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 11 | Citation Text: genes suppresses tumorigenesis suppressor epithelial mechanism plays tumor factor poorly rest neuronal tissues transcription | Reference Offset: [22755-23062', 32072-32318', 944-1088'] | Reference Text: repressing characterized genes regulator factor transcriptional molecules silencing neuronal transcription tissues aberrant suppresses tumorigenesis inhibition mechanism transformation signals response signaling reduced rest activation transcriptional suppressor tumor neuronal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 9 | Citation Text: factor published | Reference Offset: [5452-5924', 5214-5450', 6952-7314'] | Reference Text: additionally genes differentiated circuitry mirna factor transcriptional mrna regulation examined core types occupancy es transcription sites genes sequences mirna factor close prior transcriptional mature binding es regulators transcription sites mouse provide location mirna factor sequencing mirnas fate transcriptional regulatory start program primary quantitative types es mechanisms transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 1 | Citation Text: dependency a549 selected k-ras h23 strong oncogenes h358 lines end | Reference Offset: [11110-11323', 5016-5251', 4241-4507'] | Reference Text: a549 k-ras sensitivity inhibitors similarly inhibition h358 revealed kinases dependency nsclc lines mek a549 k-ras ablation harbor mutations proliferation activating h358 effects initially lung viability lines assessed k-ras requirement basis maintaining dependency sustained stratify viability features lines mutant large cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 12 | Citation Text: harbor pathway amplifications suppresses death similarly patient-derived tumors toll-like breast lines overexpressed amplified cancer ikbke inducing | Reference Offset: [1404-1570', 1572-1682', 19539-19725'] | Reference Text: reveal patient-derived tumors structural kinases breast lines analyses overexpressed amplified cancer ikbke breast suppression harbor amplifications death lines ikbke cancer induces fraction tumors observations breast kinase transforming primary lines overexpressed amplified cancer substantial ikbke | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 20 | Citation Text: ras-transformed obtained loss line ras clear h-rasv12 receptor thyroid domain frtl-5 expressing estrogen differentiation ligand oncoprotein -sensitive fusing system downstream binding conditional mutant inducible | Reference Offset: [15837-16196', 30214-30514', 1052-1275'] | Reference Text: obtained ras h-rasv12 receptor domain frtl-5 expressing extend tamoxifen estrogen ligand experimental effects oncoprotein -sensitive fusing system generated downstream context binding conditional mutant confirm inducible tamoxifen estrogen dependent ligand experimental established chimeric ras resulting setting h-rasv12 system receptor domain binding oncogene mutant inducible ras-transformed obtained loss genes differentiation measured pcr thyroid-specific ras clear presence oncogene frtl-5 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 13 | Citation Text: development marker thyroid clinical tsh cancer elevated | Reference Offset: [33034-33236', 391-540', 542-668'] | Reference Text: presence marker thyroid activated differentiated tumors poorly ras cancers mutations activating thyroid ras cancer carcinoma thyroid differentiated phenotype aggressive cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 16 | Citation Text: inhibits oncogenic thyroid differentiation ras | Reference Offset: [2619-2877', 6197-6519', 26802-27051'] | Reference Text: loss differentiation contribute partial ras cancers prognosis observations oncogenic thyroid depends aggressive systems essential responsible maintenance differentiation induction understanding finally molecular ras factors oncogenic thyroid mechanisms inducible transcription loss differentiation show ras rat induces level oncogenic thyroid interference cultured low growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 2 | Citation Text: critical oct4 sox2 additionally genes differentiation affect early | Reference Offset: [590-800', 802-1086', 1779-2078'] | Reference Text: oct4 essential lineage differentiation state embryonic factor adult implicated mediator stem homeodomain cancer transcription networks facilitate oct4 repressing lineage genes differentiation maintain recent transcriptional dual regulatory description pluripotency required self-renewal activation structure oct4 genes differentiation state lead regulating experiments respond roles pluripotency consistent chromatin self-renewal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 4 | Citation Text: mir-223 pluripotent immune numerous differentiation mir-181a mirnas implicated presence widely inflammatory bone regulation hematopoietic stem pathways intracellular thymus regulate marrow | Reference Offset: [3931-4140', 12379-12660', 1081-1360'] | Reference Text: mir-223 exclusively differentiation stages primary bone myeloid hematopoietic stem marrow mouse mir-223 uncover lineage differentiation mirna effects mirnas vectors ectopic bone hematopoietic viral marrow mouse fraction differentiation adult mirnas assays mice stem/progenitor led bone ectopic hematopoietic marrow | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 4 | Citation Text: inactivation therapeutic genetic target regression tumor validated targets | Reference Offset: [41516-41709', 47619-47854', 4562-4759'] | Reference Text: serve limited k-ras responsible therapeutic tumor type effective mediating signaling effectors stem directly targets allowed mouse pathway therapeutic synthetic lethal tumor models nsclc cdk4 identification recently k-ras-driven approaches targets kinase cycle pathway cdk4 therapeutic recently synthetic lethal approaches targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 4 | Citation Text: work fashion k-ras revealed ras recent apparatus isoform pm retrograde golgi | Reference Offset: [4249-4421', 33603-33823', 12934-13182'] | Reference Text: membranes k-ras pkc rapid apparatus induced pm translocation golgi included intracellular reticulum endoplasmic involves trafficking intermediate demonstrating ras membrane pm retrograde golgi fashion k-ras targeting pkc induces promote recruitment pm activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 11 | Citation Text: kras result single defined pathway inhibitors depend normal mutation tumor nsclc recently target induced gata2 mutant | Reference Offset: [1700-2032', 6830-7115', 8687-8785'] | Reference Text: kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth causing kras loss therapeutic inhibitors inhibition strategy established finally clinically combined suppression nsclc gata2 pathways mutant kras findings nsclc depend gata2 mutant survival | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 17 | Citation Text: ros transport chain electron established accumulation diseases mitochondrial aging | Reference Offset: [15480-15708', 21377-21514', 32765-32944'] | Reference Text: altered ros chain transport modifications electron components growing formation affected transcriptionally genomic chain transport electron components recent aging result flux ros alternative reduced chain transport electron pathways generation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 7 | Citation Text: kras understand pathway link h358 line requires lung nsclc perk viability oncogenic context oncogene cancer | Reference Offset: [5016-5251', 24219-24418', 34823-35033'] | Reference Text: a549 k-ras ablation harbor mutations proliferation activating h358 effects initially lung viability lines assessed k-ras death resulted h358 play line dependency setting pancreatic roles context yapc suggesting knockdown cancer lung loss inhibitors link oncogene egfr cancers | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 11 | Citation Text: region loss cases brca1 importantly suppressor inpp4b tumor 4q31 39 60% occurs cancers breast 21 heterozygosity ovarian chromosomal mutant cancer | Reference Offset: [18245-18453', 1429-1694', 17153-17436'] | Reference Text: involvement loss decreased correlates inpp4b occurs cancers basal-like breast patient heterozygosity ovarian locus survival frequently fraction lower majority suppressor finally tumor inpp4b cancers breast basal-like patient ovarian correlated suggesting locus survival find subtypes patterns loss brca1 mutation revealed triple-negative tumors 4q31 predominantly comparison breast 21 carrying patients heterozygosity grade cancer major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 19 | Citation Text: previous provide fibroblasts evidence determined up-regulated endothelial regard primarily | Reference Offset: [37403-37618', 2247-2484', 3792-3897'] | Reference Text: extracellular provide lymphocytes matrix endothelial mechanism chemokines presented migration provide induction structurally related signals motility molecules adhesion group chemokines small activation frequently membrane-bound inflammatory fractalkine primary induced endothelial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 9 | Citation Text: result selective genes upregulation hypoxia create response survival microenvironment growth | Reference Offset: [24041-24303', 4653-4824', 7189-7357'] | Reference Text: pathway death damage hypoxia factor response activate signaling dna action oncogene survival intracellular surrounding basis operate microenvironment circuits signals stimulation generate normal tissue tumor microenvironment growth signals | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 14 | Citation Text: inactive h3k4me3 genes modifications active chromatin | Reference Offset: [6228-6460', 5927-6226', 7955-8310'] | Reference Text: sites transcript oct4 reveal mirna tcf3 nanog transcriptional sox2 start transcripts highly method occupancy chromatin based sites model circuitry mirna sequencing transcriptional factors regulatory regulation binding es chromatin genome-wide key transcription allowed sites protocol modifications murine factor chip-seq binding es transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 18 | Citation Text: ros postulates species oxygen oxidative damage theory accumulation caused free reactive radical phosphorylation aging | Reference Offset: [228-370', 54342-54508', 491-687'] | Reference Text: postulates oxygen species theory production free intracellular reactive radical major aging basis range species remains theory free initial years radical 50 aging metabolism evidence link theory growing mitochondrial free radical formation aging | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 1 | Citation Text: ptpn12 fraction loss common uncover issue triple-negative molecular breast tyrosine phosphatase feature large | Reference Offset: [1956-2297', 54634-54710', 54711-54829'] | Reference Text: ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer breast tyrosine ptpn12 suppressor phosphatase tumor cancer breast tyrosine ptpn12 demonstrate potent suppressor phosphatase tumor cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 18 | Citation Text: direct apoptosis inhibition kill upregulated tumor bax/bak mitochondrial antiapoptotic displacement induced activator bh3-only antiapoptotics activation | Reference Offset: [4759-4962', 48997-49246', 51056-51293'] | Reference Text: oligomerization term induce binding class bh3-only activator bax/bak antiapoptotic model bak apoptosis exclusively inhibition interacting antiapoptotic present bcl-2 proapoptotic bax family bh3-only multidomain members preventing model bak apoptosis tbid antiapoptotic bcl-2 sequestering family activator inhibit consistent required activation members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 21 | Citation Text: methods class good correlation-based selection include subset representative highly correlated method feature | Reference Offset: [19687-20063', 9887-10047', 16754-16935'] | Reference Text: genes set algorithm 20 selected vector detailed feature support class correlation-based selection supervised classification method genes 40 highly correlated class individual genes 10 40 leukemia highly correlated | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 1 | Citation Text: p53 prb fibroblasts sirna v12 h-ras st sv40 | Reference Offset: [25780-26022', 4472-4657', 4923-5006'] | Reference Text: tubulin antibodies h-ras lt p21 p53 prb cdk4 directed report st sv40 p14arf p53 prb oncogenic phosphatase st lt assays growth inactivation cellular p53 prb primary fibroblasts transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 9 | Citation Text: evidence mirna influences mirnas exert pleiotropically apparent action capacity invasion ostensibly utilized mesenchymal multiple targets key networks migration potent attributable tumor effects include signaling strong mir-31 program motility downstream provided core components regulate | Reference Offset: [8818-9059', 588-816', 1201-1487'] | Reference Text: attributable mir-145 failed mirna effects biological fact mir-31 motility overexpression invasion activities specifically repress genes numerous metastasis tumor steps invasion-metastasis potentially micrornas cascade target capacity multiple regulate site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 11 | Citation Text: cycle animals compound decreased importantly ras-induced possibility express p53 target senescence proliferative due inhibitor mutant compartments | Reference Offset: [12696-13157', 30806-31021', 683-820'] | Reference Text: ras-induced induction potential lack detection arrest additional senescence examined active overexpression activator inhibitor ph facilitate mutations program importantly senescence ras-induced accumulation cellular p53 arrest induced senescence ras accumulation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 13 | Citation Text: pretrosuper prs-blast prs-hygro | Reference Offset: [26036-26216', 266-318', 320-411'] | Reference Text: pretrosuper generated resistance replacing prs-hygro locus inactivated cancer p53 p16ink4a prb inhibit growth p14arf | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 14 | Citation Text: 4-phosphatase pip2 regulation ii negative inositol dephosphorylates type polyphosphate | Reference Offset: [4584-5938', 772-1021', 3095-3262'] | Reference Text: 4-phosphatase ii phosphate inositol type rat polyphosphate initially enzyme pip2 brain 4-phosphatase anchorage-independent resulted ii epithelial inositol type enhanced polyphosphate knocking akt motility report knockdown activation growth pten family phosphatases pip2 dephosphorylates produce pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 8 | Citation Text: essential mek1lox/lox induced tumors | Reference Offset: [19594-19782', 12451-12642', 15011-15178'] | Reference Text: essential development tumors tumor partial mice presence mek1lox/lox due treated mek1 essential development tumors erk2 tumor mice presence due treated individual recombination revealed tumors mice mek1lox/lox | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 4 | Citation Text: assay peptide-induced specificity reflects bh3 lysates full-length native bax peptides suggesting construct consistent relevant activation | Reference Offset: [25320-25516', 554-708', 710-942'] | Reference Text: model bak domains conformational bh3 receptors sufficient bax peptides activation bak oligomerization domains bh3 capable short bax peptides bim release bid find inducing cytochrome bak characterized domains bh3 bad mitochondrial antiapoptotic resulting subset activate bcl-2 binds bax initiate displacement bik peptides directly | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 13 | Citation Text: t315i potent mutant | Reference Offset: [8812-9063', 24422-24675', 1302-1464'] | Reference Text: potent ap24534 inhibition abl mutants kinase native additional imatinib-resistant mutant directly targets cellular potent proliferation expressing ap24534 inhibition assays bcr-ablt315i confirmed native bcr-abl mutant potent multi-targeted ap24534 mutants t315i kinase report active bcr-abl inhibitor design | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 9 | Citation Text: position ring 4-phosphatase pathway phosphatidylinositol ii phosphate inositol type polyphosphate enzyme involved signaling regulatory | Reference Offset: [4584-5938', 772-1021', 35534-35704'] | Reference Text: 4-phosphatase ii phosphate inositol type rat polyphosphate initially enzyme pip2 brain 4-phosphatase anchorage-independent resulted ii epithelial inositol type enhanced polyphosphate knocking akt motility report knockdown activation growth pten signaling pathway phosphatase plays inpp4b show tumor suppressing pi3k/akt pten growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 1 | Citation Text: crucial guanine nucleotide hydrolysis enhance gtpases signaling factors gtpase-activating binding rho exchange | Reference Offset: [487-668', 670-824', 19729-19846'] | Reference Text: cellular functions gtpase-activating factors guanine nucleotide-binding nucleotide small exchange regulate catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing site catalytic nucleotide binding ras exchange distinct | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 6 | Citation Text: cloned lats2 pretrosuper figure targeting constructs sequences knockdown | Reference Offset: [3067-3315', 8091-8211', 3565-3646'] | Reference Text: cloned promoter targeting sequence signal transcript sirna sequences predicted utilized knockdown constructs transfected dna sirna synthetic | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 3 | Citation Text: member lats2 pathway lats inhibition suppressor tumor plays suppression family central growth | Reference Offset: [682-739', 4619-4758', 30522-30749'] | Reference Text: member lats2 lats family suppressor tumor member lats2 lats family mammalian suppressor tumor member lats2 cycle development lats suppressor regulator transition tumor inhibits involved family g1/s negative presented | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 9 | Citation Text: typically mouse model involves murine kinases programmed lines necrosis zebrafish | Reference Offset: [6458-6710', 26324-26484', 26791-27001'] | Reference Text: rip rip1 rip3 kinases family library programmed necrosis sirnas model failed jurkat rip3 type kinase inactive programmed necrosis mutant consistent functions ros rip1 rip3 kinases programmed downstream increase necrosis components | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 4 | Citation Text: level conservation residue egfr structures | Reference Offset: [5669-6003', 6829-6878', 18442-18574'] | Reference Text: complexes mutations revealed interaction effects abl molecular structures point kinase imatinib domain binding chemical imatinib structures inactive imatinib abl conformation bind structures | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 7 | Citation Text: direct loss pathway mutation suppressor tumors tumor upstream p53 bax downstream effectors inactivated regulators p14arf | Reference Offset: [423-576', 11949-12202', 17241-17387'] | Reference Text: p53 suppressors tumor disrupted factor cancer regulators transcription retinoblastoma inactivation cyclin pathway provide events exclusive evidence mutation tumor epigenetic resulting rb deletion d1 mutually p16ink4a signaling cdk4 genetic overexpression silencing p53 potent activates suppressor alternative tumor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 7 | Citation Text: necroptosis inhibits cyld fadd jurkat cultured lack factor knockdown apoptotic | Reference Offset: [10503-10602', 10359-10501', 10173-10357'] | Reference Text: necroptosis cyld inhibition jurkat necroptosis cyld fadd-deficient jurkat inhibit confirm sirnas cyld individual necroptosis l929 figure efficiency knockdown sirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 2 | Citation Text: duplexes rnai interfering rna induced silencing directly tissues pathway expressing transient sirna hairpin transcriptional mediate small | Reference Offset: [520-651', 5456-5660', 10936-11127'] | Reference Text: system vector mammalian report rnas psuper interfering synthesis small vectors mcf-7 oligonucleotides sequence transient experiment sirna synthetic ability targeted clones obtained level transient sirna comparable detected production stable | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 5 | Citation Text: site facilitate magnesium nucleotide-binding gefs | Reference Offset: [6833-7052', 10207-10285', 10606-10851'] | Reference Text: released site decreased subsequently nucleotide-binding nucleotide gefs affinity site nucleotide-binding site nucleotide-binding switch binds forms | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 12 | Citation Text: generate sequences gene-specific act sirnas | Reference Offset: [368-518', 833-1024', 2261-2498'] | Reference Text: generate phenotypes genetic loss-of-function mammalian efficiently lack approaches stable mediates stable suppression time phenotypes loss-of-function vector develop sirnas site transcript synthetic nucleotides sirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 7 | Citation Text: impaired commitment differentiation preferential recent led vitro tet2 myeloid hematopoietic depletion | Reference Offset: [1693-1890', 43625-43903', 1904-2225'] | Reference Text: stem/progenitor impaired marker tet2 differentiation idh1/2 hematopoietic suggesting finally mutant depletion normal inhibition differentiation effects idh2 mutants stem/progenitor tet2 myeloid increase hematopoietic reduction hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 6 | Citation Text: potent sensitivity phenotype kinase identical akt treated src reduction inhibitor phosphorylation | Reference Offset: [1302-1464', 5363-5704', 2726-2843'] | Reference Text: potent multi-targeted ap24534 mutants t315i kinase report active bcr-abl inhibitor design range mutations abl disease cml bcr-ablt315i kinase enzyme approved level domain potent capable matching native bcr-abl inhibitor kinase point involves mutations imatinib domain resistance binding bcr-abl inhibitor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 1 | Citation Text: cyclin radiation genotoxic stress ionizing p53-independent activate d1 degrade arrest mammalian g1 triggers | Reference Offset: [749-980', 21486-21697', 484-599'] | Reference Text: cyclin cellular degradation essential genotoxic prevents damage stress indicating response d1 arrest dna component g1 interference initiation cyclin degradation genotoxic transient stress d1 arrest overexpression g1 abolished initiation mutant cyclin d1 arrest dna damage g1 show proteolysis p53-independent rapid caused | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 6 | Citation Text: h-rasv12 lose expressing differentiation lines stable | Reference Offset: [779-1050', 27548-27780', 5396-5554'] | Reference Text: cellular constitutively expressing differentiation origin established oncoprotein effects ras analyze generated thyroid active lines frtl-5 viral forms stably status expressing genes differentiated maintain thyroid-specific ras rat lose transfected oncogenes oncogenic primary lines thyrocytes cellular clones expressing numerous established h-rasv12 oncogenes activated isoform frtl-5 viral stably | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 9 | Citation Text: anchorage-independent give rise mammary epithelial inpp4b collection growth | Reference Offset: [668-784', 4689-4856', 5924-6133'] | Reference Text: screen genetic mammary genes report epithelial suppress transformation model defined identify genes epithelial transformation mammary oncogenic genetic approach utilized suppress arise genes epithelial cancers mammary increase derived tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 20 | Citation Text: v28 termed mediated receptor seven-transmembrane domain cx3cr1 adhesion properties chemotactic | Reference Offset: [921-1181', 21161-21288', 30664-30946'] | Reference Text: termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion v28 direct chemokine responsible receptor domain adhesion engagement functions complex chemokine class properties molecular cx3c represents nature fractalkine receptor molecules adhesion chemokines | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 6 | Citation Text: site recognition strand selection coexpression rna target silencing end accessibility | Reference Offset: [21690-22100', 2820-3077', 4029-4240'] | Reference Text: site rna wild-type zebrafish dead end mutated nt complex strand mirnas mature cytoplasm silencing duplex process rna target lead mirna stability mirnas alter selection | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 13 | Citation Text: ros oxygen species normal production conditions mitochondria respiratory importance source chain generally primary aerobic reactive small energy produce | Reference Offset: [228-370', 2960-3119', 4205-4598'] | Reference Text: postulates oxygen species theory production free intracellular reactive radical major aging oxygen species research production potentially reactive central aging oxygen metabolic enzymes initially free respiratory generally suggesting hypothesis direct support experimental interaction molecular involved source radicals consistent early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 9 | Citation Text: strategies functions therapeutic considerable genes evidence normal potentially dependencies develop cancer | Reference Offset: [2567-2725', 4986-5106', 5777-5976'] | Reference Text: therapeutic inhibitors exhibit striking tyrosine kinase nsclc patients rtks resistance develop mutant dependencies therapeutic combination inhibit multiple strategies development therapeutic inhibitors candidate finally clinically factors provided screens derived drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 2 | Citation Text: relieves conserved mirna mirnas regions close located repression uridine-rich directly dead end prohibits sites homolog rbp associating rbps target binding | Reference Offset: [1248-1543', 1125-1246', 3079-3352'] | Reference Text: sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding serve docking mrnas conserved mirna regions animals translation seed mirnas regions mrnas sequence mrna inhibiting utilize suppress end | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 4 | Citation Text: sites recognized docking translation genes stability regions level mediate regulatory micrornas rna mrna regulation binding major | Reference Offset: [3079-3352', 5663-5863', 14343-14633'] | Reference Text: animals translation seed mirnas regions mrnas sequence mrna inhibiting utilize suppress end unique translation mrna stability rna-binding lats2 translation inhibition stability rt-pcr endogenous affected protects mirna-mediated mrna dnd1 suggesting quantitative reduction | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 10 | Citation Text: kinase aurora-a regulating localization centrosomal target plays phosphorylation | Reference Offset: [1193-1377', 8832-8940', 32144-32220'] | Reference Text: lats2 aurora-a s83 basis localization centrosomal target plays phosphorylation observations lats2 localization centrosomal plays show phosphorylation lats2 s83 localization centrosomal plays phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 11 | Citation Text: damaged mitochondria ros source oxidized generation mitochondrial | Reference Offset: [6393-6624', 11215-11447', 11450-11619'] | Reference Text: ros generate oxidative controlled potential mitochondrial process membrane phosphorylation generation energy site systems ros capable surprisingly believed fact source terminal vitro generation cytochrome intact mitochondria ros describe construct generation mechanisms | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 16 | Citation Text: lats2 essential domains functional suppressor tumor lcd1 lcd2 regions showed v-ras nih3t3/ abolished suggesting fully | Reference Offset: [25048-25240', 682-739', 2144-2206'] | Reference Text: lats2 lats provide tumorigenesis family mammalian evidence suppressor experimental tumor suggesting members member lats2 lats family suppressor tumor lats2 cycle suppressor transition tumor g1/s | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 4 | Citation Text: lck immunological cd2 synapse | Reference Offset: [34682-34920', 36027-36117', 774-937'] | Reference Text: obtained support form cd2ap immunological cd2 cytoskeletal blocked synapse formation clustering result lfa-1 cd2 immunological synapse clustering formation process demonstrate cytoskeletal cd2 ligand adhesion molecule engagement clustering | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 1 | Citation Text: plated cultures measured relative growth | Reference Offset: [8062-8211', 7735-7915', 8747-8900'] | Reference Text: measured cytometry h-ras flow representative vector cultures h-ras growth plated vector v12 h-ras low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 11 | Citation Text: promoter retinoic mir-223 previous importantly differentiation induction conserved revealed experimental line -induced system acid all-trans active nb4 apl | Reference Offset: [784-1003', 11431-11674', 31305-31475'] | Reference Text: retinoic mir-223 nfi-a differentiation -induced factors acid binding low mir-223 induce lineage differentiation specificity induction studied response activated nb4 hematopoietic apl retinoic granulocytic acid vitro rna mediated differentiation myeloid upregulated apl vivo specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 2 | Citation Text: mir-223 nfi-a assay mir-124 interaction putative rapid luciferase cloned reporter detection vitro downstream target approach targets | Reference Offset: [21042-21273', 5206-5544', 19151-19380'] | Reference Text: site mir-223 nfi-a assay set mirna putative luciferase order mrna target downstream mir-223 computational nfi-a genes sequences factor putative related involved binding bind targets growth transcription mir-223 nfi-a sequences predicted factor related regulatory bind targets transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 14 | Citation Text: | Reference Offset: [266-318', 320-411', 413-532'] | Reference Text: locus inactivated cancer p53 p16ink4a prb inhibit growth p14arf vectors analyze functions rna primary interference assays transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 4 | Citation Text: p6 machinery complexes loss budding defect mutation virus caused short transport domain sorting required directly motifs gag peptide demonstrated biogenesis multivesicular phenotype endosomal components bodies bind early | Reference Offset: [7129-7357', 31507-31743', 38396-38543'] | Reference Text: p6 machinery budding tumor hiv-1 susceptibility late domain report sorting facilitates required release p6 detect budding ptap motif ubiquitin hiv-1 event domain tsg101 suggesting participate required bind mvb cellular machinery facilitate hiv-1 gag budding tsg101 virus bind formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 2 | Citation Text: form induce primary activated fibroblasts senescence ras | Reference Offset: [4638-4811', 5782-6003', 5546-5780'] | Reference Text: established murine transformed ras lacking p53 oncogenic immortal primary fibroblasts lines display ras transformation coexpression cooperating primary fibroblasts immortal require oncogene growth systems mouse normal embryo line effects ras rat oncogenic primary fibroblasts | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 11 | Citation Text: processes involved segregate transport molecules active size | Reference Offset: [33068-33219', 4484-4626', 11671-11877'] | Reference Text: involved recently proposed molecules contact formation include size facilitate tcr molecules adhesion formation engagement size residues localization cd2 contact requires size 20 initial mediated c-terminal molecules adhesion central | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 11 | Citation Text: 21 newly classification 22 children signatures accuracy | Reference Offset: [20249-20469', 1301-1435', 3756-4028'] | Reference Text: model test set class samples achieved remaining classification accuracy genes subgroups leukemia insights provided signatures subtypes individual pathogenesis variety figure genetic classification leukemia parameters clinical alterations 2001 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 8 | Citation Text: system oncogenic treatment tamoxifen activated ras | Reference Offset: [15837-16196', 30214-30514', 31061-31379'] | Reference Text: obtained ras h-rasv12 receptor domain frtl-5 expressing extend tamoxifen estrogen ligand experimental effects oncoprotein -sensitive fusing system generated downstream context binding conditional mutant confirm inducible tamoxifen estrogen dependent ligand experimental established chimeric ras resulting setting h-rasv12 system receptor domain binding oncogene mutant inducible allowed direct rapidly inhibition differentiation induction effects ras demonstrating appears analyze system time oncogenic thyroid frtl-5 early activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 11 | Citation Text: generate sequences gene-specific act sirnas | Reference Offset: [368-518', 833-1024', 2261-2498'] | Reference Text: generate phenotypes genetic loss-of-function mammalian efficiently lack approaches stable mediates stable suppression time phenotypes loss-of-function vector develop sirnas site transcript synthetic nucleotides sirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 3 | Citation Text: subset kras previous oncogenic pancreatic dependent consistent survival cancer observations | Reference Offset: [7663-7895', 22242-22559', 28818-29087'] | Reference Text: result k-ras rnai ablation proliferation previous death affect apoptotic pancreatic mutant cancer k-ras ablation shrnas post-transcriptional genes resulted h358 indicating affect transcriptional dependency subset integrin reduced oncogenic signature k-ras line tumor express samples cancers subset dependency findings well-differentiated cluster suggesting significantly mutant consistent signature | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 16 | Citation Text: erk requirement crucial pathway development regard nsclcs related kras-driven propose repression increase capacity formation | Reference Offset: [702-775', 5249-5420', 5589-5668'] | Reference Text: erk development blocked tumor kinases erk essential development mutations tumor kinases investigate mice carrying encoding raf end mek erk individual prevent nsclcs kinases | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 4 | Citation Text: contrast obtained ablation importantly raf-1 established regression effectors tumors interfering ras | Reference Offset: [24981-25269', 1200-1346', 1348-1508'] | Reference Text: model ablation gtpase similarly potential tumor factor ras reduce skin carcinogenesis genetic recently tiam1 effectors small exchange rac formation signaling gtpase oncogenes oncogenic activated tumors pathways ras mutated guanine nucleotide ras phosphoinositide-3 kinases gtpases factors ral effectors raf small multiple exchange rac | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 17 | Citation Text: expressing cx3cr1 act soluble | Reference Offset: [26115-26290', 40200-40484', 2952-3031'] | Reference Text: surface expressing collectively leukocytes v28 subsets phenotypes fractalkine receptor mrna correlated soluble potent expressing induction chemotaxis enhanced fractalkine cx3cr1 adhesion blocked soluble chemokine lymphocytes act appears | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 2 | Citation Text: member bcl-2 lost additional family bcl-xl inhibit bad | Reference Offset: [19494-19702', 27315-27591', 397-552'] | Reference Text: mitochondria bcl-2 bcl-xl capacity inhibit murine endogenous wt sensitive bcl-xl display interaction bad assays antiapoptotic lysates bcl-2 bik binding bh3-only members intact bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 13 | Citation Text: methods region computational genes developed thermodynamic mirna stability matches seed targetscan prediction sequence predict target approaches based duplex | Reference Offset: [6961-7319', 56839-57184', 21274-21513'] | Reference Text: identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions nt location seed line targetscan 25 structures positions represents matches sequence generated duplex mouse defined set seed conserved targetscan mirna rat algorithm predict hypothesis targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 12 | Citation Text: metastatic issue metastasis capable mirnas breast regulating extent mir-31 recently provided unresolved cancer specifically | Reference Offset: [3895-4285', 4787-4870', 818-965'] | Reference Text: proliferation development remains apoptosis metastasis tumor influences mirnas affect exert potentially extent and/or primary unclear specifically breast mir-31 metastatic lines cancer specifically breast patients mir-31 identify metastasis correlates microrna cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 4 | Citation Text: work system mir-223 previous regulation experimental | Reference Offset: [35958-36092', 35243-35458', 622-782'] | Reference Text: site mir-223 nfi-a target experimental mir-223 nfi-a mirna findings regulation produces activator hypothesis low transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 1 | Citation Text: member form events bcl-xl interaction bcl-2 independently additional bax family participate directly | Reference Offset: [28392-28543', 397-552', 710-942'] | Reference Text: bak bcl-xl preferential interaction assays antiapoptotic prior bcl-2 proapoptotic bax binding bim intact bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome bak characterized domains bh3 bad mitochondrial antiapoptotic resulting subset activate bcl-2 binds bax initiate displacement bik peptides directly | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 19 | Citation Text: mice c-raf inhibits lung model ablation ras-driven development adenocarcinoma progression tumors | Reference Offset: [4364-4560', 4169-4362', 9143-9331'] | Reference Text: model ablation resulted tumor tumors regulatory encoding subunits reduction developed prevents mutation tumors interaction ras mice lung subunit carrying significantly likewise erk2 tumors mice lung due derived detected | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 6 | Citation Text: erk guanine nucleotide aspects lead long ras distinct gtpases activated effectors multiple exchange activation mitogenic pathway contribute transformation phosphoinositide-3 kinases implicated signaling factors ral survival small rac raf/mek/erk | Reference Offset: [1348-1508', 2667-2995', 364-526'] | Reference Text: guanine nucleotide ras phosphoinositide-3 kinases gtpases factors ral effectors raf small multiple exchange rac gtpase guanine gdp state nucleotide hydrolysis gtp response gtpases exchange formation extracellular effects signals signaling factors promote active small bound deficient gtpase activates guanine nucleotide factor ralgds investigate mice signaling ral generated small exchange | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 4 | Citation Text: treatment cml patients respond crisis develop phase | Reference Offset: [5160-5358', 5908-6284', 1750-1952'] | Reference Text: mutations blast chronic cml response patients initial imatinib myeloid crisis detected phase clones mutations blast provide treatment evidence selection observations prior independent kinase patients additional domain myeloid imatinib-resistant crisis develop detected multiple mutations frequency disease cml stages present kinase patients imatinib domain resistance bcr-abl develop | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 2 | Citation Text: complex basis treatment agents diseases response patient developing targets drug information patterns subsequent translational signatures molecular research variety include transcriptional lines discovery design | Reference Offset: [4030-4265', 35125-35312', 40834-41074'] | Reference Text: subtypes defined genes subsequent molecular distinct targeted rearrangements leukemia genetically chromosomal tyrosine kinase therapeutic receptor agents genes developed targets treatment pediatric molecular outcome database generated leukemia detailed profiles | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 15 | Citation Text: untreated total k-ras cultures dependent phosphorylated good recent mitochondrial confirmed membrane pkc-dependent suggesting portion plasma localization serine conditions steady-state 181 outer fibroblast translocation group phosphorylation | Reference Offset: [4423-4576', 21631-21971', 36352-36535'] | Reference Text: surprisingly k-ras membranes outer membrane bcl-xl phosphorylated included mitochondrial k-ras localization apoptosis phosphorylated affect mitochondrial mutants mitochondria viability sequence c-terminal suggesting golgi required k-ras basis phosphorylated affinity mitochondrial presence outer membrane reflect | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 20 | Citation Text: c-raf essential development recently k-ras-driven nsclcs | Reference Offset: [24569-24645', 27115-27183', 45308-45463'] | Reference Text: c-raf essential mediate signaling oncogenic nsclcs c-raf essential development tumor essential ras-driven pathway development maintenance recently tumors | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 9 | Citation Text: point mutations similarly treatment imatinib occurring bcr-abl | Reference Offset: [28400-28631', 495-757', 857-1066'] | Reference Text: selective mutations collectively treatment capable cml kinase imatinib domain resistance bcr-abl natural occur mutations chronic sequencing disease samples response tyrosine kinase patients initial imatinib bone leukemia domain myeloid bcr-abl inhibitor marrow amino mutations conformational state prevent contact alter inactive imatinib binding bcr-abl directly required | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 15 | Citation Text: cases activating translocations deletion tal1/scl t-all factors oncogenic undefined chromosomal overexpressed mechanisms transcription | Reference Offset: [10994-11239', 33705-33939', 2015-2335'] | Reference Text: cases genes possibility alternative factor express transformation oncogenic mechanisms transcription thymocyte patterns alternative signatures samples related lacking t-all factors leading oncogenes predict initiate oncogenic activation transcription aberrant methods obtained genes rt-pcr disease rearrangements transforming dna event clinical hypothesis central key activation transcription support absence factor samples analyze t-all combination microarray chromosomal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 15 | Citation Text: erk lung kras-driven essential importantly tumorigenesis recently nsclcs phosphorylation | Reference Offset: [5249-5420', 5589-5668', 9603-9753'] | Reference Text: erk essential development mutations tumor kinases investigate mice carrying encoding raf end mek erk individual prevent nsclcs kinases erk change downstream finally erk2 phosphorylation erk1 substrate well-known | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 16 | Citation Text: events mirnas network extensive findings search differential binding knockdown based transcription | Reference Offset: [27593-27930', 9491-9684', 31041-31248'] | Reference Text: direct effects mirnas transcriptional factors binding proposed suggesting participate es based targets transcription vertebrates sites limited events identify mirna factor imperfect start transcripts primary binding ability transcription post-transcriptional contribute mirnas network transcriptional factors regulation core es transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 9 | Citation Text: lats2 centrosomes lats1 interphase detected mitotic | Reference Offset: [27361-27668', 461-559', 27670-27790'] | Reference Text: lats2 reports aurora-a previous interphase mitotic localized centrosomes early mitosis lats2 lats1 apparatus phosphorylated mitotic localized centrosomes lats2 confirmed interphase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 4 | Citation Text: oxidative metabolism disruption accumulation mitochondrial conditions cytotoxic free leads radicals regulation depletion energy | Reference Offset: [491-687', 6393-6624', 20554-20840'] | Reference Text: metabolism evidence link theory growing mitochondrial free radical formation aging ros generate oxidative controlled potential mitochondrial process membrane phosphorylation generation energy sensitivity oxidative damage production mitochondrial mitochondria leads led dna initial increase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 14 | Citation Text: inactivation gtpase guanine nucleotide state hydrolysis gtp gefs gaps gtpases factors small bound activation exchange regulators key | Reference Offset: [487-668', 670-824', 1398-1605'] | Reference Text: cellular functions gtpase-activating factors guanine nucleotide-binding nucleotide small exchange regulate catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing cycle catalytic essential provide induce gdp hydrolysis gtp gefs abundant gaps highly regulated group release bound | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 23 | Citation Text: constructs p53kd shrna | Reference Offset: [6901-7159', 10872-11136', 12016-12111'] | Reference Text: mcf-7 p53 constructs prb transient sirna active inhibit assays prs-gfp constructs hela transient sirna retroviral assays produced vectors cloned p16ink4a active prs-hyg viral p14arf constructs hela sirna prs-hygro | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 13 | Citation Text: u937 hl-60 ester phorbol days terminal differentiation method stimulate 100 | Reference Offset: [24614-24723', 12080-12220', 13014-13172'] | Reference Text: ester phorbol terminal undergo leukemia differentiation lines stimulate u937 terminal pathway differentiation u937 days treatment leukemia differentiate induced lines | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 16 | Citation Text: catalyzing opposite controlled switch gtp steps gefs gaps small | Reference Offset: [670-824', 1398-1605', 5822-5937'] | Reference Text: catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing cycle catalytic essential provide induce gdp hydrolysis gtp gefs abundant gaps highly regulated group release bound gaps regulated molecular small mechanisms gefs | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 15 | Citation Text: biochemistry transduction understanding tumors signal time phenotypes operate formed case years cancer circuits | Reference Offset: [4653-4824', 13869-13964', 42234-42436'] | Reference Text: surrounding basis operate microenvironment circuits signals signaling majority operate tumors growth mouse appearance tumorigenesis tumors prior models lesions analyzed activated case | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 1 | Citation Text: bcl-2 proapoptotic and/or activated bcl-xl tumor depends survival mcl-1 antiapoptotic | Reference Offset: [523-714', 1607-1874', 7547-7671'] | Reference Text: unique domains bcl-xl bh3 show interaction antiapoptotic bcl-w bcl-2 pattern peptides bh3-only derived mcl-1 cellular individual bcl-xl show mitochondrial antiapoptotic bcl-w response bcl-2 family peptides mcl-1 based members bcl-w bcl-2 transfected bcl-xl fusion mcl-1 antiapoptotic | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 9 | Citation Text: mutations exclusively absence hela interestingly ptap motif structures localized hiv-1 wild-type pm mutant | Reference Offset: [991-1101', 1705-1854', 3000-3204'] | Reference Text: hiv-1 arrest vps4 budding sorting inhibit negative mutant dominant particle hiv-1 gag absence required viral production proteolytic residues p6 single mutations substitutions shows caused free hiv-1 tsg101 binding energy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 11 | Citation Text: lymphoblastic defined lyl1 upregulation phenotype acute prognosis t-cell subtype leukemia linked | Reference Offset: [1806-2013', 3004-3148', 1281-1501'] | Reference Text: subtypes lymphoblastic lineage line pathogenesis molecular research impact leukemias acute remain undefined largely leukemia lymphoblastic cases thymocytes pediatric leukemia adult disease malignant acute lyl1 treatment tal1 prognosis response surprisingly findings importance significantly clinical activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 5 | Citation Text: tyrosine ptpn12 receptor contexts tumor recent kinases | Reference Offset: [1633-1885', 884-981', 1214-1342'] | Reference Text: ptpn12 targeting provide collectively identify suppressor tumor cancers kinases tyrosine inactivated based profile tyrosine screen ptpn12 genetic identify suppressor phosphatase tumor her2 tyrosine ptpn12 oncogenic suppresses inhibiting interacting multiple transformation egfr kinases | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 8 | Citation Text: interestingly revealed 22 destruction damage enhanced nonstressed p53 dna cdc6 manner regulated | Reference Offset: [1138-1253', 31885-32010', 18191-18277'] | Reference Text: complex p53 dna cdc6 damage destruction anaphase-promoting show enhanced activation licensing dna cdt1 interestingly destruction damage manner factor p53-independent induces dna mediated ligase cdc6 damage destruction enhanced apccdh1 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 12 | Citation Text: site termed complex apc immunological synapse contact large induces formation | Reference Offset: [1651-1922', 3090-3185', 3816-3977'] | Reference Text: limited interaction contact affinity sufficient ligands order tcr antigen tight low formation critical area cytoskeletal polarity contact formation binds ligands area range cd2 adhesion participate molecule contact formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 2 | Citation Text: inhibits radixin mir-31 metastasis repression tumor phenotype rhoa targets | Reference Offset: [31549-31866', 967-1056', 4605-4776'] | Reference Text: spectrum metastatic metastasis effects rhoa colonization impact suppression mir-31 metastases repression formed multiple targets breast mir-31 suppresses metastasis overexpression tumor acts identify mirna steps invasion-metastasis cascade mir-31 repression multiple targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 17 | Citation Text: cloned targeting vector sequence retroviral produce | Reference Offset: [10872-11136', 5295-5429', 7161-7453'] | Reference Text: prs-gfp constructs hela transient sirna retroviral assays produced vectors cloned p16ink4a active prs-hyg viral p14arf vectors selected 10 days sirna retroviral virus ecotropic selected subsequently receptor vector fibroblasts encoding polyclonal drug population | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 8 | Citation Text: apoptosis anticancer strategy good targeted bcl-2 promote family discovery members drug | Reference Offset: [3520-3746', 2963-3241', 2861-2961'] | Reference Text: bak apoptosis death interaction express related bcl-2 proapoptotic family and/or bax multidomain key members death bcl-xl bh3 interaction related bcl-w short bcl-2 ligands family domain bh3-only mcl-1 members bcl-2 apoptosis family interacting key regulators | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 5 | Citation Text: sufficient leads k-ras progression established regression tumors tumor mutant malignant | Reference Offset: [2202-2525', 6491-6686', 6184-6489'] | Reference Text: kras mutations loss progression metastatic disease occurs acquisition suppressors intraepithelial tp53 cases activating subsequent tumor malignant pancreatic invasive oncogene early neoplasia progression maintenance tumor malignant p53 advanced conditional model progression events induction pdac tumor comparable long biological leads additional genetic invasive suggesting | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 15 | Citation Text: kras provide epithelial alternative phenotype signals suggesting mesenchymal pathways disrupted survival | Reference Offset: [709-913', 12560-12728', 13539-13666'] | Reference Text: primary revealed well-differentiated epithelial tumors phenotype cancer signature dependency k-ras demonstrate induction epithelial possibility phenotype affect findings support strong differentiation link epithelial survival cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 7 | Citation Text: deletion cycle kinase progression and/or examined anaphase cerevisiae telophase affect | Reference Offset: [27985-28270', 3531-3754', 6020-6170'] | Reference Text: cycle synchronized interphase block anaphase telophase fixed released transfected phase events interphase anaphase telophase considered involved chromosomal nucleus cycle aurora-a genomic crucial progression maintenance mammalian stability observations | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 2 | Citation Text: demonstrated samples t-all transcripts leukemia microarray decrease | Reference Offset: [2015-2335', 25339-25435', 5763-6077'] | Reference Text: aberrant methods obtained genes rt-pcr disease rearrangements transforming dna event clinical hypothesis central key activation transcription support absence factor samples analyze t-all combination microarray chromosomal t-all activated oncogene microarray discovery samples reverse cases pediatric pcr translocations locus-specific samples transcriptase analyze t-all oncogene quantitative acting hypothesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 6 | Citation Text: mutations conserved cortical stage arrest dna highly homeodomain interactions thymocyte differentiation maturation variety t-all involved additional genetic subtype profiles early | Reference Offset: [14622-14866', 16000-16133', 17082-17348'] | Reference Text: cases genes normal differentiation cortical stage showed undergoing pattern early thymocyte t-all recognized differentiation profiles samples stages thymocyte differentiation cd2 cortical upregulation tal1 stage contrast lck pattern late reflect appeared thymocyte | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 9 | Citation Text: lower affinities gtpase activating guanine higher nucleotide hydrolysis stimulate factor gtp contrast require ras-like small exchange | Reference Offset: [7503-7721', 487-668', 670-824'] | Reference Text: contrast lower affinities nucleotide factor exchange cellular functions gtpase-activating factors guanine nucleotide-binding nucleotide small exchange regulate catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 12 | Citation Text: residues hydrophobic ethynyl lead pdgfr steric tyrosine fgfr family src kit potent spectrum gatekeeper predicted minimize vegfr kinases inhibits inhibitor clash threonine | Reference Offset: [23874-24025', 9519-9663', 24241-24419'] | Reference Text: residues hydrophobic gatekeeper ap24534 predicted minimize general steric inhibitor clash tyrosine fgfr receptor ap24534 src inhibited families pdgfr vegfr members kinases range ap24534 potential pdgfr vegfr variety cancers kinases fgfr family src targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 18 | Citation Text: mice ablation apoptosis lethality erk2 mek1 adult vivo | Reference Offset: [9916-10007', 28092-28158', 30401-30569'] | Reference Text: mice impairs development lethality tumor adult induces kinases mice c-raf ablation adult widespread c-raf ablation adult mice concomitant conditional investigated mutant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 3 | Citation Text: screen rnai mediator necrosis rip3 recent genome-wide | Reference Offset: [815-1123', 4029-4204', 43242-43570'] | Reference Text: screen apoptosis set genes identify sirna rip1 necroptosis subset kinase involved and/or downstream act required genome-wide regulators regulate screen genes functional sirna mechanism molecular necroptosis carrying required explored genome-wide screen genes set global sirna necroptosis involved examined genome-wide | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 8 | Citation Text: mir-223 unique nfi-a mechanism demonstrated recent factors proposed myeloid transcription | Reference Offset: [622-782', 784-1003', 5206-5544'] | Reference Text: transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show retinoic mir-223 nfi-a differentiation -induced factors acid binding low mir-223 computational nfi-a genes sequences factor putative related involved binding bind targets growth transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 1 | Citation Text: cellular k-ras plasma isoforms h-ras ras distinct mitochondria membrane mammalian pathways acting golgi intracellular compartments | Reference Offset: [747-1019', 15372-15638', 611-745'] | Reference Text: region promotes k-ras membranes association bcl-xl show interacts rapid mitochondria polybasic kinase outer membrane pm intracellular phosphorylation region k-ras hypervariable predicted phosphorylated polybasic sequence c-terminal apparatus golgi intracellular compartments polybasic functions k-ras plasma membrane sequence | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 16 | Citation Text: microrna breast suppression inhibits concurrent mir-31 invasion effectors mesenchymal key cancer | Reference Offset: [818-965', 10494-10714', 15045-15197'] | Reference Text: breast patients mir-31 identify metastasis correlates microrna cancer unique proliferation affect anoikis breast reduced mir-31 motility invasion resistance aggressive cancer suppression viability 20-fold mir-31 motility invasion inhibitor enhanced | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 13 | Citation Text: tel-aml1-positive cases receptor classification higher b-all | Reference Offset: [14713-14824', 19188-19541', 3756-4028'] | Reference Text: subtypes figure cases genetic b-all genes classified chimeric subset mll characterized cases lineage t-all hyperdiploid presence classification bcr-abl subtypes individual pathogenesis variety figure genetic classification leukemia parameters clinical alterations 2001 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 12 | Citation Text: extracellular absence immortal matrix proliferate | Reference Offset: [6499-6673', 16326-16612', 6675-6989'] | Reference Text: screen extracellular absence matrix proliferate extracellular surface proliferation loss induce matrix endogenous alter response signaling reduced suggesting culture interactions single anchorage-independent pathway demonstrated recent transformation experiments genetic event ectopic proliferate manner suggesting mutant ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 10 | Citation Text: gfp shrnas expressing hela vectors level reduced mrna lines act shrna sirnas | Reference Offset: [9796-9933', 7075-7235', 833-1024'] | Reference Text: suppression level p53 reduced mrna vectors constructs transcripts failed transient suppress sirnas mediates stable suppression time phenotypes loss-of-function vector develop sirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 8 | Citation Text: telomerase htert percentage common immortalized events 2002 tumor show suggested 1996 cancer key | Reference Offset: [7046-7187', 13389-13732', 32947-33245'] | Reference Text: stimulation reduced show tumor growth exogenous understand proliferation deregulation normal play endothelial tumor present apparent roles fibroblasts key contributions growth essential development progression immortalized state potential tumor phenotype malignant acquired suggesting types culture vivo growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 14 | Citation Text: | Reference Offset: [452-588', 590-800', 802-1086'] | Reference Text: characterized features highly differentiate stem types ability oct4 essential lineage differentiation state embryonic factor adult implicated mediator stem homeodomain cancer transcription networks facilitate oct4 repressing lineage genes differentiation maintain recent transcriptional dual regulatory description pluripotency required self-renewal activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 9 | Citation Text: response arrest underwent fibroblasts predicted 1999 ras | Reference Offset: [10089-10222', 19622-19852', 26656-26811'] | Reference Text: arrest program fibroblasts onset conserved rodent ras phase induces prior ras-induced ras mice response independent p53 arrest oncogenic identical wild-type contribution derived response cellular aberrant arrest signaling ras-induced ras outcome observations | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 8 | Citation Text: lymphoblastic unique support cases recent leukemias distinct provided chromosomal hypothesis large | Reference Offset: [7855-8044', 4030-4265', 11251-11396'] | Reference Text: subtypes cases assigned collection leukemias heterogeneous profile distinct subtypes defined genes subsequent molecular distinct targeted rearrangements leukemia genetically chromosomal defined cases genes distinct mll t-all hyperdiploid bcr-abl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 2 | Citation Text: suggests mutations report approach bcr-abl imatinib-resistant initiation therapy recent effective prior | Reference Offset: [28180-28347', 9869-9966', 20964-21136'] | Reference Text: mutations prior t315i exhibited patient dna sequence initiation bcr-abl therapy kinase mutations imatinib detailed domain bcr-abl disease therapy prior mutations state mechanism properties disease prior kinase imatinib domain resistance proposed bcr-abl therapy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 3 | Citation Text: p53 replicating cdc6 increase reversed downregulation knockdown | Reference Offset: [1427-1556', 11065-11269', 19534-19766'] | Reference Text: demonstrate p53 loss replicating cdc6 reversed damage factor demonstrating showed stabilized p53 dna activated target increase transcription mcf-7 targeting constructs destruction p53 transfected cdc6 knockdown required p27kip1 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 6 | Citation Text: breast her2 ptpn12 signaling recently rtks inhibiting tumors mapk egfr | Reference Offset: [18924-18976', 1214-1342', 1956-2297'] | Reference Text: her2 ptpn12 signaling suppresses mapk egfr her2 tyrosine ptpn12 oncogenic suppresses inhibiting interacting multiple transformation egfr kinases ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 6 | Citation Text: methods region duplexes single mirna regions imperfect search complementarity pairing end sophisticated near-perfect site extend seed mrna target | Reference Offset: [4009-4269', 632-862', 5036-5117'] | Reference Text: near-perfect unique mirna mirnas 13 families search complementarity targets region sites genes conserved mirna mirnas regulatory mrnas predict complementary target pairing near-perfect analogous search pairing mirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 12 | Citation Text: ros oxidative excess mitochondria reduced term generally atp synthesis phosphorylation generation | Reference Offset: [16786-17004', 6393-6624', 12437-12664'] | Reference Text: obtained ros observation oxidative resulted mitochondria reduction consistent phosphorylation generation early ros generate oxidative controlled potential mitochondrial process membrane phosphorylation generation energy ros oxidative production mitochondria chain increase approach phosphorylation based cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 5 | Citation Text: implicated firing regulating pathway origin 13 12 | Reference Offset: [1030-1136', 1899-2115', 2903-3013'] | Reference Text: licensing complex p53 pathway target cdc6 factor complex recognition loading maintenance origin factor putative cdt1 origins cdc6 g1 led loss association cdc6 origin mcm | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 10 | Citation Text: mutations pathway epithelial cancers altered signaling dna genetic pi3k activated components mechanisms alterations multiple frequently copy | Reference Offset: [2203-2488', 3264-3589', 1717-1978'] | Reference Text: systems model mutations spectrum pathway neoplastic lead transformation cancers loss-of-function components contributes loss metastasis tumors indicating variety cancers mice deletion signaling pi3k cancer formation frequently pten cellular aberrant proliferation progression apoptosis genes suppressor epithelial tumor tumors resulting oncogenes alterations generation multiple | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 16 | Citation Text: proliferation development remains apoptosis metastasis tumor influences mirnas affect exert potentially extent and/or primary unclear specifically | Reference Offset: [935-1177', 9657-9902', 29624-29847'] | Reference Text: cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 development identify rasv12 tumor contribute mirnas process subsequently vector fibroblasts cellular development proliferation suppressor tumor homolog promising deletion kinase large tumorigenic | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 4 | Citation Text: mice kras-driven selective inhibitors gata2 finally nsclcs pathways regulated combined | Reference Offset: [6830-7115', 1323-1482', 1700-2032'] | Reference Text: causing kras loss therapeutic inhibitors inhibition strategy established finally clinically combined suppression nsclc gata2 pathways mutant inhibitors tumor clinically caused combined suppression approved gata2 pathways kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 3 | Citation Text: mitochondria previous proven induce death abt-737 observations signals | Reference Offset: [55320-55546', 1958-2087', 20496-20638'] | Reference Text: sensitivity agents induce death identify signals cytotoxic activate priming bh3-only cancer subset bcl-2 proapoptotic family select death sensitive signals death induced report abt-737 prior | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 16 | Citation Text: site cyclin inactivation degradation activates subsequent leads p53 dephosphorylation cdk2 cdc6 g1 | Reference Offset: [4974-5305', 7432-7643', 6196-6403'] | Reference Text: cyclin sites degradation subsequent potential cdk2 cdc6 wild-type proposed translocation phosphorylation phase nucleus based mutated cyclin d1 p53 cdk4 directed cdk2 antibodies cdc6 p21 apoptosis maintenance induction prior transcriptional sustained p53 arrest target g1 required phase activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 5 | Citation Text: rate-limiting reduced prb susceptibility mutation tumor tumors retinoblastoma exhibit | Reference Offset: [423-576', 11949-12202', 11659-11752'] | Reference Text: p53 suppressors tumor disrupted factor cancer regulators transcription retinoblastoma inactivation cyclin pathway provide events exclusive evidence mutation tumor epigenetic resulting rb deletion d1 mutually p16ink4a signaling cdk4 genetic overexpression silencing loss disruption tumor types occurs retinoblastoma rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 4 | Citation Text: ptpn12 suppressor tumor mapk suppressing egfr breast signaling rtks recently interact acting cancer | Reference Offset: [5116-5285', 17960-18012', 18924-18976'] | Reference Text: ptpn12 identify suppressor tumor dependency signaling target cancer key her2 ptpn12 rtks hmecs interact egfr her2 ptpn12 signaling suppresses mapk egfr | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 10 | Citation Text: modulate oct4 primers evidence potential tissue tumor patients nature qrt-pcr bmi1 stem detected self-renewal cancer | Reference Offset: [3645-3939', 5498-5709', 18265-18413'] | Reference Text: oct4 dependent differentiation epithelial embryo tumors interfering tumor adult dose promote manner stem growth oct4 commitment genes lineage lead marker identification pluripotency stem central early self-renewal oct4 bmi1 hematopoietic negative stem maintaining neuronal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 12 | Citation Text: recruit bax tbid bim bh3-only puma directly bind | Reference Offset: [38189-38426', 49371-49467', 51997-52198'] | Reference Text: bak bh3 activate bcl-2 hands bax context bim puma acting directly bind ability bak and/or bax bim bh3-only activator required bid activation bax evidence provided interact puma directly | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 3 | Citation Text: cortical maturation stage differences arrested arrest and/or negative activation | Reference Offset: [14622-14866', 17082-17348', 18770-19118'] | Reference Text: cases genes normal differentiation cortical stage showed undergoing pattern early thymocyte differentiation cd2 cortical upregulation tal1 stage contrast lck pattern late reflect appeared thymocyte cases thymocytes cortical upregulation relative stage targeted factors resistance downregulation survival reflect early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 12 | Citation Text: typical reactions hydrolysis gtp ph gap | Reference Offset: [12609-12839', 670-824', 1398-1605'] | Reference Text: magnitude hydrolysis interaction gtp requires gtpases fact called gap catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing cycle catalytic essential provide induce gdp hydrolysis gtp gefs abundant gaps highly regulated group release bound | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 19 | Citation Text: contributes feed-forward differentiation block maturation rapid let-7g pri-let-7g led transcripts mature let-7 primary lin28 loop participate hypothesis incoherent | Reference Offset: [28943-29116', 5030-5212', 25085-25419'] | Reference Text: cellular let-7 feed-forward differentiation downstream participate contribute incoherent rapid mature transcripts primary mirnas promotes suggests contributes degradation development additionally mirna rapid transcripts family mrna mammalian zebrafish early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 5 | Citation Text: mice diet tamoxifen | Reference Offset: [13773-14077', 20333-20482', 20168-20331'] | Reference Text: erk single diet tamoxifen maintain interestingly show adult sufficient mice mice diet leading death tamoxifen rapid weeks essential diet tamoxifen adult mice kinase days 30 mek1lox/lox mek | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 7 | Citation Text: dual enzymatic specificity domain phosphatase inpp4b required residue motif pten | Reference Offset: [1362-1427', 13907-14039', 15480-15672'] | Reference Text: dual cellular resulted senescence inpp4b knockdown pten dual functions order redundant inpp4b knockdown pten dual knocking senescence inpp4b hairpin construct knockdown retroviral pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 15 | Citation Text: pcmvmyc-lats2 plasmids dr | Reference Offset: [45132-45283', 45395-45624', 46136-46273'] | Reference Text: pcmvmyc-lats2 chain construct prepared lats2 released pcmvmyc-lats2 vector bamhi produce sites pcmvmyc-lats2 constructed bamhi | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 1 | Citation Text: mir-223 recognized granulocytic differentiation due included mirnas | Reference Offset: [622-782', 1005-1152', 5063-5204'] | Reference Text: transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show mir-223 nfi-a granulocytic translation differentiation loop mir-223 granulocytic identify differentiation target activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 1 | Citation Text: hypermethylation promoter observation mutations induce line frequency idh1 remodeling hypothesis chromatin | Reference Offset: [2378-2598', 23278-23517', 31214-31334'] | Reference Text: aberrant hypermethylation demonstrate mutations generate induce metabolism genes differentiation leukemic metabolite neomorphic idh2 idh1 dna hematopoietic hypermethylation mutations association global determine idh2 samples idh1 sufficient patient idh1/2 aml increase mutant based mutations aml frequency relative idh2 idh1 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 9 | Citation Text: kras oncogenic functional dependent mutant appears | Reference Offset: [1250-1525', 3569-3694', 9755-9913'] | Reference Text: c-raf therapeutic prevents dependent normal adult mice nsclc target k-ras-driven initiation information mediate signaling oncogenic pathways ras cancer erk single development erk2 erk1 observations process sufficient kinase nsclc signaling oncogenic initiate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 3 | Citation Text: cd4+ chemokine toxin exclusive seven-transmembrane -sensitive cx3c cd8+ receptor monocytes nk | Reference Offset: [4906-5123', 23900-23992', 22670-22883'] | Reference Text: migration functional leukocytes mediate fractalkine receptor identification report cx3cr1 adhesion directly monocytes nk high-affinity cd4+ cd8+ monocytes cd4+ figure expressing fractalkine cd8+ receptor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 14 | Citation Text: anchorage-independent rnai appearance selective immortalized identify normal potential capable transformation recently screens negative regulators growth | Reference Offset: [2451-2823', 2113-2449', 31490-31754'] | Reference Text: telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth telomerase genes recombination ras transformation vectors altered apparent p53 prb pi3k rna ectopic recently pathways mutant viral homologous screen model identify evidence tumor transformation prostate suppressors fibroblasts susceptibility relevant cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 8 | Citation Text: patient-matched events metastatic distant downregulated tumors rhoa m-rip itga5 reduced primary rdx mmp16 relative colonization breast metastasized mir-31 motility metastases early fzd3 | Reference Offset: [33749-33901', 33568-33707', 7697-7899'] | Reference Text: breast detection itga5 patient-matched rdx primary distant metastases tumors rhoa breast patient-matched mir-31 primary distant metastases tumors fraction expressing tumors relative lung reduced mir-31 primary metastases derived note | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 6 | Citation Text: direct reduced evidence pitx1 significantly bladder mutated cancers | Reference Offset: [14788-14902', 14904-15032', 15693-15779'] | Reference Text: prostate altered normal pitx1 tissue bladder relative cancers cases reduced pitx1 tumor significantly prostate lower normal pitx1 bladder tissues cancers | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 4 | Citation Text: kinase complex death rip1 activities rip3 required formation | Reference Offset: [4657-4850', 25361-25478', 1023-1224'] | Reference Text: complex essential species oxygen rip1 rip3 production stable controls kinase downstream critically reactive formation kinase complex context controlled ii rip1 activities rip3 complex species oxygen association activates rip1 rip3 production kinase downstream triggers reactive phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 17 | Citation Text: selected roles mirnas relevant hematopoiesis | Reference Offset: [503-620', 2115-2276', 2278-2470'] | Reference Text: micrornas inhibitors genes roles differentiation target translational play acting limited development show types mirnas stages tissues involved regulatory provide genes differentiation sets tissue-specific mirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 12 | Citation Text: dna damage cdc6 rapid | Reference Offset: [6405-6566', 36574-36726', 1138-1253'] | Reference Text: inactivation cyclin d1 cycle arrest dna promote progression damage rapid suggests firing mutations origin destruction damage rapid response blocking dna cdc6 complex p53 dna cdc6 damage destruction anaphase-promoting show enhanced activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 6 | Citation Text: idh enzymatic mutations genetic functional inhibiting myeloid contribute part tet neomorphic transformation | Reference Offset: [7909-8187', 916-1045', 4968-5119'] | Reference Text: methylation cellular cycle normal isoforms interfering contribute enzymes transformation malignant idh dna tet2 inhibiting induced mutant hypothesis demethylation enzyme idh characterized mutations resultant 2-hydroxyglutarate production neomorphic mutations genetic idh1/2 context mechanism contribute phenotype malignant occur | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 3 | Citation Text: hypervariable unique domains ras distinct gtpases membrane features effectors lipid rho sites amino localization interaction display families charged mediate moieties phosphorylation | Reference Offset: [13823-14091', 6648-6906', 9206-9295'] | Reference Text: sites k-ras conserved mechanism switch families ras general gtpases analogous suggesting phosphorylation rho region k-ras hypervariable localization extended h-ras demonstrating dominant pkc polybasic sequence membrane sites gtpases sequence potential pkc phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 12 | Citation Text: tyrosine ptpn12 genomic loss similarly phosphatase multiple activation kinases | Reference Offset: [1956-2297', 1214-1342', 884-981'] | Reference Text: ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer her2 tyrosine ptpn12 oncogenic suppresses inhibiting interacting multiple transformation egfr kinases tyrosine screen ptpn12 genetic identify suppressor phosphatase tumor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 15 | Citation Text: result findings previous microarray sequencing based | Reference Offset: [457-696', 3664-3808', 5494-5600'] | Reference Text: species mirna sequencing mirnas abundant rna mir-21 library mir-24 small caski result iii steps mirnas enzymes mediated mature cloned protocol rnas published based | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 9 | Citation Text: foxd3 primers pcr nanog utf1 | Reference Offset: [16910-17187', 16690-16730', 17655-17767'] | Reference Text: amplification primers pcr locus type targeted produced primers pcr analyses clones mutation pcr nanog | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 8 | Citation Text: promotes complexes cyld apoptosis rip1 apoptotic caspase-8 conditions critical kinase signaling necrotic suggesting activation formation | Reference Offset: [571-813', 3253-3430', 9810-10053'] | Reference Text: termed activates death dependent rip1 receptors type apoptotic conditions necroptosis stimulation kinase necrotic conditions necroptosis kinase receptor death rip1 required activation cyld pathway rip1 factor substrate represent regulatory receptor suggesting key activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 8 | Citation Text: telomerase genes recombination ras transformation vectors altered apparent p53 prb pi3k rna ectopic recently pathways mutant viral homologous | Reference Offset: [3951-4135', 4659-4886', 20286-20689'] | Reference Text: genes recombination process apparent involved p53 prb pathways mutant 1999 viral homologous model technology individual pathway neoplastic genes suppressor tumor transformation p53 p16ink4a prb rna combination contribution interference directly p14arf result overcome derivatives ras showed observations response arrest bj fibroblasts premature previous expressing ras-induced phenotype indicating defective arrested p53 prb senescence binding mutant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 7 | Citation Text: 43% mutations cases activating pathogenesis indicating t-all signaling types major | Reference Offset: [5563-5761', 5763-6077', 12653-12868'] | Reference Text: subset t-all cases strong receptor activated places reverse cases pediatric pcr translocations locus-specific samples transcriptase analyze t-all oncogene quantitative acting hypothesis cases lyl1 expressing tal1 independently oncogenes major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 10 | Citation Text: sites recruit factors and/or budding virus class vps motifs ubiquitin | Reference Offset: [6695-7007', 31745-31920', 3472-3647'] | Reference Text: cellular sites preventing facilitate actively docking targeting degradation gag budding interfering defective proteolytic ubiquitination factors molecules participate viral sites model gag assembly budding stages affinity ubiquitination recruit hiv-1 tsg101 binding viral cellular membranes budding virus create discrete event membrane enveloped viral | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 2 | Citation Text: arrest maintenance differentiated tissues terminally | Reference Offset: [33254-33481', 226-421', 1123-1329'] | Reference Text: cycle radiation apoptosis drugs induce treatment normal tumors lacking p53 arrest cancer tissues series normal transformed tumor malignant surrounding genetic cancer tissues complex animals host metastasis tissue tumor invasion cancer interactions tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 12 | Citation Text: chemokine lymphocytes mediates leukocytes migratory fractalkine inflammatory receptor cx3cr1 monocytes killer natural brain | Reference Offset: [759-919', 1589-1725', 4507-4723'] | Reference Text: migratory functions fractalkine receptor identify mediates seven-transmembrane show high-affinity migratory defense host essential lymphocytes leukocytes immunological properties functions chemokine standard effects induces migratory fractalkine receptor combination adhesion directly | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 8 | Citation Text: stress proposed bh3-only | Reference Offset: [4033-4174', 4482-4765', 4361-4480'] | Reference Text: subset family bik molecules bh3-only bim puma bad bid include individual display assays lysates bcl-2 vitro experiments molecules binding bh3-only multidomain multiple members bcl-2 demonstrate order family domain binding require bh3-only multidomain members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 3 | Citation Text: defined translational mirna list mirnas frequent surprisingly extensive system regulatory rbps experimentally regulation targets | Reference Offset: [2027-2251', 2253-2520', 3745-3879'] | Reference Text: genes regulation protein-coding mirnas recent large existence processes suggests cellular majority evidence developmental tissue show mirnas variety regulation participate large clear importantly regulation biogenesis mirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 3 | Citation Text: thyroid mir-146a up-regulated cervical papillary cancer carcinoma | Reference Offset: [18627-18941', 22218-22290', 1338-1652'] | Reference Text: decreased papillary appears prostate level thyroid mir-146a lines lymphoma cancer carcinoma tissues mir-146b thyroid highly papillary carcinoma normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 1 | Citation Text: degraded phosphatase inositol polyphosphate | Reference Offset: [772-1021', 4584-5938', 20594-20834'] | Reference Text: 4-phosphatase anchorage-independent resulted ii epithelial inositol type enhanced polyphosphate knocking akt motility report knockdown activation growth pten 4-phosphatase ii phosphate inositol type rat polyphosphate initially enzyme pip2 brain cellular mutations loss tumors inpp4b showed deletion senescence phosphatase lipid investigated pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 4 | Citation Text: leads progenitors promote mesodermal differentiation specification endodermal ectodermal alterations primitive | Reference Offset: [3483-3643', 3645-3939', 590-800'] | Reference Text: leads oct4 progenitors promote mesodermal differentiation specification endodermal ectodermal alterations primitive oct4 dependent differentiation epithelial embryo tumors interfering tumor adult dose promote manner stem growth oct4 essential lineage differentiation state embryonic factor adult implicated mediator stem homeodomain cancer transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 11 | Citation Text: cycle functions individual exclusive transition tumor targeted mutually regulating manner components consistent | Reference Offset: [11949-12202', 745-930', 2346-2565'] | Reference Text: inactivation cyclin pathway provide events exclusive evidence mutation tumor epigenetic resulting rb deletion d1 mutually p16ink4a signaling cdk4 genetic overexpression silencing functions individual provide basis tumors rb p53 developing catalytic complexes individual cyclin-dependent cyclins kinases cdk4 induced g1 subunits manner phase early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 20 | Citation Text: subtypes information yield tissue tumor molecular outcome cancers predict oncogenic active profiles clinical pathways | Reference Offset: [25596-25818', 35315-35461', 40834-41074'] | Reference Text: subtypes single unable identify differences relapse predict genetic leukemia subtype profiles signature subtypes profiles pathways differences transformation occur distinct treatment pediatric molecular outcome database generated leukemia detailed profiles | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 2 | Citation Text: cairns complex complexes actin swi/snf baf53 revealed kda components | Reference Offset: [27369-27654', 38101-38228', 812-943'] | Reference Text: complex actin hela baf53 matrix revealed baf lacking brg1 nuclear experiments stably cairns complex swi/snf peptide baf53 sequences homologs actin-related complex peptide baf53 revealed subunits sequencing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 11 | Citation Text: typical model observation gdp state gtp difficult gap | Reference Offset: [14140-14398', 670-824', 1398-1605'] | Reference Text: model complex structure gtp based gap catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing cycle catalytic essential provide induce gdp hydrolysis gtp gefs abundant gaps highly regulated group release bound | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 7 | Citation Text: 2002 perou armstrong tumors differences recent cancers alizadeh analyses clinical multiple 2001 2000 heterogeneous | Reference Offset: [39143-39299', 3756-4028', 5944-6313'] | Reference Text: limited pediatric armstrong profiles recent 2001 presented subtypes individual pathogenesis variety figure genetic classification leukemia parameters clinical alterations 2001 microarrays single genes profiling leukemic determine 12 patients alizadeh utilized 1999 pediatric analyze prognostic approaches 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 9 | Citation Text: expressing ras-induced line oncoprotein thyroid-specific rat h-rasv12 down-regulation analyzed thyroid called inducible | Reference Offset: [15837-16196', 779-1050', 2879-3353'] | Reference Text: obtained ras h-rasv12 receptor domain frtl-5 expressing extend tamoxifen estrogen ligand experimental effects oncoprotein -sensitive fusing system generated downstream context binding conditional mutant confirm inducible cellular constitutively expressing differentiation origin established oncoprotein effects ras analyze generated thyroid active lines frtl-5 viral forms stably genes epithelial line tsh rat considered receptor thyroid frtl-5 transcription essential maintenance differentiation thyroid-specific factors combination culture | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 5 | Citation Text: sites 372 endogenous luciferase sensor family dnd1 target wild-type molecules mir-372 mutant directly | Reference Offset: [33539-33771', 935-1177', 10324-10492'] | Reference Text: sites mcf-7 lats2 potent expressing inhibition luciferase mediated target significantly construct mir-372 mutated cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 constructs largely due 372 mir-372 close | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 18 | Citation Text: lats2 lats1 demonstrate localization association centrosomal 22 mitotic 20 apparatus | Reference Offset: [4155-4330', 22438-22610', 1827-1974'] | Reference Text: mitosis lats1 localization apparatus truncated mitotic lats2 mitosis fraction localization apparatus cytoplasmic mitotic exogenous lats2 mitosis nih3t3 interphase apparatus cytoplasmic mitotic localized | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 11 | Citation Text: mouse effects validated retroviral hematopoiesis vectors tet2 bone encoding silencing investigated shrna marrow | Reference Offset: [38897-39098', 42106-42256', 40591-40807'] | Reference Text: constructs mutations revealed murine validated led tet2 primary bone idh1/2 increase shrna marrow loss tet2 bone differentiation wild-type effects murine idh2 assessed marrow mouse mutations effects stable idh2 investigate biological bone primary wild-type idh1/2 examined myeloid mutant marrow | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 12 | Citation Text: actin-related complex atpase derived | Reference Offset: [812-943', 945-1096', 4579-4805'] | Reference Text: actin-related complex peptide baf53 revealed subunits sequencing brg1 complex association atpase baf53 required complex observation swi/snf potential molecular atpase mammalian | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 6 | Citation Text: subunit targeting swi/snf mammalian regulation required chromatin | Reference Offset: [1098-1279', 40884-41242', 2431-2582'] | Reference Text: direct work complex swi/snf baf signals signaling membrane mammalian regulation chromatin complex complexes targeting observation baf stimulation 10 time receptor increase antigen required synthesis chromatin activation stably transcription subunit complex fact swi/snf homologous related | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 6 | Citation Text: caspase kinase assembly inhibition rip1 rip3 requires intact | Reference Offset: [9658-10012', 1023-1224', 4657-4850'] | Reference Text: apoptosis events inhibition rip1 sensitizes contribute caspase-8 caspase kinase regulatory additional programmed necrosis detected complex species oxygen association activates rip1 rip3 production kinase downstream triggers reactive phosphorylation complex essential species oxygen rip1 rip3 production stable controls kinase downstream critically reactive formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 7 | Citation Text: inactivation cycle mouse cyclin-dependent interestingly embryo upregulated ras proteolysis kinases arf p53 p16ink4a arrest prb primary fibroblasts capacity | Reference Offset: [5546-5780', 29821-29930', 422-568'] | Reference Text: systems mouse normal embryo line effects ras rat oncogenic primary fibroblasts deficient mouse p53 fact oncogenic fibroblasts primary ras inactivation p53 cooperating suppressors primary oncogene tumor ras requires transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 7 | Citation Text: viability loss and/or pc9 gata2 reduction inhibited alter egfr growth | Reference Offset: [772-890', 6257-6338', 7392-7618'] | Reference Text: nsclc viability mutations loss reduced wild-type gata2 nsclc viability loss vitro gata2 line mutant vivo kras factors led viability loss apoptosis increase gata2 factor mutant decrease transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 7 | Citation Text: apoptosis death state primed rapid abt-737 staining suggesting consistent large | Reference Offset: [40593-40846', 41309-41432', 1173-1373'] | Reference Text: death state bh3 magnitude primed antiapoptotic priming programmed response apoptosis undergo state primed antiapoptotic cellular death profiling state bh3 correlates antiapoptotic family determined survival members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 12 | Citation Text: erk kras reports responsible potential tumors ras mediating perk signaling wild-type isoform mutant consistent raf required phosphorylation | Reference Offset: [44042-44219', 44490-44726', 46791-47058'] | Reference Text: erk k-ras absence tumor kinases signaling mediate oncogenic suggesting raf phosphorylation appeared erk c-raf k-ras essential activates efficiently ras kinases setting binds signaling mediate oncogenic isoform mek k-ras pathway inhibitors mechanism tumors activate carrying involving wild-type molecules raf mutant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 1 | Citation Text: development gatekeeper inhibitors mutation regard frequent cml t315i represents patients advanced treated clinical inhibitor discovery triggered | Reference Offset: [4743-5029', 31294-31450', 1120-1300'] | Reference Text: development mutation cml t315i patients advanced molecules due clinical phase therapy cml t315i patients advanced active clinical inhibitor make compound therapeutic mutation bcr-ablt315i mutants approved selected remain clinical inhibitor therapy major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 11 | Citation Text: apoptosis induce bcl-xl inhibition increase resistance downregulation cancer | Reference Offset: [2672-2858', 17295-17423', 23220-23396'] | Reference Text: therapeutics machinery activating apoptosis death anticancer normal overcome approach resistance directly apoptosis sensitizes downregulation mcl-1 abt-737 carcinoma limited level bcl-xl resistance overexpression inactivated mcl-1 targets abt-737 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 12 | Citation Text: networks signaling death discovery regulate existence | Reference Offset: [30775-31090', 39311-39545', 2780-3056'] | Reference Text: complex complexes cyld death interacts factors signaling component receptor consistent directly regulate death rip1 mediating gaps involved signaling mediate downstream types multiple regulate termed cellular apoptosis death mechanism lead receptors existence fact discrete features necrosis regulated activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 6 | Citation Text: hbp kras metabolism pdac tumor ductal mice enzyme gfpt1 rate-limiting kras-driven adenocarcinoma pancreatic glucose anabolic depends activation growth | Reference Offset: [1028-1162', 25822-26146', 26785-27096'] | Reference Text: critical kras adenocarcinoma event oncogenic pancreatic mutation initiation tumor ductal signature hbp serve potent collectively metabolism ppp production enzymes transcriptional rate-limiting level glucose regulation anabolic pathways kras remains expressing maintenance pdac tumor recent setting lose vitro oncogenic pancreatic advanced oncogene lines mutant relevant vivo | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 10 | Citation Text: response level genes activated state senescent oncogene cultured ras inducible | Reference Offset: [343-420', 422-568', 951-1145'] | Reference Text: transform oncogenic immortal state ras rodent tumorigenic inactivation p53 cooperating suppressors primary oncogene tumor ras requires transformation cellular onset stimulus accumulation observations response oncogenic activated senescence reflect | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 10 | Citation Text: oxygen form species oxidative damage stress factor mitochondria implicated widely accepted generated reactive aging | Reference Offset: [228-370', 2960-3119', 22428-22662'] | Reference Text: postulates oxygen species theory production free intracellular reactive radical major aging oxygen species research production potentially reactive central aging cellular ros oxygen species stress represent response mechanisms aging formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 12 | Citation Text: kras mutations common mediates effects tumor ras oncogenic ral pi3k effector active raf cancer formation | Reference Offset: [4128-4385', 2362-2664', 26500-26719'] | Reference Text: pathway activating ralgef capable ras transformation mutants pi3k ral loop effector affecting raf potential ras critical signaling led oncogenic identification effector downstream active interact pathways multiple involvement evaluate provide dependent evidence tumor ras ralgds oncogenic pathways activation formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 8 | Citation Text: remodeling chromatin suppressing | Reference Offset: [15088-15384', 15387-15463', 24523-24721'] | Reference Text: repress complexes swi/snf epigenetic polycomb activate mediate remodeling group chromatin oct4 implicated genes correlated remodeling chromatin cellular differentiation interestingly damage implicated dna recently remodeling chromatin | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 16 | Citation Text: targeting il-1 suggested ras recent effective network transcriptional nsclc oncogene-driven importance proteasome gata2 | Reference Offset: [1700-2032', 18249-18408', 35420-35633'] | Reference Text: kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth transcriptional nsclc impaired loss proteasome gata2 mutant wt maintain regulates network transcriptional proteasome gata2 pathways mutant survival mechanisms | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 1 | Citation Text: complex emerged normal tumors transformed tumor phenotype conscripted ostensibly make cancer contributions | Reference Offset: [14334-14599', 13389-13732', 15676-15928'] | Reference Text: serve complex neoplastic normal tumors time conscripted active mutant types cancer tissues understand proliferation deregulation normal play endothelial tumor present apparent roles fibroblasts key contributions growth sites normal potential tumor enhance inflammatory promote conscripted cancer neoplasia growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 3 | Citation Text: work systems model suggested recent abt-737 acute leukemia resistance mcl-1 key | Reference Offset: [23897-23986', 1255-1340', 18747-18907'] | Reference Text: model mouse vitro resistance overexpression mcl-1 lymphoma abt-737 mouse model resistance mcl-1 lymphoma mcf-7 mouse rnai hela resistance construct mcl-1 abt-737 targeted | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 6 | Citation Text: direct diseases t-cell system signaling and/or cx3cr1 recruitment central | Reference Offset: [40575-40863', 921-1181', 15477-15562'] | Reference Text: direct association independent membrane-bound signaling fractalkine mediated cx3cr1 adhesion termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion v28 signaling adhesion investigated | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 21 | Citation Text: characterization mirna tumors tumor mirnas type research prognosis potentially manner widespread cancer signature | Reference Offset: [4871-5381', 3895-4285', 588-816'] | Reference Text: profiling characterization mirna tumors mirnas selected clinical sites localization identify global metastasis breast 10 identification chromosomal cancer regulate proliferation development remains apoptosis metastasis tumor influences mirnas affect exert potentially extent and/or primary unclear specifically repress genes numerous metastasis tumor steps invasion-metastasis potentially micrornas cascade target capacity multiple regulate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 7 | Citation Text: result membranes surface targeting lattice budding block sufficient released inactive vps4 membrane atpase mutagenesis fusion participate detected required formation site cellular actively recycling hairpin phenotype process hiv-1 target analyses | Reference Offset: [3649-3839', 6695-7007', 39624-40088'] | Reference Text: cellular machinery budding process recruit hiv-1 membrane enveloped viruses cellular sites preventing facilitate actively docking targeting degradation gag budding interfering defective proteolytic ubiquitination factors molecules participate viral complex targeting budding state finally ubiquitin substrate domain tsg101 cellular suggests requirement observation gag requires mvb process ubiquitination hiv-1 binding | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 20 | Citation Text: functions interestingly show tumors cancers breast prostate independently mir-31 oncogenic low activation | Reference Offset: [24304-24468', 24503-24653', 23309-23569'] | Reference Text: tumors breast mir-31 primary target survival based signature tumors breast patients mir-31 primary target survival based cancer signature progression rdx profiling mmp16 tumors rhoa m-rip disease cancers breast itga5 concomitant primary determined repression correlated clinical fzd3 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 15 | Citation Text: oct4 h3k4me3 mes chip-seq occupancy published | Reference Offset: [6228-6460', 7699-7953', 13823-13893'] | Reference Text: sites transcript oct4 reveal mirna tcf3 nanog transcriptional sox2 start transcripts highly method occupancy chromatin based oct4 genes circuitry tcf3 mirna nanog transcriptional sox2 generated core occupancy es genome-wide oct4 sox2 regulation tcf3 mirna promoters nanog occupancy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 1 | Citation Text: analyzed table | Reference Offset: [6767-6996', 20065-20247', 41484-41625'] | Reference Text: microarrays subgroups identify profiling leukemic determine affymetrix samples probe 12 analyzed bone sets marrow total cases set resulted class prediction table selected approach analyzed 25 samples | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 16 | Citation Text: models thymocytes differentiation demonstrated overexpression block murine tumors double-positive stage tal1 | Reference Offset: [11716-11967', 14622-14866', 17082-17348'] | Reference Text: networks development proliferation lyl1 differentiation tal1 transcriptional overexpression survival directly regulate thymocyte cases genes normal differentiation cortical stage showed undergoing pattern early thymocyte differentiation cd2 cortical upregulation tal1 stage contrast lck pattern late reflect appeared thymocyte | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 7 | Citation Text: mir-24 cancers | Reference Offset: [457-696', 1990-2166', 4493-4750'] | Reference Text: species mirna sequencing mirnas abundant rna mir-21 library mir-24 small caski cases common global 000 cancers approximately cervical incidence cancer defense functions development contribute mirnas recent cancers biological remain component largely infection viral natural | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 25 | Citation Text: advantage relative calculated growth | Reference Offset: [12439-12746', 15244-15387', 30453-30795'] | Reference Text: percentage sirna relative conditions vectors advantage identical knockdown growth population time advantage increase decrease relative growth population advantage higher increase period relative growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 1 | Citation Text: precisely blast 2002 mutation cml occurs gorre t315i analogous imatinib context resistance bcr-abl crisis 2001 | Reference Offset: [6286-6506', 1750-1952', 5160-5358'] | Reference Text: mutations provide collectively status evidence establish mutation cml kinase primary imatinib domain resistance bcr-abl clinical mutations frequency disease cml stages present kinase patients imatinib domain resistance bcr-abl develop mutations blast chronic cml response patients initial imatinib myeloid crisis detected phase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 10 | Citation Text: lung loss infection established regression tumors induces | Reference Offset: [6617-6828', 52636-52702', 1232-1321'] | Reference Text: kras model mouse loss tumorigenesis regression established tumors induces lung gata2 mutant required kras loss regression established tumors mutant deletion striking kras induced gata2 established regression tumors mutant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 20 | Citation Text: systems factors evidence cognate growing mirnas regulate frequently transcription animal | Reference Offset: [32591-32898', 622-782', 784-1003'] | Reference Text: systems evidence differentiation experimental indicating variety arrest terminal provided growth transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show retinoic mir-223 nfi-a differentiation -induced factors acid binding low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 15 | Citation Text: response arrest oncogenes primary undergo rasv12 mitogenic growth signals | Reference Offset: [570-681', 1244-1399', 19622-19852'] | Reference Text: arrest oncogenic primary g1 show rodent ras family receptors ras small mitogenic signals ras-induced ras mice response independent p53 arrest oncogenic identical wild-type contribution derived | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 6 | Citation Text: mouse rnai genes numerous rnas hairpin distinct short consortium widely identification library lentiviral knockdown multiple | Reference Offset: [20414-20694', 6851-7144', 11621-11685'] | Reference Text: screen rnai essential proliferation genes developed collection consortium viability library lines part required shrna cancer large constitutively targeting pathway pik3ca akt1 hairpin myristoylated activate short pi3k rna active mutant pten myristoylated kinase oncogenes identification library | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 18 | Citation Text: reflected metastasis tumors signatures tumor relapse predict primary clinical cancer population | Reference Offset: [3255-3559', 1201-1487', 2118-2569'] | Reference Text: status tumorigenesis profiling mirna signatures tumor disease regions outcome breast altered predict chromosomal clinical site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically complex neoplastic distant secondary tumors leads primary extravasation tissues tumor invasion-metastasis process cascade involving survival | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 1 | Citation Text: processes proliferation development death differentiation play mirna embryonic biological roles targets key regulate | Reference Offset: [2661-3032', 18133-18475', 20143-20435'] | Reference Text: mouse protocol unique development play mirnas hematopoiesis cloned roles bone mammalian examined regulate specifically marrow complex proliferation development apoptosis commitment events lineage differentiation controlled maturation molecular process stem/progenitor lineages hematopoietic stem regulate development lineage differentiation translational mirna hematopoiesis analogous roles regulation hematopoietic | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 4 | Citation Text: lats2 result lats1 45 36 transition tumor transformation sufficient vitro overexpression downregulation cancer suppress growth 50 | Reference Offset: [2144-2206', 2716-2910', 3855-4153'] | Reference Text: lats2 cycle suppressor transition tumor g1/s lats1 lats drosophila developmental tumor homolog defects mutants suppress formation cyclin inactivation preventing lats1 nude development tumor g2/m mice kinase blocking leads level and/or ectopic lines downregulation cdc2 cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 14 | Citation Text: pathway progression evidence tumor ralgds skin size mice importance reduced effector wild-type malignancy incidence null | Reference Offset: [642-815', 16146-16326', 11005-11204'] | Reference Text: progression tissue tumor lack ras ralgds transformation skin size carcinogenesis reduced malignancy incidence culture treatment determine tumor skin mice reduced analyzed wild-type growth mice animals reduced ral treatment similarly induced wild-type activation skin | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 6 | Citation Text: involvement rest-fs tumorigenesis differentially truncated exon c-terminal types linked cancer | Reference Offset: [28641-28822', 455-555', 2362-2531'] | Reference Text: rest-fs mediates interacts transcriptional c-terminal repression domain silencing rest molecule process characterized genetic tumorigenesis epigenetic alterations genes tumorigenesis play tumor phenotype contribute alterations frequent | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 9 | Citation Text: nilotinib drugs inhibitors developed candidate cml targeted dasatinib imatinib bcr-abl therapy generation | Reference Offset: [1997-2214', 4514-4691', 44448-44666'] | Reference Text: mutations development chronic stage cml effective caused point kinase patients relapse imatinib domain advanced due resistance bcr-abl therapy phase frequently kinase tyrosine targeting imatinib bcr-abl therapy cml effective drug result inhibitors advances abl cml kinase tyrosine additional clinical therapy generation major availability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 13 | Citation Text: mice controls proliferation ral resulted tumor incidence | Reference Offset: [364-526', 642-815', 817-946'] | Reference Text: deficient gtpase activates guanine nucleotide factor ralgds investigate mice signaling ral generated small exchange progression tissue tumor lack ras ralgds transformation skin size carcinogenesis reduced malignancy incidence culture controls proliferation regulation transformed participate survival ralgds | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 10 | Citation Text: region promoter mir-302 oct4 pluripotent species previous conserved mirna factor findings analyses microarray consistent transcription | Reference Offset: [13894-14090', 14388-14492', 30506-30706'] | Reference Text: oct4 species location conserved determine mirna promoters factor occupancy es genome-wide transcription suggests promoter regulation conserved factor occupancy transcription model pluripotent genes state mirna factor molecular occupancy targets transcription presented | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 10 | Citation Text: therapeutics death bcl-xl regression tumors derivatives induces abt-737 apoptotic bcl-w bcl-2 solid resistance clinical inhibitor mcl-1 phase cancer early triggered targets | Reference Offset: [2963-3241', 9702-10029', 23220-23396'] | Reference Text: death bcl-xl bh3 interaction related bcl-w short bcl-2 ligands family domain bh3-only mcl-1 members mimetic compounds bcl-xl bh3 assays abt-737 affinity contrast bcl-w bcl-2 mcl-1 bound limited level bcl-xl resistance overexpression inactivated mcl-1 targets abt-737 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 11 | Citation Text: earlier ras-driven pathway ral tumorigenesis required ralgds skin | Reference Offset: [948-1094', 13130-13344', 23350-23686'] | Reference Text: pathway experiments mediates tumors survival ralgds activation skin requirement previous extend ralgds transformation observations setting ras-driven signaling ral vivo detect proliferation pathway ralgef tissue suggested variety experiments ral papillomas required types culture activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 17 | Citation Text: lats2 nuclear localization | Reference Offset: [22986-23104', 21949-22063', 22438-22610'] | Reference Text: cellular cycle lats2 localization exogenous cellular mitosis lats2 localization examined plays lats2 mitosis fraction localization apparatus cytoplasmic mitotic exogenous | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 1 | Citation Text: limited information development metabolism metabolic contribute transformation impact altered importance tumorigenicity interest respond oncogenic recently cancer vivo | Reference Offset: [28189-28489', 1825-2054', 4332-4611'] | Reference Text: metabolism metabolic tumor rapid enzymes impact showed prior biological active downregulation pathways consistent vivo promotes work kras benefit therapeutic metabolic potential pdac tumors native oncogenic insights vivo targets kras essential maintenance metabolism metabolic tumor remain oncogenic active pathways microenvironment mechanisms growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 10 | Citation Text: migration chemokine transmembrane leukocytes receptors putative signals cx3c v28 orphan mediate fractalkine receptor recently cx3cr1 adhesion | Reference Offset: [609-757', 4906-5123', 921-1181'] | Reference Text: migration chemokine transmembrane fractalkine leukocytes stalk mucin domain adhesion molecule induces migration functional leukocytes mediate fractalkine receptor identification report cx3cr1 adhesion directly monocytes nk high-affinity termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 8 | Citation Text: series compounds ap24534 inhibitors pha-739358 capable co-crystal t315i inhibiting bcr-abl | Reference Offset: [1861-2026', 3529-3710', 5363-5704'] | Reference Text: inhibitors chronic strategy disease effective sustained tyrosine kinase leukemia target myeloid bcr-abl inhibitors effective response patients oral leading bcr-abl availability drug range mutations abl disease cml bcr-ablt315i kinase enzyme approved level domain potent capable matching native bcr-abl inhibitor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 4 | Citation Text: cyclin neck lymphomas loss mantle tumors occurs retinoblastoma d1 upstream cdk4 functionally bmi-1 inactivated head regulators direct suppressor tumor melanoma include breast altered lung pancreatic lymphoma small carcinoma | Reference Offset: [12650-12796', 13595-13813', 29088-29469'] | Reference Text: lung p16ink4a loss majority tumors non-small small occurs rb cancers cyclin promoter lymphomas mantle tumor d1 chain overexpression translocation types cyclin development selective treatment tumors disease breast dependency d1 cdk4 types produce | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 2 | Citation Text: intriguingly ablation inhibitors death induce dependent receptors caspase-8 process kinase caspase presence necrotic recently | Reference Offset: [9658-10012', 12746-13024', 2054-2314'] | Reference Text: apoptosis events inhibition rip1 sensitizes contribute caspase-8 caspase kinase regulatory additional programmed necrosis detected complex death ii induction rip1 appears kinase necrotic undergo programmed recruitment necrosis correlate death disease acute models necrotic critically regulate animal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 5 | Citation Text: patients 45 approximately ebv upregulated tumors mir-155 7% related | Reference Offset: [1338-1652', 1990-2166', 2716-2905'] | Reference Text: normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer cases common global 000 cancers approximately cervical incidence cancer squamous cervical detected 7% | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 3 | Citation Text: apoptosis senescence induction approach proposed cancer | Reference Offset: [12696-13157', 28791-28906', 30597-30804'] | Reference Text: ras-induced induction potential lack detection arrest additional senescence examined active overexpression activator inhibitor ph conditions normal senescence induction depends culture mutations induction ras transform program oncogenic primary senescence rodent premature | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 2 | Citation Text: ablation topical progression nucleotide finally factor ralgds reduced genetic incidence papillomas exchange | Reference Offset: [364-526', 642-815', 24981-25269'] | Reference Text: deficient gtpase activates guanine nucleotide factor ralgds investigate mice signaling ral generated small exchange progression tissue tumor lack ras ralgds transformation skin size carcinogenesis reduced malignancy incidence culture model ablation gtpase similarly potential tumor factor ras reduce skin carcinogenesis genetic recently tiam1 effectors small exchange rac formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 5 | Citation Text: promotes support development differentiation tumor ras ralgds contrast blocking downstream raf-1 survival targets | Reference Offset: [23788-23855', 642-815', 2027-2232'] | Reference Text: support tumor survival ralgds progression tissue tumor lack ras ralgds transformation skin size carcinogenesis reduced malignancy incidence culture cellular functions range proliferation differentiation interaction ras gtpases family effector survival small | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 8 | Citation Text: modulate machinery mrna target mirna demonstrated silencing dead interactions end | Reference Offset: [7326-7500', 1248-1543', 3079-3352'] | Reference Text: migration affects germ mirna required dead survival zebrafish end sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding animals translation seed mirnas regions mrnas sequence mrna inhibiting utilize suppress end | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 1 | Citation Text: loss functional suppressor biogenesis tumor p53 prb alterations cancer major tissues | Reference Offset: [20882-21172', 17241-17387', 226-421'] | Reference Text: mouse loss apoptosis tumorigenesis functional tumor indicating lacking rb models activate arf p53 e2f pathways p53 potent activates suppressor alternative tumor series normal transformed tumor malignant surrounding genetic cancer tissues | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 8 | Citation Text: actin-related complexes remodeling chromatin | Reference Offset: [41335-41656', 611-810', 2297-2429'] | Reference Text: direct rapidly complexes actin matrix transduction baf mechanism signal capable targeted actin-related findings nuclear vitro regulation remodeling chromatin complex complexes baf stimuli related sufficient vitro pip2 target remodeling regulated chromatin activation complexes remodeling years chromatin recent | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 8 | Citation Text: inactivation papillomavirus typically virus ras achieved dna pathways oncoproteins 1999 sv40 emerged tumor e7 transformation general requires p53 prb antigen large 2001 | Reference Offset: [422-568', 1993-2139', 2525-2676'] | Reference Text: inactivation p53 cooperating suppressors primary oncogene tumor ras requires transformation papillomavirus oncoproteins viral ras sv40 e7 inactivation p53 mutations suppressors tumor tumors ras | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 7 | Citation Text: process involves tumorigenesis types multiple | Reference Offset: [3434-3675', 2207-2440', 52219-52333'] | Reference Text: mice models rate-limiting involves tumorigenesis steps multiple tumorigenesis evidence normal steps derivatives malignant transformation process genetic highly lines alterations reflect involved complexity display types multiple | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 15 | Citation Text: constructs p53kd shrna | Reference Offset: [29538-29756', 7768-7885', 8295-8386'] | Reference Text: targeting constructs proliferation stability p53kd stable effective investigate transfected p53 cdc6 polyclonal knockdown cloned constructs vector cdc6 pcr pgl3 cloned constructs vector retroviral stable sirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 5 | Citation Text: cellular phosphatases akt suppressor tumor inpp4b phosphorylation reduce pten | Reference Offset: [21716-22005', 16598-16781', 1362-1427'] | Reference Text: insulin play tumor inpp4b effects indicating enhanced response signaling pi3k suppressors phosphatases akt roles downstream knockdown activation pten knocking dual akt inpp4b knockdown phosphorylation pten caused dual cellular resulted senescence inpp4b knockdown pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 9 | Citation Text: response breast kinase mediator oncogene cancer interferon | Reference Offset: [1780-1999', 5867-6036', 19785-19855'] | Reference Text: provide pathway mechanism observations breast genomic pi3k downstream mediator oncogene approaches discovery cancer activation acts percentage identify tumors breast kinase akt downstream oncogene amplified approaches ikbke substantial breast findings oncogene ikbke cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 16 | Citation Text: 2002 armstrong transformed leukemias acute showed mll rearrangements findings pattern identical myeloid 2001 | Reference Offset: [33700-33908', 4267-4560', 13876-14130'] | Reference Text: differ mll limited rearrangements profiles acute leukemias observations mll rearrangements hyperdiploid lineage chromosome leukemias include cases intermediate leukemias mll rearrangements level rna correlated low detected | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 9 | Citation Text: cycle proliferation genes earlier factors dna report consistent group included major regulators growth | Reference Offset: [1531-1777', 11767-11983', 22294-22756'] | Reference Text: cycle structure essential apoptosis genes nuclear led dna identification stem chromatin cycle oct4 genes revealed positively transcriptional signaling dna mrna regulation highly correlated intracellular chromatin apoptosis progression genes strand thought stability caspase dna mediated initial programmed recruitment processes cycle death induction damage stages nuclear genomic act | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 14 | Citation Text: strategies kras inhibition cancers tbk1 rna screens gata2 interference mutant wt1 | Reference Offset: [1484-1629', 1700-2032', 7190-7390'] | Reference Text: druggable kras therapeutic network cancers lung gata2 pathways mutant discovery kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth screen kras targeting rna genes wild-type interference mutant 000 cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 2 | Citation Text: microarrays unique previous barcode sequencing detection additional efforts microarray | Reference Offset: [8416-8569', 750-933', 7368-7471'] | Reference Text: detection proliferation additionally made mirna effects microarray functions expressing majority developed barcode mirnas vectors cloned dna genetic library screens experiment barcode culture weeks | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 16 | Citation Text: indispensable importantly normal rasv12 growing ras tumorigenic reduce | Reference Offset: [2825-2977', 9922-10068', 10909-11113'] | Reference Text: model indispensable oncogenic resulted rasv12 transformed ras vectors antibody analyzed rasv12 western ras cyclin pathway activates higher rasv12 pitx1 ras suppression d1 vector induced | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 3 | Citation Text: p53 stimulated validated shrna | Reference Offset: [9257-9359', 320-411', 534-623'] | Reference Text: p53 prb stimulated inhibition lt combined p53 p16ink4a prb inhibit growth p14arf inactivation p53 prb show required transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 10 | Citation Text: direct lats2 inhibits down-regulation suppressor transition tumor g1/s activities putative targets | Reference Offset: [30522-30749', 2144-2206', 5943-6128'] | Reference Text: member lats2 cycle development lats suppressor regulator transition tumor inhibits involved family g1/s negative presented lats2 cycle suppressor transition tumor g1/s present lats2 inhibits tumorigenicity suppresses ectopic evidence suppressor tumor growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 6 | Citation Text: cyclin ir firing complexes targeting degraded 19 origin potential p21 13 affect 12 d1 free cdk2 inhibit pathways bind bound | Reference Offset: [7432-7643', 4974-5305', 6405-6566'] | Reference Text: cyclin d1 p53 cdk4 directed cdk2 antibodies cdc6 p21 cyclin sites degradation subsequent potential cdk2 cdc6 wild-type proposed translocation phosphorylation phase nucleus based mutated inactivation cyclin d1 cycle arrest dna promote progression damage rapid | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 6 | Citation Text: essential induced tumors | Reference Offset: [12451-12642', 19594-19782', 45308-45463'] | Reference Text: essential development tumors erk2 tumor mice presence due treated essential development tumors tumor partial mice presence mek1lox/lox due treated mek1 essential ras-driven pathway development maintenance recently tumors | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 1 | Citation Text: limited model show ras defects ralgds transformation mice involved tumorigenicity reduced ras-mediated oncogenic effector downstream | Reference Offset: [24891-24979', 642-815', 1660-2011'] | Reference Text: signaling oncogenic show required ras ralgds transformation progression tissue tumor lack ras ralgds transformation skin size carcinogenesis reduced malignancy incidence culture involvement model mouse provide previous evidence mechanism tissue suggested dominant transformation involved signaling carcinogenesis ras-mediated ral genetic regulation overexpression negative approaches survival culture | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 11 | Citation Text: direct lats2 suppressor transition tumor putative involved inhibits down-regulation loop g1/s activities positive targets | Reference Offset: [30522-30749', 2144-2206', 5943-6128'] | Reference Text: member lats2 cycle development lats suppressor regulator transition tumor inhibits involved family g1/s negative presented lats2 cycle suppressor transition tumor g1/s present lats2 inhibits tumorigenicity suppresses ectopic evidence suppressor tumor growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 18 | Citation Text: mir-223 mechanism granulopoiesis factor regulates nuclear factors binding transcription | Reference Offset: [33654-33841', 5206-5544', 784-1003'] | Reference Text: initially mir-223 nfi-a nuclear family binding regulator factor transcription mir-223 computational nfi-a genes sequences factor putative related involved binding bind targets growth transcription retinoic mir-223 nfi-a differentiation -induced factors acid binding low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 2 | Citation Text: ectopic malignancy ikbke malignant transformation frequently | Reference Offset: [929-1067', 24046-24315', 27445-27671'] | Reference Text: critical exhibited mutations efforts identify epithelial malignant transformation cancers amplification genes induce possibility tumors transformation observations breast findings target lines cancer key ikbke constructs expressing determine transformed promoters transformation introduced induced required shrna activation ikbke | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 1 | Citation Text: druggable evaluate kras mouse therapeutic validated recently utilized elements targets mitogenic pathway potential well-known include kinases models nsclc signaling cascade efforts directed downstream genetically components survival natural pi3k/akt raf/mek/erk | Reference Offset: [47619-47854', 5057-5247', 2902-3029'] | Reference Text: allowed mouse pathway therapeutic synthetic lethal tumor models nsclc cdk4 identification recently k-ras-driven approaches targets model mouse kinases present nsclc cascade genetic k-ras-driven contribution raf/mek/erk accepted cascade generally primary mediator mitogenic raf/mek/erk kinases | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 6 | Citation Text: kras viability differentiation epithelial addicted pdac indicating regulators | Reference Offset: [1155-1343', 15443-15625', 22580-22692'] | Reference Text: findings viability therapeutic differentiation epithelial tumor candidate regulators targets cancers represent dependency k-ras viability differentiation maintain state epithelial mutant cancer observations dependency k-ras viability genes differentiation epithelial required cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 10 | Citation Text: member bak oligomerization permeabilization apoptosis bcl-xl caspase-9 bax/bak mitochondrial bcl-2 binds outer bax membrane bik cytoplasm triggers mcl-1 activation forms cytochrome | Reference Offset: [3782-4274', 11317-11628', 10949-11148'] | Reference Text: bak oligomerization permeabilization induce mitochondrial resulting factors outer proapoptotic bax and/or membrane cytoplasm release cytochrome preventing bak apoptosis induce interaction mitochondrial bcl-2 bax inhibiting binding activator sequestered release bound cytochrome bak oligomerization induce domains bh3 mitochondrial system bax bim release bid ability cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 13 | Citation Text: cellular model hallmark tumors tumor medium transformation mice independently grow ability | Reference Offset: [27645-27825', 28171-28458', 36931-37169'] | Reference Text: suppressor tumors tumor growing apoptotic mice prb functionally inactivated appearance impaired pathway apoptosis progression tumorigenesis tumor tumors mice activated small growth telomerase tumors tumor mice concomitant reduced incidence substantial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 12 | Citation Text: http://www predicted targetscan prediction org database targets presented algorithm | Reference Offset: [55318-55483', 6961-7319', 21274-21513'] | Reference Text: process consortium http://www genes target predicted org database identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions mouse defined set seed conserved targetscan mirna rat algorithm predict hypothesis targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 7 | Citation Text: model mutations development resistant system ba/f3 resistance develop occur | Reference Offset: [866-1118', 2726-2843', 2845-2964'] | Reference Text: nilotinib mutations attributable inhibition chronic lead switch second-line induces dasatinib kinase patients relapse imatinib leukemia domain resistance myeloid bcr-abl therapy kinase point involves mutations imatinib domain resistance binding bcr-abl inhibitor confer kinase mutations spectrum domain resistance drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 20 | Citation Text: complex actin baf occurs transcriptional level cytoskeletal recently regulation initiation case remodeling chromatin note | Reference Offset: [41335-41656', 611-810', 1098-1279'] | Reference Text: direct rapidly complexes actin matrix transduction baf mechanism signal capable targeted actin-related findings nuclear vitro regulation remodeling chromatin complex complexes baf stimuli related sufficient vitro pip2 target remodeling regulated chromatin activation direct work complex swi/snf baf signals signaling membrane mammalian regulation chromatin | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 3 | Citation Text: loss metastatic potential effects combined mice p53 additional genetic | Reference Offset: [2202-2525', 6184-6489', 1825-2054'] | Reference Text: kras mutations loss progression metastatic disease occurs acquisition suppressors intraepithelial tp53 cases activating subsequent tumor malignant pancreatic invasive oncogene early neoplasia model progression events induction pdac tumor comparable long biological leads additional genetic invasive suggesting promotes work kras benefit therapeutic metabolic potential pdac tumors native oncogenic insights vivo targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 12 | Citation Text: kras test panc-1 kras-dependent signaling apc pancreatic context wild-type lines yapc investigated mutant linked cancer | Reference Offset: [11325-11564', 33093-33383', 522-707'] | Reference Text: suppressor regulator tumor related striking signaling pancreatic akt lines negative cancer pten k-ras differentiation epithelial frequent deletion signaling component pancreatic undergo context k-ras shrnas mutations maintain lung viability pancreatic lines require cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 9 | Citation Text: animals rna interference reduce | Reference Offset: [1277-1443', 3970-4073', 3879-3968'] | Reference Text: process proven rna interference suppress rna total transfected rna | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 10 | Citation Text: leads loss proliferation oncogenes thyroid activated differentiation culture forms | Reference Offset: [670-777', 49971-50122', 779-1050'] | Reference Text: likewise loss oncogenes thyroid differentiation frtl-5 viral ras rat 20 proliferation loss thyroid normal differentiation epithelial oncogene ras activation induces 2000 cellular constitutively expressing differentiation origin established oncoprotein effects ras analyze generated thyroid active lines frtl-5 viral forms stably | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 11 | Citation Text: sites vicinity dnd1 prevents germ repression binding mirna primordial | Reference Offset: [1248-1543', 18143-18235', 30939-31126'] | Reference Text: sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding dnd1 germ repression primordial zebrafish provide genes evidence germ mirnas factors dnd1 repression primordial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 3 | Citation Text: genes aspects suppressor potential ca2+ signals distinct observations additional interest ability | Reference Offset: [25542-25707', 537-724', 3419-3540'] | Reference Text: plasma rasal1 association membrane ras ca2+ signals pathway ras distinct cancers activated wild-type suggesting manner large rnai grow library ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 6 | Citation Text: cervical mir-24 cancers | Reference Offset: [1990-2166', 5101-5216', 17900-18077'] | Reference Text: cases common global 000 cancers approximately cervical incidence cancer subset lesions demonstrate cervical significantly mirnas cancers mir-145 recently mir-143 cervical downregulation lymphoma cancer cancers | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 13 | Citation Text: acid actin cytoskeleton cd2ap molecule brain regulates tissues | Reference Offset: [16894-17024', 42718-42912', 774-937'] | Reference Text: northern analyze tissue detected brain tissues total murine lysates lung kidney prepared brain thymus tissues process demonstrate cytoskeletal cd2 ligand adhesion molecule engagement clustering | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 17 | Citation Text: limited k-ras play nucleotide-free isoforms h-ras ras exhibit signaling regulating active suggesting forms | Reference Offset: [8398-8574', 14490-14560', 13823-14091'] | Reference Text: affected k-ras inhibition play suggesting translocation k-ras signaling ras phosphorylation induces sites k-ras conserved mechanism switch families ras general gtpases analogous suggesting phosphorylation rho | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 8 | Citation Text: point kinase amplification mutations imatinib domain resistance binding bcr-abl caused | Reference Offset: [1750-1952', 3981-4253', 6286-6506'] | Reference Text: mutations frequency disease cml stages present kinase patients imatinib domain resistance bcr-abl develop amplification mutations revealed distinct kinase point patients detailed domain binding mechanisms mutations provide collectively status evidence establish mutation cml kinase primary imatinib domain resistance bcr-abl clinical | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 10 | Citation Text: lesions pathway exclusive evidence lines manner tumors act rb | Reference Offset: [11949-12202', 11278-11657', 12349-12564'] | Reference Text: inactivation cyclin pathway provide events exclusive evidence mutation tumor epigenetic resulting rb deletion d1 mutually p16ink4a signaling cdk4 genetic overexpression silencing machinery essential mutations evidence tumor rb regulatory suppressors components act cancer occur formation frequently fashion mutually pathway mutations generally exclusive affecting occur rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 8 | Citation Text: cycle progression play predominantly localized expected homologs nucleus | Reference Offset: [6020-6170', 8395-8518', 31010-31176'] | Reference Text: cycle aurora-a genomic crucial progression maintenance mammalian stability observations cycle lats progression apoptosis suppressors inhibition act kinases observations lats2 cycle aurora-a s83 phosphorylated endogenous localized | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 14 | Citation Text: lymphocytes chromatin | Reference Offset: [1770-1998', 5215-5629', 6101-6336'] | Reference Text: hr structure lymphocytes genes chromatin activation structure mutations lymphocytes events block dominant rapid lacking mice physiological domain negative chromatin activation complexes lymphocytes association rapid occurs receptor require regulated remodeling antigen chromatin engagement | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 3 | Citation Text: alteration affects likewise issue microrna recent anoikis phenotypes motility report resistance invasion multiple targets | Reference Offset: [10494-10714', 17214-17468', 16919-17140'] | Reference Text: unique proliferation affect anoikis breast reduced mir-31 motility invasion resistance aggressive cancer proliferation immortalized anoikis breast mir-31 motility hmecs invasion resistance affecting cancer tumorigenic stably enhanced stable anoikis suppression strong mir-31 motility invasion resistance | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 7 | Citation Text: chemokine requirement icam-1 leukocytes conditions recruit physiological additional reduced domain mucin molecules fusion adhesion derived ability | Reference Offset: [609-757', 921-1181', 36665-36823'] | Reference Text: migration chemokine transmembrane fractalkine leukocytes stalk mucin domain adhesion molecule induces termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion chemokine support mucin domain molecules adhesion | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 10 | Citation Text: sets list probe | Reference Offset: [6767-6996', 9075-9246', 14480-14711'] | Reference Text: microarrays subgroups identify profiling leukemic determine affymetrix samples probe 12 analyzed bone sets marrow samples probe 10 generated sets cd2 samples probe determined sets profiles | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 1 | Citation Text: result additionally oxidative disease diseases mitochondrial age-related respiratory and/or antioxidant acquired decreased stress chain mechanisms | Reference Offset: [3121-3398', 23349-23477', 31625-31878'] | Reference Text: cellular evaluate ros oxidative stress production mitochondrial response major response altered oxidative stress due rapid mitochondrial occurs oxidative interestingly stress conserved factor regulates appears mammalian antioxidant transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 6 | Citation Text: nilotinib potency imatinib higher ii inhibitor type | Reference Offset: [6504-6591', 42882-43167', 1307-1497'] | Reference Text: superior vitro potency imatinib bcr-abl inhibitor vivo potency expressing higher mutants cytotoxic imatinib primary highly bcr-abl hematopoietic lines imatinib-resistant inhibit ability presented potent selective describe imatinib active bcr-abl imatinib-resistant significantly inhibitor mutants | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 11 | Citation Text: proapoptotic complexity bh3 pockets regions interactions members | Reference Offset: [7371-7545', 40126-40308', 1173-1373'] | Reference Text: domains determine bh3 assays antiapoptotic bcl-2 family binding bh3-only interactions members signaling proapoptotic death family describe bh3 members antiapoptotic caused cellular death profiling state bh3 correlates antiapoptotic family determined survival members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 3 | Citation Text: cellular suggests contributes proliferation development pathway apoptosis metabolism set differentiation mirna biogenesis pathogenesis disease mirnas regulation mechanisms cancer | Reference Offset: [18133-18475', 20143-20435', 1920-2037'] | Reference Text: complex proliferation development apoptosis commitment events lineage differentiation controlled maturation molecular process stem/progenitor lineages hematopoietic stem regulate development lineage differentiation translational mirna hematopoiesis analogous roles regulation hematopoietic preventing proliferation apoptosis drosophila tissue mirna regulates growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 18 | Citation Text: receptor cx3cr1 monocytes express | Reference Offset: [6538-6761', 4906-5123', 6075-6271'] | Reference Text: functions single lymphocytes fractalkine receptor ligand demonstrated class receptors monocytes express high-affinity migration functional leukocytes mediate fractalkine receptor identification report cx3cr1 adhesion directly monocytes nk high-affinity lymphocytes experiments fractalkine receptor respond binding monocytes | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 1 | Citation Text: promoter facilitate actin cd2ap order cytoskeletal membrane polarity interact antigen | Reference Offset: [1651-1922', 3090-3185', 13114-13175'] | Reference Text: limited interaction contact affinity sufficient ligands order tcr antigen tight low formation critical area cytoskeletal polarity contact formation cytoskeletal polarity cd2 domain cytoplasmic regulates | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 7 | Citation Text: unique mediate crucial programmed sequences induction rip1 necrosis interaction rip3 homologous | Reference Offset: [24098-24361', 581-639', 826-966'] | Reference Text: screen complex rnai unique crucial induction ii rip1 show rip3 recent programmed mediator necrosis genome-wide formation kinase crucial programmed rip1 necrosis screen tnf crucial rna programmed induced infection virus activator interference necrosis rip3 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 18 | Citation Text: added chimera expressing generated tamoxifen active | Reference Offset: [779-1050', 15837-16196', 17001-17328'] | Reference Text: cellular constitutively expressing differentiation origin established oncoprotein effects ras analyze generated thyroid active lines frtl-5 viral forms stably obtained ras h-rasv12 receptor domain frtl-5 expressing extend tamoxifen estrogen ligand experimental effects oncoprotein -sensitive fusing system generated downstream context binding conditional mutant confirm inducible obtained tamoxifen induce numerous absence chimeric tsh demonstrating expected presence generated oncogene frtl-5 growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 5 | Citation Text: nilotinib mutations potency common inhibitors treatment higher mutation show inhibited dasatinib kinase 20 approved imatinib domain gatekeeper inhibition t315i imatinib-resistant bcr-abl | Reference Offset: [1997-2214', 2216-2358', 5669-6003'] | Reference Text: mutations development chronic stage cml effective caused point kinase patients relapse imatinib domain advanced due resistance bcr-abl therapy phase frequently kinase native potency inhibitors higher imatinib-resistant bcr-abl clinical abl substantial mutants complexes mutations revealed interaction effects abl molecular structures point kinase imatinib domain binding | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 11 | Citation Text: inactivation ablation development impaired tumor erk2 erk1 | Reference Offset: [10840-10934', 31887-32008', 579-700'] | Reference Text: development absence tumor erk2 required erk1 observations response c-raf ablation signaling development impaired examined tumor mechanisms lung k-ras ablation due erk2 activities erk1 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 13 | Citation Text: direct germ signal pgcs | Reference Offset: [47351-47469', 1248-1543', 5123-5266'] | Reference Text: germ measured signal sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding subset suggests evidence germ repression zebrafish targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 16 | Citation Text: mir-223 regulating target granulopoiesis molecule | Reference Offset: [1371-1574', 6034-6162', 27033-27252'] | Reference Text: mir-223 nfi-a crucial pathway lineage plays granulopoiesis molecular mediating point repression point findings mir-223 nfi-a crucial circuitry granulopoiesis molecular mir-223 form oligonucleotides mirna granulopoiesis inactive analyze order acid complementary utilized | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 5 | Citation Text: proliferation suppressor mechanism ras putative induces transforming presence additional genetic oncogenic primary senescence premature | Reference Offset: [30597-30804', 33090-33236', 5146-5319'] | Reference Text: mutations induction ras transform program oncogenic primary senescence rodent premature demonstrate p53 association oncogenic primary senescence induction rodent ras premature cellular demonstrate ras induces p53 arrest oncogenic senescence involving | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 7 | Citation Text: mir-223 model previous propose conserved mechanism alternative | Reference Offset: [33114-33223', 622-782', 784-1003'] | Reference Text: mir-223 model nfi-a granulocytic differentiation transcriptional mir-223 nfi-a regulatory granulocytic factors differentiation involving circuitry controlled show retinoic mir-223 nfi-a differentiation -induced factors acid binding low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 22 | Citation Text: telomerase joint reverse combined suppression transcriptase sufficient h-rasv12 subunit p53 p16ink4a oncogenic fibroblasts primary antigen tumorigenic | Reference Offset: [4137-4470', 5217-5293', 6590-6758'] | Reference Text: region telomerase joint reverse transformation transcriptase h-rasv12 subunit oncogenic fibroblasts primary viral small sv40 early large suppression p53 prb primary fibroblasts stable sufficient direct initially p53 prb primary fibroblasts inhibition examined lt transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 10 | Citation Text: sites decreased genes targetscan screened version algorithm target parameters local | Reference Offset: [6961-7319', 16767-16976', 15273-15562'] | Reference Text: identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions sites mirna targetscan properties mirnas impact controls expected shuffled sequence target vertebrates sites cases genes conserved predicted targetscan utrs involving target detected | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 16 | Citation Text: result model affects therapeutic agents dependent tumors differences mitochondrial mice mitochondria membrane pkc-dependent activation decreased extended demonstrated tumor pkc size system outer translocation | Reference Offset: [6164-6433', 16334-16494', 18076-18335'] | Reference Text: region gfp information k-ras amino targeting extended demonstrating pkc response full-length 20 acid identical pm manner translocation required activation mitochondria red pattern outer localization membrane suggested mitochondrial association ras demonstrating endogenous mitochondrial mitochondria outer 30 located membrane pkc-dependent nm | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 10 | Citation Text: sites mammals complex states mirnas rapid typical binding rna-binding | Reference Offset: [1248-1543', 833-984', 2820-3077'] | Reference Text: sites demonstrate germ conserved mirnas associating mrnas target binding primordial zebrafish dead end rna-binding mammals mrnas sequence seed inhibit nucleotides untranslated mirnas regions nt complex strand mirnas mature cytoplasm silencing duplex | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 7 | Citation Text: kinase catalytic essential domain demonstrated directly growth substrate | Reference Offset: [4968-5128', 18061-18211', 19427-19552'] | Reference Text: kinase lats2 lats1 lats sequence drosophila domain cyclin kinase lats2 e/cdk2 negatively transition g1/s directly regulates kinase lats2 domain conserved kinases | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 13 | Citation Text: hypermethylation catalytic impaired mutations induce global 2-hydroxyglutarate production idh dna tet2 recently leukemia resultant | Reference Offset: [916-1045', 1904-2225', 1047-1248'] | Reference Text: enzyme idh characterized mutations resultant 2-hydroxyglutarate production neomorphic hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile hypermethylation global profiling revealed display epigenetic acute patient dna leukemia myeloid large signature | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 6 | Citation Text: necroptosis pan-caspase pathway inhibitors death alternative blocked apoptotic | Reference Offset: [571-813', 2336-2533', 32044-32184'] | Reference Text: termed activates death dependent rip1 receptors type apoptotic conditions necroptosis stimulation kinase necrotic pathway fadd death caspases receptors induces apoptotic caspase-8 upstream family recruitment activation necroptosis cellular extensive signaling pathway necrotic death show regulates network | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 5 | Citation Text: dependency kras sensitivity differentiation correlated epithelial signature | Reference Offset: [27204-27481', 10813-10942', 11669-11731'] | Reference Text: k-ras genes differentiated differentiation state classified epithelial tumors predominantly ras demonstrating dependency findings consistent mutant culture signature dependency k-ras differentiation associations state overexpression epithelial copy dependency k-ras differentiation state epithelial linked | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 12 | Citation Text: kinase tyrosine blast resistant crisis inhibitor therapy | Reference Offset: [4514-4691', 44448-44666', 1149-1305'] | Reference Text: kinase tyrosine targeting imatinib bcr-abl therapy cml effective drug result inhibitors advances abl cml kinase tyrosine additional clinical therapy generation major availability kinase tyrosine lymphoblastic leukemia chronic oncogene bcr-abl acute | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 12 | Citation Text: assay | Reference Offset: [45076-45188', 304-393', 395-482'] | Reference Text: 10 assay program analyzed 000 stabilization p53 arrest leading dna induction damage g1 process response exert requires transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 8 | Citation Text: work catalytic mutations exclusive metabolic demonstrated 2-hydroxyglutarate enzymes recent production idh2 neomorphic idh1 inhibits mutually tet2 idh1/2 mutant | Reference Offset: [48169-48351', 1349-1571', 1904-2225'] | Reference Text: idh mutually mutations tet2 exclusive idh1/2 wild-type aml disrupted mutant mutations exclusive epigenetic defects mutants enzyme mutually loss-of-function tet2 idh1/2 aml hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 4 | Citation Text: confer advantage contribution defective p14arf growth silenced | Reference Offset: [4659-4886', 13436-13685', 13687-13939'] | Reference Text: model technology individual pathway neoplastic genes suppressor tumor transformation p53 p16ink4a prb rna combination contribution interference directly p14arf loss proliferation absence tissue indicating conditions p53 advantage primary manner culture growth p14arf advantage p53 lost exclusively dependent inactivated detected growth p14arf | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 27 | Citation Text: increase period weeks | Reference Offset: [30453-30795', 6167-6214', 5904-6056'] | Reference Text: advantage higher increase period relative growth weeks protocol increase relative 3t3 monitored | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 12 | Citation Text: typically oxidative ppp flow comparison reduced carbon lines cancer elevated | Reference Offset: [16425-16570', 17828-18075', 17616-17826'] | Reference Text: unique reduced ppp significantly intermediate cycle oxidative possibility ppp pdac production relative generated glucose context cellular facilitate oxidative ppp suggested affecting nonoxidative biosynthesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 12 | Citation Text: necroptosis termed kinase form necrosis rip3 requires related | Reference Offset: [7352-7423', 1439-1604', 4420-4544'] | Reference Text: kinase induce domains programmed necrosis rip3 requires essential virus innate rip3 response controls kinase initiating inflammatory cascade programmed necrosis infections kinase upstream crucial activating report programmed necrosis rip3 regulates | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 3 | Citation Text: arf gtpases critically case depends small gefs activation | Reference Offset: [3487-3599', 4645-4849', 5822-5937'] | Reference Text: arf acts family domain gefs members ras families gefs representative gaps arf rho gaps regulated molecular small mechanisms gefs | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 7 | Citation Text: hydrophobic mutations form effects conformation exert imatinib loop cage drug | Reference Offset: [16747-16943', 5360-5637', 13499-13743'] | Reference Text: site change structural abl conformation network stabilize imatinib loop binding part required activation interactions drug residues mutations change substitutions 13 contact kinase imatinib domain required drug direct sites structure amino conformational include acid led binding based sites mutations contact imatinib atp binding affecting significantly group directly drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 11 | Citation Text: dasatinib kinase tyrosine development nilotinib inhibitors treatment imatinib due | Reference Offset: [1997-2214', 30746-31101', 4514-4691'] | Reference Text: mutations development chronic stage cml effective caused point kinase patients relapse imatinib domain advanced due resistance bcr-abl therapy phase frequently proven treatment tumors receptors effective kinase tyrosine inhibits imatinib bcr-abl drug kinase tyrosine targeting imatinib bcr-abl therapy cml effective drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 11 | Citation Text: lose deficient endoderm lineage pluripotency extraembryonic differentiate nanog | Reference Offset: [1272-1370', 18281-18365', 30655-30777'] | Reference Text: lost endoderm lineage pluripotency differentiated extraembryonic es endoderm loss pluripotency extraembryonic differentiation nanog null contrast actively independently endoderm pluripotency extraembryonic differentiation prevents nanog | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 12 | Citation Text: involvement additional regulation microarray es chromatin transcription | Reference Offset: [11767-11983', 14583-14643', 18006-18202'] | Reference Text: cycle oct4 genes revealed positively transcriptional signaling dna mrna regulation highly correlated intracellular chromatin oct4 implicated genes correlated regulation chromatin structure complexes unique support provide interaction maintaining strong regulation chromatin | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 3 | Citation Text: breast genes metastasis invasion tumor linked regulates cancer | Reference Offset: [13487-13571', 14251-14315', 14817-14947'] | Reference Text: breast amplification patient-derived lines tumor ikbke cancer samples breast lines tumor amplified ikbke cancer samples breast mcf-7 amplification primary lines tumor cancer ikbke | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 5 | Citation Text: promotes transcript structure oct4 tumor plays maintaining pluripotency manner stem chromatin self-renewal growth | Reference Offset: [1779-2078', 31285-31529', 28484-28792'] | Reference Text: structure oct4 genes differentiation state lead regulating experiments respond roles pluripotency consistent chromatin self-renewal oct4 defined genes importantly differentiation regulator plays embryonic involved regulating experiments pluripotency stem pathways central self-renewal key structure oct4 importantly genes differentiation revealed state lead regulating experiments respond roles pluripotency consistent chromatin self-renewal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 14 | Citation Text: screening proliferation atp primary assays based | Reference Offset: [6251-6367', 5052-5202', 6059-6174'] | Reference Text: result screening individual primary sirna confirm sirnas level standard scored atp sirna positive cellular viability atp 100 measuring | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 9 | Citation Text: technology subgroups myeloid advances microarray profiles distinguished recent based acute | Reference Offset: [14170-14334', 14500-14620', 19548-19898'] | Reference Text: lyl1 genes profiles tal1 based considered close studied findings technology lineage tumors microarray patterns cases genes distinguished poorly molecular clusters generated group based | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 17 | Citation Text: kras mutations genes tumors egfr | Reference Offset: [466-520', 522-707', 709-913'] | Reference Text: k-ras mutations epithelial occur frequently cancers k-ras shrnas mutations maintain lung viability pancreatic lines require cancer primary revealed well-differentiated epithelial tumors phenotype cancer signature | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 16 | Citation Text: proliferation mir-145 mir-146a mir-21 mir-143 increase inhibit growth | Reference Offset: [1338-1652', 1825-1967', 9687-10279'] | Reference Text: normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer carcinogenesis mir-145 collectively mir-146a mir-143 cervical play upregulation downregulation normal signal showed abundant mir-21 tissues population mir-145 mir-143 000 cervical lines low cancer based | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 5 | Citation Text: cellular respiration mitochondria ros generated oxidative majority phosphorylation | Reference Offset: [6215-6391', 12437-12664', 16786-17004'] | Reference Text: cellular mitochondria ros majority oxidative contribute ros oxidative production mitochondria chain increase approach phosphorylation based cytochrome obtained ros observation oxidative resulted mitochondria reduction consistent phosphorylation generation early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 10 | Citation Text: constructed plasmids mirna | Reference Offset: [5428-5594', 6211-6358', 2232-2376'] | Reference Text: functions constructed vector identify approach mirna retroviral mirnas confirmed mir-vec expressing plasmids mirna mirnas functions screening identify approach mirna mirnas small stresses | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 17 | Citation Text: neoplastic uncover genes sufficient transcriptase h-rasv12 subunit oncogenic primary fibroblasts recently telomerase joint reverse suppressor tumor assays transformation combined suppression p53 p16ink4a antigen tumorigenic | Reference Offset: [2451-2823', 2113-2449', 6605-6821'] | Reference Text: telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth telomerase genes recombination ras transformation vectors altered apparent p53 prb pi3k rna ectopic recently pathways mutant viral homologous screen tumor-suppressor neoplastic genes inhibition ras assays transformation vitro oncogenic rna combination library interference | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 11 | Citation Text: pretrosuper rasv12 pmscv-blast pmscv-gfp-st | Reference Offset: [5431-5580', 7455-7730', 8362-8466'] | Reference Text: selected subsequently expressing oncogenic rasv12 st polyclonal rasv12 vectors selected 10 p53 days prb polyclonal drug presence oncogenic grow examined induced stress rasv12 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 3 | Citation Text: lats2 aurora-a previous state kinase report downstream suggesting phosphorylation monitored | Reference Offset: [651-728', 36157-36278', 41933-42213'] | Reference Text: kinase lats2 aurora-a target show phosphorylation kinase lats2 aurora-a s83 centrosomal candidate residue phosphorylation kinases aberrant amplification aurora-a form previous hela defects mitotic inactive kinase wild-type report phase triggered formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 1 | Citation Text: mammals complexes swi/snf baf53 homolog present point remodeling chromatin 2000 | Reference Offset: [3825-4073', 4205-4301', 38470-38632'] | Reference Text: complexes swi/snf drosophila higher baf remodeling chromatin related present complexes higher remodeling chromatin demonstrate complexes swi/snf excess remodeling chromatin based related | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 1 | Citation Text: animals factors presence rna binding | Reference Offset: [17469-17654', 32617-32837', 31128-31269'] | Reference Text: telomerase revealed endogenous clear mrnas rna dnd1 binding coding animals development loss additionally genes germ lead tumors disruption recent showed involved rna allowed presence rna germ primordial targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 1 | Citation Text: oct4 previous common genes upregulated possibility ectopic lentiviral targets | Reference Offset: [28250-28482', 3942-4248', 8756-8965'] | Reference Text: transcriptional networks modulate oct4 factors previous regulatory stem targets series oct4 revealed circuitry nanog recent transcriptional sox2 identification core escs targets oct4 commitment genes lineage setting implicated pluripotency parameters early targets self-renewal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 11 | Citation Text: caspase necrotic death inhibitors chemical activities compromised viral | Reference Offset: [18761-18948', 21068-21251', 2054-2314'] | Reference Text: test death virus type caspase activated examined inhibitor hypothesis viral cellular machinery apoptosis death inhibitors programmed mechanism necrosis show inhibited viral death disease acute models necrotic critically regulate animal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 9 | Citation Text: rasal1 genes mechanism pitx1 gtp sufficient level family pathways reduction directly transcription screen loading gaps effector knockdown gap anchorage-independent lost loss mutation ras endogenous appears controls suppressors fibroblasts encoding suggesting couple homeodomain regulators activation member induce sequences potential tumor promoters factor implicated signaling gtpase-activating led grow wild-type downstream manner negative | Reference Offset: [537-724', 6074-6389', 7630-7936'] | Reference Text: pathway ras distinct cancers activated wild-type suggesting manner large induce gdp hydrolysis gtp ras gtpase-activating factors binding regulated bound targeting constructs rasv12 pitx1 factor comparable transforming proapoptotic binding approach overexpression knockdown homeodomain transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 5 | Citation Text: model tp53 bortezomib tumors long process fasudil nsclc patients wild-type treated suggesting aggressive discovery early drug | Reference Offset: [1700-2032', 19509-19662', 56838-57044'] | Reference Text: kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth hr figure nsclc bortezomib treated lines nm bortezomib inhibited approved fasudil cascade proteasome clinical drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 3 | Citation Text: obtained constructs collection type vectors prostate generated 293t lentiviral prepared culture cancer | Reference Offset: [7075-7235', 3565-3646', 3648-3808'] | Reference Text: vectors constructs transcripts failed transient suppress sirnas constructs transfected dna sirna synthetic detect 10% prepared | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 8 | Citation Text: respiration superoxide oxygen hydrogen generates peroxide reduction dismutation mitochondrial produced | Reference Offset: [36329-36508', 10048-10244', 11621-11708'] | Reference Text: contrast response findings superoxide hydrogen peroxide consistent heterogeneous mutants exogenous sites ros oxygen potential iii relative believed reduction generation major large energy occur oxygen term reduction | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 15 | Citation Text: druggable mouse ablation therapeutic considerable regression tumor factor suggested promising models lung leads regulating adenocarcinoma genetic interest proteasome gata2 approaches targets transcription | Reference Offset: [65307-65555', 1484-1629', 1700-2032'] | Reference Text: serve functions therapeutic intriguing determine finally factor kinases kinase regulatory factors gata2 regulated phosphorylation targets transcription druggable kras therapeutic network cancers lung gata2 pathways mutant discovery kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 4 | Citation Text: expressing immortalized substitute enhanced ras transformation system akt colony activated overexpression significantly utilizing mek activation formation | Reference Offset: [42996-43241', 27445-27671', 32189-32559'] | Reference Text: induce failed potential mapk transformation h-rasv12 pi3k akt activated pathways tumorigenic mek constructs expressing determine transformed promoters transformation introduced induced required shrna activation ikbke degradation amino pathway expressing resistant determine substitutions inhibited transformation acid induced mutant phosphorylation activation ikbke | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 5 | Citation Text: model metastatic rhoa 16 anoikis radixin recently ectopic invasion inhibit reduction multiple key sites migration majority matrix metastasis play tumor steps orthotopic colonization breast lung integrin 95% promote leading mir-31 cascade myosin roles analyses repressed suppress cancer 50 growth | Reference Offset: [20939-21198', 1201-1487', 31549-31866'] | Reference Text: matrix revealed rhoa 16 interacting assays reporter integrin radixin myosin mir-31 repressed site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically spectrum metastatic metastasis effects rhoa colonization impact suppression mir-31 metastases repression formed multiple targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 5 | Citation Text: tnf fadd-deficient jurkat observations clear necroptosis fact undergo treated manner | Reference Offset: [10359-10501', 10503-10602', 11366-11472'] | Reference Text: necroptosis cyld fadd-deficient jurkat inhibit confirm sirnas necroptosis cyld inhibition jurkat cyld fadd-deficient jurkat electroporated sirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1423_EVAL | Citance Number: 3 | Citation Text: untreated observation loss commitment possibility bad localized conditions bcl-2 mitochondria signaling leading cascade event formed translocation consistent make | Reference Offset: [31391-31776', 397-552', 710-942'] | Reference Text: transmembrane loss pathway induce transition potential mitochondria mammalian report peptides consistent release cytochrome inducing bak kill mitochondria bcl-2 proapoptotic family bax require release members cytochrome bak characterized domains bh3 bad mitochondrial antiapoptotic resulting subset activate bcl-2 binds bax initiate displacement bik peptides directly | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 13 | Citation Text: apoptotic bcl-2 believed displacement family target binding bh3-only multidomain interactions vivo | Reference Offset: [7371-7545', 2401-2687', 8152-8303'] | Reference Text: domains determine bh3 assays antiapoptotic bcl-2 family binding bh3-only interactions members regions antiapoptotic bcl-2 proapoptotic family bh3-only multidomain based bcl-2 family domains bh3 bh3-only interactions antiapoptotic nm | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 16 | Citation Text: compound resistant inhibitors abl cml bcr-ablt315i effective represent mutants undergoing future current clinical trials | Reference Offset: [5032-5361', 29218-29488', 30138-30388'] | Reference Text: reports compound resistant select inhibitors potential abl recent mutants t315i kinase importance current resistance inhibitor therapy compound mutations resistant expressing clinically bcr-ablt315i mutants represent additional mutagenesis screens bcr-abl treatment abl cml represent undergoing kinase patients increase incidence survival inhibitor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 1 | Citation Text: sites promoter made luciferase reporter upstream located construct artificial | Reference Offset: [37993-38225', 20332-20671', 24546-24958'] | Reference Text: sites reporter promoter constructs binding factor artificial transcription site clones promoter constructs expressing tamoxifen absence measured oncoprotein reporter transiently upstream transfected presence binding low inducible promoter chimeric ras reporter upstream mediated repression transcription site stimulated specificity inhibition possibility factor thyroid-specific transfected factors binding | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 19 | Citation Text: mice cyclin e/cdk2 mouse fibroblasts overexpression inhibit embryonic transformation | Reference Offset: [17780-18059', 1450-1663', 3855-4153'] | Reference Text: cyclin kinase lats2 e/cdk2 mouse responsible failed inhibiting active mutant demonstrating regulate cyclin cycle revealed downregulated transition affected kinase e/cdk2 g1/s regulators cyclin inactivation preventing lats1 nude development tumor g2/m mice kinase blocking leads level and/or ectopic lines downregulation cdc2 cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 1 | Citation Text: functions affects chimera normal functional differentiate rara produced pml translocation atra apl | Reference Offset: [3895-4035', 6760-7052', 7950-8670'] | Reference Text: pml normal chimeric disruption mutant apl considered suggests patterns localization treatment differentiation normal rara pml presence oncogenic fusion reversed atra therapy apl remains revealed leukemic pml replication dna rna utilized apl sites functions rara factor transcriptional nuclear transcripts small | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 6 | Citation Text: site sites promoter element mir-223 unique nfi-a distinct experiments start based transcription | Reference Offset: [19382-19589', 34675-34847', 5206-5544'] | Reference Text: site sites promoter mir-223 nfi-a presence search revealed binding site promoter mir-223 nfi-a binding elements mir-223 computational nfi-a genes sequences factor putative related involved binding bind targets growth transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 9 | Citation Text: lats2 affects lats1 decreased inhibition stability cyclins g2/m arrest binding g1/s case | Reference Offset: [6130-6297', 16942-17307', 25821-26104'] | Reference Text: g2/m controls lats2 lats1 regulating negatively proliferation interestingly transition g1/s cyclin mcf-7 lats2 cycle lats1 degradation resulted cyclins p57kip2 caused level cdk2 ectopic g1/s negative p27kip1 regulators lats2 mitosis cycle revealed potential transition inhibited g2/m arrest experiments ectopic g1/s profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 11 | Citation Text: pretrosuper prs-blast prs-hygro | Reference Offset: [33313-33524', 33268-33311', 37103-37253'] | Reference Text: prs-blast rasv12 pmscv-blast replacing pmscv-gfp-st pretrosuper prs-blast primer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 2 | Citation Text: nt upstream recognition pre-mirna 40 ectopic downstream sequences mirna hairpin required | Reference Offset: [9200-9472', 8939-9198', 11442-11744'] | Reference Text: mir-223 responsible recognition sequences predicted mirna hairpin recent nuclear transcripts primary report elements nt mir-223 constructs rnas mirna efficiently hairpin pattern mature bone 40 marrow nt sequences mirna strategy hairpin general genomic transcripts mature sequence primary determined included | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 2 | Citation Text: facilitate genes tumorigenesis play suppressor establish potential candidate tumor models oncogenes identification approaches cancer | Reference Offset: [1478-1640', 2362-2531', 4858-5000'] | Reference Text: provide development genes suppressor approach tumor candidate rest suppress cancer genes tumorigenesis play tumor phenotype contribute alterations frequent suppressors genes approximately epithelial potential candidate tumor 25 transformation represent | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 2 | Citation Text: member death induction bim downregulation required activation | Reference Offset: [38905-39093', 49371-49467', 27376-27612'] | Reference Text: preventing model support subsequent bax/bak bcl-2 leukemia largely momp bim survival required activation bak and/or bax bim bh3-only activator required bid activation change death conformational interaction prior bcl-2 sequestering bax bim consistent prevented | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 7 | Citation Text: structure model bcl-xl inhibitor bound abt-737 | Reference Offset: [9702-10029', 968-1068', 10031-10289'] | Reference Text: mimetic compounds bcl-xl bh3 assays abt-737 affinity contrast bcl-w bcl-2 mcl-1 bound bcl-w bcl-2 refractory bcl-xl types affinity abt-737 direct bcl-xl abt-737 confirmed binding bim mcl-1 tight bind drug | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 12 | Citation Text: disrupts retinoic potential pml fact importance acid fusion manner | Reference Offset: [1726-2086', 4037-4186', 635-792'] | Reference Text: product retinoic acid receptor genes fusion chimeric translocation apl pml retinoic acid presence all-trans domain places acid receptor leukemia fusion acute | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 10 | Citation Text: ptpn12 rest-mir-124 mir-124 resulted circuitry controlled demonstrated phosphatases increase reduction substantial | Reference Offset: [39142-39330', 9742-10097', 12672-12834'] | Reference Text: ptpn12 endogenous level led increase lines rest consistent hypothesis substantial ptpn12 proliferation loss apoptosis revealed lead oncogenic ectopic increase significantly consistent depletion aberrant ptpn12 exhibited expressing increase shrna | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 12 | Citation Text: direct suggests post-transcriptional tumorigenesis global mirna tumor mirnas cancers widely oncogenes suppressors act decrease | Reference Offset: [4304-4491', 21270-21550', 457-696'] | Reference Text: direct rnai strand functional translational mirna resulting mrna act characterized development proliferation tumorigenesis inhibition potential mirnas promote oncogenes recently primary lymphoma species mirna sequencing mirnas abundant rna mir-21 library mir-24 small caski | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 10 | Citation Text: cellular functions proliferation apoptosis differentiation regulation mirnas | Reference Offset: [18133-18475', 1081-1360', 1920-2037'] | Reference Text: complex proliferation development apoptosis commitment events lineage differentiation controlled maturation molecular process stem/progenitor lineages hematopoietic stem regulate mouse fraction differentiation adult mirnas assays mice stem/progenitor led bone ectopic hematopoietic marrow preventing proliferation apoptosis drosophila tissue mirna regulates growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 9 | Citation Text: kras mouse development progression give revealed models critical lineages remaining oncogenic rise act | Reference Offset: [2527-2800', 1028-1162', 1561-1633'] | Reference Text: kras mouse progression genes evidence suppressor tumor pdac models oncogenic genetically provided driver initiation major critical kras adenocarcinoma event oncogenic pancreatic mutation initiation tumor ductal signature promotes kras reveal oncogenic biogenesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 3 | Citation Text: individual considerable complexity mirna rnas mirnas targeted bioinformatic mrna target analyses multiple regulate | Reference Offset: [6961-7319', 20558-21071', 22334-22702'] | Reference Text: identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions 2002 mirna mirnas complementary complementarity elements targets portion sites observation numerous mediate importance mrna regulation observation functional conserved reflects mirna signal difficult mirnas utrs multiple | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 10 | Citation Text: kras model mouse previous nucleotide ppp ductal induces kras-dependent adenocarcinoma oncogenic largely pancreatic nonoxidative biosynthesis | Reference Offset: [1028-1162', 26148-26322', 18876-19084'] | Reference Text: critical kras adenocarcinoma event oncogenic pancreatic mutation initiation tumor ductal signature functions kras provide ppp dna rna oncogenic nonoxidative biosynthesis individual ppp kras-dependent oncogenic differential glucose manner nonoxidative | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 6 | Citation Text: clones mutations importantly revealed lbc kinase carrying sequence domain imatinib-resistant multiple | Reference Offset: [5908-6284', 3981-4253', 26234-26510'] | Reference Text: clones mutations blast provide treatment evidence selection observations prior independent kinase patients additional domain myeloid imatinib-resistant crisis develop detected multiple amplification mutations revealed distinct kinase point patients detailed domain binding mechanisms region clones fraction mutations possibility sequencing regions kinase patients domain bcr-abl detected large | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 10 | Citation Text: hr sds-page constructs hela psuper 95% analyzed western efficiency electroporated targets | Reference Offset: [24339-24558', 10197-10362', 15986-16121'] | Reference Text: cyclin hr cycle irradiated vectors d1 10 analyzed wild-type treated mutant electroporated cyclin sds-page antibodies made 10% lysates d1 p53 western hr d1 sds-page antibodies 10% prepared lysates | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 18 | Citation Text: 10% ecotropic fcs dmem bj grown receptor fibroblasts primary | Reference Offset: [36124-36410', 37272-37447', 2451-2823'] | Reference Text: ecotropic p53kd 500 selected carrying bj receptor generation dmem 10% fcs telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 11 | Citation Text: pml body nuclear leukemia determined formed reminiscent bodies molecular | Reference Offset: [11551-11738', 28426-28669', 3642-3893'] | Reference Text: sites antibodies domains pml nuclear fail bodies antigen body nuclear component pods antibodies determine bodies pod nuclear leukemia lymphocytic fusion translocations acute leukemias | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 6 | Citation Text: mitochondria contributes believed ros damage production diseases major | Reference Offset: [3121-3398', 8869-8995', 10048-10244'] | Reference Text: cellular evaluate ros oxidative stress production mitochondrial response major sites ros superoxide pathways iii production major sites ros oxygen potential iii relative believed reduction generation major large energy occur | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 11 | Citation Text: amino domains budding defect mutation sequences stage short deletion acid late called viruses | Reference Offset: [4442-4654', 846-989', 5706-5882'] | Reference Text: cellular machinery facilitate budding domains virus structural general distinct enveloped late viruses recruitment cellular budding interfering stage hiv-1 rna late tsg101 depletion small cellular inhibitors budding stage ubiquitin free late proteasome blocked 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 17 | Citation Text: 2002 genes mechanism armstrong leukemias abundant mll rearrangements transforming fusion 1999 activation targets meis1 experimental transformation transcriptional li combination 2001 | Reference Offset: [4267-4560', 13876-14130', 16091-16290'] | Reference Text: mll rearrangements hyperdiploid lineage chromosome leukemias include cases intermediate leukemias mll rearrangements level rna correlated low detected cases meis1 exclusively similarly leukemic indicating mll rearrangements involved directly alterations growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 13 | Citation Text: kras genes suppressor colon tumor well-known lung p53 oncogene tumorigenic cancer | Reference Offset: [2202-2525', 2527-2800', 4747-4965'] | Reference Text: kras mutations loss progression metastatic disease occurs acquisition suppressors intraepithelial tp53 cases activating subsequent tumor malignant pancreatic invasive oncogene early neoplasia kras mouse progression genes evidence suppressor tumor pdac models oncogenic genetically provided driver initiation major kras reveal activating metabolism maintain tumor oncogene analyses pathways growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 9 | Citation Text: model demonstrate development dependent tumors ras ralgds skin mice mediated resistance part activation | Reference Offset: [948-1094', 21081-21337', 26500-26719'] | Reference Text: pathway experiments mediates tumors survival ralgds activation skin apoptosis mediates defect tumors show ralgds stimuli apoptotic mice signaling due activation involvement evaluate provide dependent evidence tumor ras ralgds oncogenic pathways activation formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 14 | Citation Text: cyclin lats2 cycle complex transition regulator p57kip2 kinase e/cdk2 inhibits overexpression g1/s p27kip1 regulators major | Reference Offset: [26590-26857', 1450-1663', 16942-17307'] | Reference Text: cyclin lats2 cycle transition cyclins affect kinase e/cdk2 ectopic g1/s affecting downregulation regulators cyclin cycle revealed downregulated transition affected kinase e/cdk2 g1/s regulators cyclin mcf-7 lats2 cycle lats1 degradation resulted cyclins p57kip2 caused level cdk2 ectopic g1/s negative p27kip1 regulators | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 3 | Citation Text: libraries rnai tumor-suppressor development loss-of-function genes mammalian candidate approaches | Reference Offset: [1478-1640', 4466-4687', 22522-22753'] | Reference Text: provide development genes suppressor approach tumor candidate rest suppress cancer potentially enabled rna loss-of-function mammalian mechanism interference manner emergence rnai genes candidate table genomic highly approach rest included | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 4 | Citation Text: cycle phosphorylation rbp | Reference Offset: [7359-7547', 10428-10495', 16295-16466'] | Reference Text: cycle stimulated phosphorylation rb cycle figure phosphorylation transiently cycle events late state phase phosphorylation early rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 2 | Citation Text: gtpases strong binding nucleotide-free gefs | Reference Offset: [39072-39197', 670-824', 826-974'] | Reference Text: clear sites gaps largely active pockets binding due lack molecule small gefs catalyzing gdp hydrolysis gtp gefs general gaps signaling exchange inducing cellular gaps extracellular time events regulated multidomain gefs localized signals | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 15 | Citation Text: information 10 patterns genomic provide identify | Reference Offset: [27386-27619', 37874-38085', 2144-2362'] | Reference Text: independent information t-all hyperdiploid provide features profiles chips provide identify enhance patients relapse future underlying ability subtypes demonstrate identify profiling enhance leukemia therapy ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 3 | Citation Text: tumorigenesis interestingly overexpression mirnas linked | Reference Offset: [935-1177', 5015-5142', 645-748'] | Reference Text: cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 screen system model oncogenes genetic identify tumorigenesis functional act mirnas functionally mirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 1 | Citation Text: therapeutic potential factor related bcl-2 findings prognostic target positive presented | Reference Offset: [23738-23894', 2963-3241', 3520-3746'] | Reference Text: strategies suggests bcl-2 therapeutic potential tumors mcl-1 abt-737 elevated death bcl-xl bh3 interaction related bcl-w short bcl-2 ligands family domain bh3-only mcl-1 members bak apoptosis death interaction express related bcl-2 proapoptotic family and/or bax multidomain key members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 13 | Citation Text: cyclin lats2 p53 loss additionally absence stimulated comparable overexpressed | Reference Offset: [7807-7961', 7963-8393', 11579-11721'] | Reference Text: lats2 heterozygosity loss located primary chromosome frequently cancers cyclin lats2 nih3t3 mouse lats2/kpm apoptosis induce hela inhibition transition g2/m kinase e/cdk2 down-regulation tumorigenicity arrest inhibit g1/s cdc2 suppress cyclin lats2 time western release prepared | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 8 | Citation Text: kras therapeutic inhibitors potential network cancers transcriptional tbk1 gata2 approaches mutant explored | Reference Offset: [1484-1629', 1700-2032', 6830-7115'] | Reference Text: druggable kras therapeutic network cancers lung gata2 pathways mutant discovery kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth causing kras loss therapeutic inhibitors inhibition strategy established finally clinically combined suppression nsclc gata2 pathways mutant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 8 | Citation Text: set tumor inpp4b signals suppressed negatively suppressors multiple mechanisms cancer regulate pten | Reference Offset: [21716-22005', 11578-11790', 20228-20592'] | Reference Text: insulin play tumor inpp4b effects indicating enhanced response signaling pi3k suppressors phosphatases akt roles downstream knockdown activation pten model mouse suppresses inpp4b tumor knocking xenograft clusters overexpression culture growth pten revealed tumors tumor inpp4b showed deletion 10 ovarian investigated locus pten copy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 11 | Citation Text: primers sets | Reference Offset: [42691-42837', 391-540', 542-668'] | Reference Text: designed sequence program sets primer express mutations activating thyroid ras cancer carcinoma thyroid differentiated phenotype aggressive cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 4 | Citation Text: exposure defined mutations treatment select dependent revealed cml dose patients vitro mutagenesis screens manner bcr-abl | Reference Offset: [29218-29488', 866-1118', 1466-1669'] | Reference Text: compound mutations resistant expressing clinically bcr-ablt315i mutants represent additional mutagenesis screens bcr-abl nilotinib mutations attributable inhibition chronic lead switch second-line induces dasatinib kinase patients relapse imatinib leukemia domain resistance myeloid bcr-abl therapy cellular ap24534 tumor inhibited assays mutants mice suppressed mutagenesis resistance screens bcr-abl growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 14 | Citation Text: limited treatment finally outcome initially leads fact patients relapse dramatically imatinib resistance acquired drug | Reference Offset: [19565-19784', 12865-13007', 1750-1952'] | Reference Text: mutations treatment possibility clinically caused achieved patients respond imatinib resistance drug patients exhibited blast mutations treatment imatinib primary myeloid resistance crisis detected prior mutations frequency disease cml stages present kinase patients imatinib domain resistance bcr-abl develop | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 16 | Citation Text: tp53 ptpn12 mutations brca1 suppressors tumor recent interactions occur pten | Reference Offset: [4479-4627', 6372-6537', 27833-27889'] | Reference Text: tyrosine screen ptpn12 suppressors functional phosphatase tumor independent shrnas suppressors genes tumor multiple pten targeted ptpn12 mutations occur frequently | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 3 | Citation Text: retinoic treatment domains normal pml pod suggests subcellular structure numerous structures localized 30 acid discrete nuclear all-trans wild-type bodies nucleus speckles small | Reference Offset: [6760-7052', 9998-10216', 11551-11738'] | Reference Text: suggests patterns localization treatment differentiation normal rara pml presence oncogenic fusion reversed atra therapy apl domains normal pml figure dna mature granulocyte nucleus sites antibodies domains pml nuclear fail bodies antigen | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 5 | Citation Text: surprisingly k-ras fashion apoptosis bcl-xl-dependent phosphorylated induces | Reference Offset: [23046-23275', 1122-1226', 4578-4686'] | Reference Text: k-ras form pathway apoptosis death induce suggesting phosphorylated ability induces position 181 k-ras pathway apoptosis bcl-xl residue induces requires k-ras fashion apoptosis bcl-xl-dependent stimulated phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 5 | Citation Text: machinery mouse marson genes mirna combined transcriptional clusters dataset dna recently analyzed chip-seq binding published multiple | Reference Offset: [933-1241', 2016-2296', 5214-5450'] | Reference Text: genes circuitry protein-coding mirna promoters sequencing transcriptional short regulatory identification transcripts describe chip-seq quantitative types es multiple based marson state mirna promoters sequencing short factors promote identification program transcripts describe chip-seq quantitative types es multiple key transcription sites genes sequences mirna factor close prior transcriptional mature binding es regulators transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 12 | Citation Text: cellular lats2 lats1 essential lats 36 effects kinase implicated remain 30 | Reference Offset: [4968-5128', 1665-1825', 6413-6575'] | Reference Text: kinase lats2 lats1 lats sequence drosophila domain kinase lats2 tumorigenicity lats domains conserved inhibit required suppress growth kinase lats2 demonstrate tumorigenicity lats proliferation domains conserved inhibit required ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 7 | Citation Text: cycle interestingly differentially phosphorylated rb | Reference Offset: [8850-8995', 3732-3813', 4357-4467'] | Reference Text: cycle loss phosphorylated phase primarily rb phosphorylated multiple forms rb cycle events state rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 8 | Citation Text: cyclin cycle preventing progression dependent regulates retinoblastoma kinases kinase point binding g1/s inhibitor phosphorylation | Reference Offset: [4019-4242', 8970-9234', 2964-3084'] | Reference Text: cyclin pathway phosphatidylinositol stability regulates distinct enhance kinase negatively akt cyclin family inhibit prevent phosphorylation specifically kinases rb stimulation cyclin leads nucleus accumulation mitogenic kinases | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 19 | Citation Text: migration pleiotropy mir-31 invasiveness genes target demonstrated contribute vivo | Reference Offset: [1058-1127', 14428-14568', 17972-18080'] | Reference Text: mir-31 microrna strategy inhibit stable vivo mir-31 metastatic malignancy demonstrated observations proliferation mir-31 primary failed inhibition tumor vivo alter growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 5 | Citation Text: short rnai rna inhibition advanced target produces hairpin knockdown | Reference Offset: [1277-1443', 1525-1722', 2500-2695'] | Reference Text: process proven rna interference suppress short suppression mediate strong synthetic transcript reverse short designed sequence target derived gene-specific | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 14 | Citation Text: kras apoptosis noted viability approximately underwent tumor-derived lines knockdown large | Reference Offset: [4241-4507', 9481-9697', 522-707'] | Reference Text: k-ras requirement basis maintaining dependency sustained stratify viability features lines mutant large cancer k-ras involves requirement shrnas tumor viability lines multiple large k-ras shrnas mutations maintain lung viability pancreatic lines require cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 6 | Citation Text: ligand abt-737 12 | Reference Offset: [21337-21503', 878-966', 968-1068'] | Reference Text: blocking binds colony ligand treated mutant effective abt-737 growth apoptosis bh3 putative abt-737 triggered bcl-w bcl-2 refractory bcl-xl types affinity abt-737 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 8 | Citation Text: kras series mouse mutations common type disease ductal appears panin event develop required intraepithelial support maintenance exhibit targeted models initiating lesions adenocarcinoma sequence pancreatic mutant neoplasia | Reference Offset: [2202-2525', 1028-1162', 26785-27096'] | Reference Text: kras mutations loss progression metastatic disease occurs acquisition suppressors intraepithelial tp53 cases activating subsequent tumor malignant pancreatic invasive oncogene early neoplasia critical kras adenocarcinoma event oncogenic pancreatic mutation initiation tumor ductal signature kras remains expressing maintenance pdac tumor recent setting lose vitro oncogenic pancreatic advanced oncogene lines mutant relevant vivo | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 11 | Citation Text: nsclc kras-dependent refractory treatment largely classified pdac | Reference Offset: [2277-2655', 23966-24217', 1671-1809'] | Reference Text: k-ras refractory development clinically effective cancers remain largely mutant cancer loss death resulted h358 pdac nsclc yapc depletion k-ras mutations classified lines cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 5 | Citation Text: cellular rnai loss pitx1 lead show ras transformation suppression sufficient leads reduction resultant activation gap | Reference Offset: [5585-5817', 400-535', 2113-2449'] | Reference Text: cellular proliferation mutations activating colon tumors ras transformation stimulation point lung promote survival tissues subsets mutations activating tumorigenesis indicating ras activation occur frequently cancers telomerase genes recombination ras transformation vectors altered apparent p53 prb pi3k rna ectopic recently pathways mutant viral homologous | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 5 | Citation Text: sequences mirna stimulate utrs mirnas mrnas rbps sequence regulation manner components negative positive bind motifs elements key | Reference Offset: [833-984', 3079-3352', 5865-6039'] | Reference Text: mammals mrnas sequence seed inhibit nucleotides untranslated mirnas regions animals translation seed mirnas regions mrnas sequence mrna inhibiting utilize suppress end pathway mrnas sequence target controlled binding mirna stability observations | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 9 | Citation Text: constructs encoding bartel wt | Reference Offset: [1427-1650', 33090-33401', 32903-33088'] | Reference Text: nt translation genes play bartel rnas protein-coding endogenous micrornas regulatory mrna roles repression pairing reporter represents measured mutant wt reporter renilla wt luciferase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 7 | Citation Text: ablation impairs concomitant erk2 tumor erk1 growth | Reference Offset: [579-700', 10840-10934', 825-889'] | Reference Text: lung k-ras ablation due erk2 activities erk1 development absence tumor erk2 required erk1 observations ablation development tumor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 10 | Citation Text: first-line mutations treatment agents mutation cml effective considered confer t315i approved patients recently resistance | Reference Offset: [3712-3931', 866-1118', 2028-2237'] | Reference Text: confer kinase mutations domain mutation resistance bcr-ablt315i nilotinib mutations attributable inhibition chronic lead switch second-line induces dasatinib kinase patients relapse imatinib leukemia domain resistance myeloid bcr-abl therapy first-line chronic disease cml effective targeted patients imatinib bcr-abl inhibitor therapy phase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 4 | Citation Text: neck squamous chronic upregulated colon tumors mir-155 melanoma breast lung pancreatic leukemia thyroid lymphocytic cervical kidney head lymphoma cancer carcinoma | Reference Offset: [21822-22147', 18627-18941', 22292-22508'] | Reference Text: mir-223 targeting development apoptosis chronic mutation mir-155 implicated mir-146a leukemia cervical lymphocytic cancer regulate tissues decreased papillary appears prostate level thyroid mir-146a lines lymphoma cancer carcinoma tissues lymphoblastic development ii mir-155 type lung implicated receptor recently regulation fibroblast lymphoma cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 5 | Citation Text: lats2 nude proliferation development transformed inhibited mice suppressed vitro v-ras ectopic | Reference Offset: [1151-1343', 10611-10726', 24869-25046'] | Reference Text: lats2 nude assay proliferation development suppresses tumors mice inhibits vitro ectopic mice lats2 suppressed nude tumorigenesis ectopic lats2 nude form demonstrated tumors mice suppressed ectopic develop ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 5 | Citation Text: processes development death play tumor fate suppression biological micrornas programmed hematopoietic animal | Reference Offset: [1585-1796', 688-892', 1362-1582'] | Reference Text: targeting development translation genes play rnas protein-coding micrornas roles repression development drosophila play mirnas mrnas roles repression target pairing controls mouse micrornas regulatory development roles circuitry components molecular hematopoiesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 15 | Citation Text: methylation involved dna mechanism tissue types type regulate sample distinct | Reference Offset: [4281-4555', 2115-2276', 2278-2470'] | Reference Text: family genes differentiation target myeloid included types members growth regulate limited development show types mirnas stages tissues involved regulatory provide genes differentiation sets tissue-specific mirnas | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 16 | Citation Text: complexes drosophila recently subunits homologs | Reference Offset: [2713-2897', 3825-4073', 23384-23490'] | Reference Text: complexes similarly drosophila identical discovery complexes swi/snf drosophila higher baf remodeling chromatin related complexes subunits jurkat swi/snf-like | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 12 | Citation Text: compounds depend tumors related clear expected factors bcl-xl-dependent clinical | Reference Offset: [2302-2467', 9099-9229', 34728-35018'] | Reference Text: mimetic compounds provide basis bh3 promising highly clinical trials cytotoxic bak mimetic compounds and/or bax depend bh3 effectively compound induce bcl-xl developmental effects defects abt-737 lacking related bcl-w mice bcl-2 expected targets vivo | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 13 | Citation Text: complex replication dna origins cdt1 recognition cdc6 origin recruitment bound mcm | Reference Offset: [31573-31743', 1899-2115', 1780-1897'] | Reference Text: complex recognition origin factor licensing replication dna cdt1 origins cdc6 mcm bound complex recognition loading maintenance origin factor putative cdt1 origins cdc6 g1 process licensing replication dna origins cdc6 plays key major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 3 | Citation Text: 293t construct proviral | Reference Offset: [16358-16536', 9277-9417', 12561-12905'] | Reference Text: hiv-1 test budding tsg101 sirna construct required proviral residues p6 vitro tsg101 domain interaction construct p6 series mutations virus block ptap embryonic confirmed hiv-1 mediate replication sequence late domain 293t lines blocked kidney release | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 20 | Citation Text: g2/m lats2 inhibits arrest hela excess overexpression transition transformed g1/s | Reference Offset: [25821-26104', 6130-6297', 11219-11280'] | Reference Text: lats2 mitosis cycle revealed potential transition inhibited g2/m arrest experiments ectopic g1/s profile g2/m controls lats2 lats1 regulating negatively proliferation interestingly transition g1/s lats2 inhibits blocking proliferation transition g1/s | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 11 | Citation Text: promotes complex cyld loss apoptosis dependent rip1 rip3 inhibited caspase-8 necroptosis consistent activation formation | Reference Offset: [10604-10781', 16543-16754', 17022-17428'] | Reference Text: necroptosis marker efficiently inhibited activation formation induce death innate rip1 requires necroptosis kinase l929 presence induced consistent activation cellular species rip1 glutathione plays necroptosis mediating expected free leads fact increase consistent radical activation availability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 7 | Citation Text: aberrant alteration typically rnai proliferation genes change mutation characterization candidate tumors affect selected vitro suppressors vivo copy identify strategy tumor oncogenes sequence screens survival genome-wide | Reference Offset: [36013-36371', 3187-3336', 37241-37571'] | Reference Text: amplification translation proliferation evidence functional mutation tumors putative occurs clear viability primary clinical identify properties exhibit oncogenes oncogene translocation based cancer models oncogenes identification genes suppressor tumor candidate proliferation responsible pathway mechanism tumors breast signaling undefined lines survival required lymphoma large members | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 1 | Citation Text: show inhibited l929 exhibited programmed induced silencing effectively tnf nih essential sirna rip1 effects rip3 mediator necrosis consistent 3t3 | Reference Offset: [24587-24716', 16543-16754', 30524-30773'] | Reference Text: necroptosis l929 induced sirna rip1 inhibited activation induce death innate rip1 requires necroptosis kinase l929 presence induced consistent activation nih apoptosis death genes necroptosis involved l929 induced required 3t3 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_TRAIN | Citance Number: 11 | Citation Text: previous oncogenic largely ppp nonoxidative synthesis ras showed | Reference Offset: [18876-19084', 21658-21993', 26148-26322'] | Reference Text: individual ppp kras-dependent oncogenic differential glucose manner nonoxidative kras flux selective ppp indicating reduced mediated oncogenic roles glucose combination regulation significantly nonoxidative knockdown functions kras provide ppp dna rna oncogenic nonoxidative biosynthesis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 17 | Citation Text: induction isoforms phosphorylated accumulation time system 30 recently active discrepancies | Reference Offset: [31061-31379', 779-1050', 4467-4733'] | Reference Text: allowed direct rapidly inhibition differentiation induction effects ras demonstrating appears analyze system time oncogenic thyroid frtl-5 early activation cellular constitutively expressing differentiation origin established oncoprotein effects ras analyze generated thyroid active lines frtl-5 viral forms stably mutations finally differences accumulation differential examined due lines frtl-5 culture | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 17 | Citation Text: mice kras lung oncogenic requires formation | Reference Offset: [4169-4362', 9143-9331', 11242-11370'] | Reference Text: developed prevents mutation tumors interaction ras mice lung subunit carrying significantly likewise erk2 tumors mice lung due derived detected mice lung staining treatment | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 10 | Citation Text: contributes form immortalized akt1 determine line epithelial phosphorylated rendered transformation myristoylated stabilized kidney tumorigenic forced | Reference Offset: [6115-6314', 19117-19309', 929-1067'] | Reference Text: htert immortalized expressing epithelial embryonic lt rendered showed h-rasv12 st kidney tumorigenic result amplifications examined wild-type rendered wt ikbke tumorigenic forced critical exhibited mutations efforts identify epithelial malignant transformation cancers | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 6 | Citation Text: patterns basis set differentiated differentiation embryonic stages investigated stem bodies types carcinoma | Reference Offset: [7865-8091', 590-800', 7655-7863'] | Reference Text: total set differentiated affymetrix embryonic adult derivatives variety samples biological stem oct4 essential lineage differentiation state embryonic factor adult implicated mediator stem homeodomain cancer transcription basis 45 form set murine samples selected stem part stembase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 10 | Citation Text: her2+ progression tumors patients inverse fail and/or primary grade correlate clinical aggressive subtypes association markers metastasis persisted tumor molecular basal-like breast independent stratify prognostic mir-31 largely subtype cancer 50 | Reference Offset: [33966-34095', 36183-36383', 36570-36839'] | Reference Text: independent association mir-31 subtype metastasis grade persisted tumor low molecular association metastatic tumors tumor appears breast independent mir-31 subtype grade correlate her2+ profiling revealed tumors disease breast basal-like reduced mir-31 correlate reduction clinical aggressive | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 14 | Citation Text: mir-223 progenitors regulator granulocyte granulopoiesis negative required | Reference Offset: [1371-1574', 6034-6162', 21910-22128'] | Reference Text: mir-223 nfi-a crucial pathway lineage plays granulopoiesis molecular mediating point repression point findings mir-223 nfi-a crucial circuitry granulopoiesis molecular site mir-223 obtained presence wild-type target negative reduction luciferase mutated substrate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 13 | Citation Text: result amino mutations guanine gtp-bound nucleotide hydrolysis substitutions 13 ras conformation defective 12 acid oncogenic active 61 | Reference Offset: [15684-15846', 44204-44313', 1135-1281'] | Reference Text: arginine position mutations block finger 13 ras 12 oncogenic 61 presence mutations oncogenic hydrolysis gtp ras inactive cycle typically gtp-bound active conformation small kda size | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 6 | Citation Text: synchronized g1 rs due phase phosphorylation | Reference Offset: [16295-16466', 3316-3426', 4882-5030'] | Reference Text: transiently cycle events late state phase phosphorylation early rb residues serine predominantly phosphorylation threonine occurs measured stability phosphorylation vivo rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 13 | Citation Text: member chemokine fractalkine family endothelial sole produced cx3c | Reference Offset: [36133-36310', 609-757', 921-1181'] | Reference Text: biological chemokine collectively effector domain cx3cr1 chemokines sole migration chemokine transmembrane fractalkine leukocytes stalk mucin domain adhesion molecule induces termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 18 | Citation Text: jude biological dataset leukemia st childhood research hospital database | Reference Offset: [41729-41866', 45703-45850', 40834-41074'] | Reference Text: total jude patients treated therapy research hospital support research jude patients hospital treatment pediatric molecular outcome database generated leukemia detailed profiles | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 1 | Citation Text: mir-146a cervical detected cancer tissues | Reference Offset: [1338-1652', 13685-13955', 15542-15717'] | Reference Text: normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer cultures upregulation indicating northern confirmed mir-146a cervical downregulation cancer tissues level mir-146a cervical play increase cancer tissues growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 11 | Citation Text: arise nature genetic and/or evidence occurring tumors epigenetic selection | Reference Offset: [43143-43249', 2207-2440', 33930-34308'] | Reference Text: and/or normal evidence tissue tumors tumorigenesis evidence normal steps derivatives malignant transformation process genetic highly lines alterations reflect mouse proliferation apoptosis considerable evidence chronic tumors widespread accumulation malignant apoptotic models concomitant | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 15 | Citation Text: cycle thought phosphorylated stages nuclear dephosphorylation prb regulation phosphorylation mechanisms regulators dephosphorylated | Reference Offset: [16866-17014', 5351-5549', 6121-6466'] | Reference Text: sites apparent sds-page regulation suggesting phosphorylated phosphorylation multiple forms rb degradation dephosphorylation phosphate suggested synthesis phosphorylation relative rapid occur rb cellular proliferation lymphocytes state induction phosphorylated investigate rb primary examined phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_TRAIN | Citance Number: 6 | Citation Text: e2f1 acts ligase thought mdm2 proteolysis ubiquitin critical upstream and/or e2f targets inducing direct pathway suppressor tumor include p53 promote binding inhibitor mechanisms phosphorylation | Reference Offset: [17241-17387', 17634-17841', 20882-21172'] | Reference Text: p53 potent activates suppressor alternative tumor genes regulator mdm2 plays response p53 proapoptotic encoding induced negative inhibitor mouse loss apoptosis tumorigenesis functional tumor indicating lacking rb models activate arf p53 e2f pathways | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 15 | Citation Text: mutations tet2 exclusive genes suppresses recently aml manner idh2 occur idh1 | Reference Offset: [8198-8275', 9199-9487', 9489-9590'] | Reference Text: mutually mutations exclusive aml frequent idh2 idh1 mutations exclusive thought idh2 malignant idh1 mutually patients concurrent aml based patients mutually mutations exclusive aml large idh2 idh1 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 2 | Citation Text: functions metabolism intermediate kinase signaling leading akt molecules survival cancer key growth | Reference Offset: [29718-30048', 6379-6611', 12148-12335'] | Reference Text: extracellular loss suppressor tumor signal ras signals signaling factors akt activated phosphatase survival intracellular pten extracellular transmembrane matrix receptors signals factors signaling molecules components bind growth direct kinase interaction survival ras growth signals | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 9 | Citation Text: promyelocytic acute size present 10 discrete 30 pods leukemia malignancy disrupted nucleus | Reference Offset: [1584-1724', 635-792', 3642-3893'] | Reference Text: leukemia proliferative promyelocytic myeloid developing malignancy hematopoietic blocked stage acute acid receptor leukemia fusion acute nuclear leukemia lymphocytic fusion translocations acute leukemias | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 5 | Citation Text: cellular complex actin component swi/snf mammalian recently | Reference Offset: [13941-14213', 1098-1279', 4579-4805'] | Reference Text: complex amino swi/snf baf kda remaining acid signaling component sequence respond mammalian determined subunits direct work complex swi/snf baf signals signaling membrane mammalian regulation chromatin complex observation swi/snf potential molecular atpase mammalian | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 14 | Citation Text: kras proliferation inhibitors inhibition tumors effects antitumor enhanced enhance signaling inhibiting raf knockdown mek targets | Reference Offset: [48174-48339', 30245-30399', 43174-43426'] | Reference Text: c-raf nsclc proliferation cdk4 inhibitors inhibit effects antitumor mechanisms resulting kinase result limited inhibitors inhibition suggesting display raf kinases series inhibitors nsclcs tumors antitumor showed solid advanced early | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 1 | Citation Text: mouse loss metastatic epithelial tumors mice findings surrounding patients order affecting presented metastasis demonstrated tumor metastasize breast models suppression xenograft mir-31 lines cancer suppress growth | Reference Offset: [41387-41753', 5452-5658', 31947-32192'] | Reference Text: experimental murine tumor influences breast models independent findings patients mammary loss-of-function lines multiple cancer major mouse metastatic normal epithelial candidate tumor mirnas 10 mammary lines included tumorigenic established extended breast patients xenograft mir-31 malignancy analyses lines clinical fully cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 15 | Citation Text: migration mouse pooled proliferation identify models tumorigenicity phenotypes genetic screens adhesion survival cancer shrna regulators drug | Reference Offset: [1510-1622', 5585-5817', 23450-23587'] | Reference Text: harbor genetic genes differentiation tumors survival alterations multiple growth cellular proliferation mutations activating colon tumors ras transformation stimulation point lung promote survival tissues cellular inhibits tumorigenicity proliferation pitx1 show low | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 3 | Citation Text: alteration form nilotinib inhibitors mutation conserved abl dominant structurally dasatinib kinase findings leading imatinib active resistance design | Reference Offset: [1997-2214', 2216-2358', 5520-5666'] | Reference Text: mutations development chronic stage cml effective caused point kinase patients relapse imatinib domain advanced due resistance bcr-abl therapy phase frequently kinase native potency inhibitors higher imatinib-resistant bcr-abl clinical abl substantial mutants kinase tyrosine potent additional inhibitors active bcr-abl imatinib-resistant mutants | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_TRAIN | Citance Number: 13 | Citation Text: implicated similarly resistance experimental mechanism inhibitor therapy major abt-737 | Reference Offset: [1912-2006', 15537-15653', 18747-18907'] | Reference Text: expected apoptosis induced bh3 mechanism putative abt-737 caspase point time inhibitor abt-737 mcf-7 mouse rnai hela resistance construct mcl-1 abt-737 targeted | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 17 | Citation Text: t-all pattern cases global analyses published 39 | Reference Offset: [11969-12186', 46263-46555', 5563-5761'] | Reference Text: sufficient microarrays analyze t-all patterns test rna global hypothesis 39 samples aberrant cases lyl1 set genes signal 39 tal1 t-all order oncogenes context subset t-all cases strong receptor activated places | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_EVAL | Citance Number: 7 | Citation Text: region site structure seed secondary long selection affected rna target determined complementarity silencing accessibility | Reference Offset: [35505-35697', 2683-2818', 4029-4240'] | Reference Text: structure recognition change secondary mirna sequence rna dnd1 binding required rna ii rnas long transcribed mirnas process rna target lead mirna stability mirnas alter selection | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 6 | Citation Text: inactivation carcinogenesis sv40 suppressor tumor variety breast p53 mrnas mammary genetic alterations small early coding | Reference Offset: [1687-1824', 1116-1259', 3239-3592'] | Reference Text: p53 prb genetic suppressor tumor pathways alterations cancers individual genetic tumorigenesis contribution tumor alterations mutations suppressor tumor affect product mice point presence p16ink4a locus small 2001 major specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 11 | Citation Text: cyclin site d1 ubiquitination apparent requirement efficiently phosphorylation | Reference Offset: [15076-15311', 3103-3229', 14491-14651'] | Reference Text: cyclin site degradation refractory d1 induced mutant fully phosphorylation mutated cyclin ubiquitination d1 286 degradation nuclear triggers threonine cyclin d1 leads 286 degradation pathway threonine phosphorylation activation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 2 | Citation Text: process common oncogenic suppressor tumor phosphorylation | Reference Offset: [1389-1486', 19316-19611', 1488-1677'] | Reference Text: genes suppressor class tumor retinoblastoma mutations functional tumor retinoblastoma rb suppression proposed directly phosphorylation cloned leads basis loss location tumor chromosomal properties formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 15 | Citation Text: predict mir-21 targetscan targets | Reference Offset: [6961-7319', 21274-21513', 11533-11714'] | Reference Text: identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions mouse defined set seed conserved targetscan mirna rat algorithm predict hypothesis targets 20 targetscan mirna putative interactions targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 4 | Citation Text: functions understand generate previous progression complexity researchers hallmark tumor suggested logical scientific acquired manner cancer | Reference Offset: [772-1059', 32947-33245', 46459-46604'] | Reference Text: complex complexity treatment origin disease recent search scientific manner essential development progression immortalized state potential tumor phenotype malignant acquired suggesting types culture vivo growth mass depend primary metastasis hallmark invasion acquired tumor formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 2 | Citation Text: suggests proliferation functional mirna showed cancers promote oncogenic mir-146a introduced cervical lines cancer | Reference Offset: [1742-1823', 7905-7989', 1338-1652'] | Reference Text: proliferation promote mir-146a introduced lines cervical mirna lines cancer profile tissues showed normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 10 | Citation Text: functions pathway suppressor epithelial stimulus ras transformation gtpase-activating intracellular | Reference Offset: [12167-12374', 15641-15800', 29162-29367'] | Reference Text: pathway suppressor ii epithelial tumor type transformation transforming receptor growth implicated potent regulating proliferation pathway vitro oncogenic epithelial inhibitor transformation suggests functions rest-fs shrnas epithelial endogenous transformation transforming rest mutant ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 15 | Citation Text: and/or mir-21 roles due contributions mitogenic specifically | Reference Offset: [2379-2582', 9324-9466', 10324-10492'] | Reference Text: complex genes mechanism mirnas sequence largely action target due response arrest oncogenes primary undergo rasv12 mitogenic growth signals constructs largely due 372 mir-372 close | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 10 | Citation Text: radiation degradation activates inhibition induction p21 ionizing transcriptional p53 cdk2 cdc6 inhibitor | Reference Offset: [6782-6888', 6196-6403', 5943-6080'] | Reference Text: cyclin cycle e/cdk2 p53 inhibition induction inhibitor activation caused apoptosis maintenance induction prior transcriptional sustained p53 arrest target g1 required phase activation response radiation p53 pathway dna activated induced damage ionizing factor transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 13 | Citation Text: htert expressing mammary hmecs epithelial cultured lt sv40 medium growth | Reference Offset: [43499-43631', 668-784', 4689-4856'] | Reference Text: htert expressing mammary hmecs epithelial cultured lt sv40 medium growth screen genetic mammary genes report epithelial suppress transformation model defined identify genes epithelial transformation mammary oncogenic genetic approach utilized suppress | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 1 | Citation Text: superior nilotinib inhibition properties abl mice kinase 20-fold imatinib due | Reference Offset: [1997-2214', 5669-6003', 17424-17654'] | Reference Text: mutations development chronic stage cml effective caused point kinase patients relapse imatinib domain advanced due resistance bcr-abl therapy phase frequently complexes mutations revealed interaction effects abl molecular structures point kinase imatinib domain binding cellular kinase obtained viability proliferation imatinib inhibition correlated effects activities comparable | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 1 | Citation Text: implicated recent ikbke malignant transformation | Reference Offset: [929-1067', 2627-2829', 26707-26945'] | Reference Text: critical exhibited mutations efforts identify epithelial malignant transformation cancers systems mutations murine transformation models implicated roles genetically cancer sophisticated work immune pathway activates innate factor recent response part infections viral ikbke interferon transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_TRAIN | Citance Number: 19 | Citation Text: animals cognate mirna factor regulates transcription | Reference Offset: [5206-5544', 19151-19380', 33654-33841'] | Reference Text: mir-223 computational nfi-a genes sequences factor putative related involved binding bind targets growth transcription mir-223 nfi-a sequences predicted factor related regulatory bind targets transcription initially mir-223 nfi-a nuclear family binding regulator factor transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1421_EVAL | Citance Number: 12 | Citation Text: babst complex li 1996 recently tsg101 vps37 homologs 2001 2000 | Reference Offset: [19885-20051', 34871-35131', 34271-34499'] | Reference Text: babst functions pathway trafficking vps4 tsg101 endosomal vps 2001 2000 targeting previous pathway functional hydrolysis good demonstrating observations roles vps 2001 2000 babst surface class phenotype deletion li inhibits receptor rise tsg101 sorting vps downregulation golgi 2000 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 7 | Citation Text: mouse species involving insights mirna transcription | Reference Offset: [6952-7314', 10080-10550', 13894-14090'] | Reference Text: sites mouse provide location mirna factor sequencing mirnas fate transcriptional regulatory start program primary quantitative types es mechanisms transcription mouse genes mirna residue transcribed recent initiation transcription sites observation identify transcriptional advantage start oct4 species location conserved determine mirna promoters factor occupancy es genome-wide transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_TRAIN | Citance Number: 4 | Citation Text: complex chromatin/nuclear swi/snf baf53 matrix play binding components | Reference Offset: [17245-17438', 27369-27654', 27246-27368'] | Reference Text: cellular total complex mammalian baf53 antibodies determine baf components complex actin hela baf53 matrix revealed baf lacking brg1 nuclear experiments stably brg1 chromatin/nuclear actin association baf53 matrix stable induces | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 3 | Citation Text: oct4 genes akt1 profiling global revealed positively negatively correlated directly regulate transcription | Reference Offset: [11767-11983', 16500-16744', 20370-20539'] | Reference Text: cycle oct4 genes revealed positively transcriptional signaling dna mrna regulation highly correlated intracellular chromatin oct4 complexes provide development positively negatively nature identification correlated rest oct4 genes revealed positively related correlated | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 14 | Citation Text: lower bh3 synthetic antiapoptotic full-length time apparent differential helix multidomain activities bid targets interactions direct detect association peptide measured interaction apoptotic bax peptides binding part | Reference Offset: [45104-45355', 7902-7986', 46282-46488'] | Reference Text: direct test peptide bh3 antiapoptotic peptides binding bim ability bcl-2 pattern peptide family bh3 binding interaction antiapoptotic patterns peptide domains specificity bh3 interaction antiapoptotic critical ligands binding pockets consistent vivo | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 14 | Citation Text: cellular cycle ros damage production variety mitochondrial mitochondria leading dna generated rna vicious core intracellular energy | Reference Offset: [47689-47856', 20554-20840', 3121-3398'] | Reference Text: cycle ros organelle damage putative mitochondrial potentially mitochondria dna generated vicious components directly sensitivity oxidative damage production mitochondrial mitochondria leads led dna initial increase cellular evaluate ros oxidative stress production mitochondrial response major | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 9 | Citation Text: complex level potent h2o2 iii production | Reference Offset: [8869-8995', 14945-15133', 35227-35420'] | Reference Text: sites ros superoxide pathways iii production major complex ros recent level additional chain entry highly regulation regulated cytochrome complexes resulted demonstrated iii level respiratory chain components | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 15 | Citation Text: surface stalk mucin structurally | Reference Offset: [609-757', 921-1181', 2247-2484'] | Reference Text: migration chemokine transmembrane fractalkine leukocytes stalk mucin domain adhesion molecule induces termed migration chemokine support induce occurs requires signaling receptor stalk mucin domain molecules cx3cr1 adhesion migration provide induction structurally related signals motility molecules adhesion group chemokines small activation frequently | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 1 | Citation Text: fashion oct4 differentiated tcf3 mirnas nanog recent polycomb transcriptionally sox2 factors co-occupied tissue-specific group silenced transcription | Reference Offset: [30012-30425', 22686-22873', 1438-1589'] | Reference Text: oct4 reveal pluripotent genes set differentiated protein-coding states mirnas polycomb sets key silenced serve actively facilitate maintenance tcf3 promoters nanog sox2 regulated group es suggests repress model oct4 set genes mirna tcf3 nanog polycomb subset co-occupied sox2 tissue-specific group es fashion co-occupied genes set differentiated mirna tissue-specific group es polycomb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 7 | Citation Text: member multi-targeted nilotinib inhibitors abl date second-line dasatinib kinase achieved regulatory family imatinib inhibitor | Reference Offset: [2216-2358', 5669-6003', 34374-34518'] | Reference Text: kinase native potency inhibitors higher imatinib-resistant bcr-abl clinical abl substantial mutants complexes mutations revealed interaction effects abl molecular structures point kinase imatinib domain binding dual kinase involved signaling inhibitors potential bcr-abl src abl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 5 | Citation Text: additionally set seed sequences random mirna frequency preserve controls expected matching shuffled generated complementary | Reference Offset: [13115-13307', 18765-19061', 52929-53099'] | Reference Text: positions controls shuffled set seed alternative mirna mirnas targets sites sequences mirna properties mirnas controls expected selected shuffled sequence target targets controls shuffled sequence generated program seed mirna | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 2 | Citation Text: tnf rip1 rip3 inhibited production l929 autocrine recently silencing necrosis | Reference Offset: [12354-12682', 24587-24716', 4532-4667'] | Reference Text: contributes peptide inhibitors inhibition caspases virus necroptosis caspase l929 autocrine regulation induced necrosis inhibitor multiple necroptosis l929 induced sirna rip1 inhibited activation necroptosis l929 induce treatment inhibited | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_EVAL | Citance Number: 5 | Citation Text: tubulin analyzed mrna | Reference Offset: [13336-13438', 14023-14209', 18744-18863'] | Reference Text: level tubulin mrna measured sample tubulin percentage transcripts mrna measured frtl-5 level markers mrna analyzed induction ras decrease showed | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_TRAIN | Citance Number: 13 | Citation Text: promoter essential development amplifications tumors tumor factor binds lung traf6 genomic oncogenic gata2 locus elevated transcription | Reference Offset: [1700-2032', 50056-50166', 53828-54030'] | Reference Text: kras reveal loss suppresses tumors non-small network pathways drug essential inhibition tumor combined models transcriptional lung nsclc gata2 chip-seq mutant cancer growth lung kras-driven oncogenic gata2 initiation tumor total loss treatment tamoxifen inhibition recombination subsequent tumors show lung leads findings gata2 regulated locus pathways | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 3 | Citation Text: cycle dependent phosphorylated manner rb | Reference Offset: [8850-8995', 3732-3813', 4357-4467'] | Reference Text: cycle loss phosphorylated phase primarily rb phosphorylated multiple forms rb cycle events state rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 3 | Citation Text: loss pathway induce senescence due pi3k/akt pten | Reference Offset: [20594-20834', 25132-25392', 25020-25130'] | Reference Text: cellular mutations loss tumors inpp4b showed deletion senescence phosphatase lipid investigated pten result pathway inpp4b knocking findings pi3k senescence increase consistent knockdown pten loss previous senescence vivo pten | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_TRAIN | Citance Number: 14 | Citation Text: antibodies 3d10 | Reference Offset: [23993-24278', 50179-50286', 12096-12167'] | Reference Text: lats2 gfp aurora-a unable antibodies interaction endogenous assays and/or 293t confirm 3d10 5% antibodies western 3d10 antibody western 3d10 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 7 | Citation Text: treatment induced atra formation | Reference Offset: [1110-1204', 6760-7052', 7209-7560'] | Reference Text: pml generate treatment pods triggers apl suggests patterns localization treatment differentiation normal rara pml presence oncogenic fusion reversed atra therapy apl agents line factor distinct transforming nuclear induced features myeloid growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_EVAL | Citance Number: 2 | Citation Text: libraries rnai tumor-suppressor development loss-of-function genes mammalian candidate approaches | Reference Offset: [726-921', 1624-1721', 1723-1889'] | Reference Text: tumor-suppressor constructs genes uncover absence ras screened transform oncogenic primary introduced library knockdown inactivation tumor-suppressor oncogenes genetic genes activation altered p53 tumor-suppressor oncogenes prb genes components pathways ras mutated frequently | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 14 | Citation Text: damage targetscan prediction potential enzyme dna target targets key mutated | Reference Offset: [6961-7319', 11533-11714', 11265-11346'] | Reference Text: identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions 20 targetscan mirna putative interactions targets micrornas mammalian prediction targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1425_EVAL | Citance Number: 5 | Citation Text: mutations progression treatment confer critical kinase acquisition represents event imatinib domain resistance | Reference Offset: [13222-13497', 28400-28631', 1750-1952'] | Reference Text: structure amino mutations potential abl confer kinase acid imatinib domain resistance mechanisms bound selective mutations collectively treatment capable cml kinase imatinib domain resistance bcr-abl natural occur mutations frequency disease cml stages present kinase patients imatinib domain resistance bcr-abl develop | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 2 | Citation Text: inactivation papillomavirus 19 overcome ras-induced 22 transformed e7 rb 21 contrast 20 p53 senescence antigen pathways required sv40 large | Reference Offset: [20286-20689', 534-623', 10186-10310'] | Reference Text: result overcome derivatives ras showed observations response arrest bj fibroblasts premature previous expressing ras-induced phenotype indicating defective arrested p53 prb senescence binding mutant inactivation p53 prb show required transformation sufficient p53 loss oncogenic primary overcome ras-induced stress | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 7 | Citation Text: cloned gfp constructs oligonucleotides vector psuper | Reference Offset: [520-651', 1026-1154', 3023-3065'] | Reference Text: system vector mammalian report rnas psuper interfering synthesis small analyze system vector mammalian psuper types variety vector psuper | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 20 | Citation Text: acquisition information patients rna leukemia detailed microarray | Reference Offset: [26547-26652', 1503-1627', 1806-2013'] | Reference Text: sufficient cases rna microarray leukemia pathways profiles relevant transformation subtypes lymphoblastic lineage line pathogenesis molecular research impact leukemias acute remain undefined largely leukemia | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 2 | Citation Text: mutations maintain predicted date oncogenes features well-differentiated required survival cancer | Reference Offset: [522-707', 23490-23574', 466-520'] | Reference Text: k-ras shrnas mutations maintain lung viability pancreatic lines require cancer dependency k-ras genes differentiation epithelial required survival k-ras mutations epithelial occur frequently cancers | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1420_EVAL | Citance Number: 19 | Citation Text: cyclin development revealed developmental tumors stage leukemias stages t-all arranged highly | Reference Offset: [14336-14498', 23911-24150', 31053-31237'] | Reference Text: striking recognized development normal revealed signatures resultant stages thymocyte development markers differentiation leukemias stages arrest bone myeloid consistent early marrow thymus subtypes defined development identify normal link molecular stages t-all oncogenes activation thymocyte | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 16 | Citation Text: kras assay colon post-infection measuring dependency 21 days viability lines shrna cancer | Reference Offset: [4241-4507', 19543-19742', 522-707'] | Reference Text: k-ras requirement basis maintaining dependency sustained stratify viability features lines mutant large cancer k-ras predictions shrnas assay dependency derived lines growth k-ras shrnas mutations maintain lung viability pancreatic lines require cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 9 | Citation Text: telomerase model catalytic anchorage-independent inhibition transformation vectors h-rasv12 subunit p53 p16ink4a bj oncogenic primary recently combination overexpression fibroblast antigen small sv40 shrna growth | Reference Offset: [4137-4470', 5007-5178', 4659-4886'] | Reference Text: region telomerase joint reverse transformation transcriptase h-rasv12 subunit oncogenic fibroblasts primary viral small sv40 early large protocol htert transformation h-rasv12 bj primary overexpression fibroblast small sv40 large model technology individual pathway neoplastic genes suppressor tumor transformation p53 p16ink4a prb rna combination contribution interference directly p14arf | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 2 | Citation Text: predictions computational numerous experimentally mirna targetscan targets | Reference Offset: [864-1117', 5957-6227', 6961-7319'] | Reference Text: mammals fraction mouse predictions majority mirna rat controls shuffled targets animals computational provide evidence experimental mirna present mammalian describe approach targets identify developed conserved targetscan mirna mirnas algorithm predict sequence called multiple duplex targets interactions | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 2 | Citation Text: k-ras endomembranes relocalization apoptosis mammalian induction demonstrated | Reference Offset: [21040-21224', 28493-28588', 1021-1120'] | Reference Text: k-ras apoptosis oncogenic dependent induction suggesting phosphorylated apoptotic position 181 k-ras apoptosis bcl-xl induction phosphorylated required k-ras promote apoptosis oncogenic manner transformed pkc | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 10 | Citation Text: genes line tumors endogenous ras skin mice ester phorbol carcinogenesis chemical effectors required key formation activates induce tumor presence tiam1 | Reference Offset: [24981-25269', 11207-11490', 642-815'] | Reference Text: model ablation gtpase similarly potential tumor factor ras reduce skin carcinogenesis genetic recently tiam1 effectors small exchange rac formation protocol topical treatment tumor tumors ralgds carcinogenesis subsequently chemical formation progression tissue tumor lack ras ralgds transformation skin size carcinogenesis reduced malignancy incidence culture | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 14 | Citation Text: nilotinib yield resistant treatment abl effective dasatinib t315i imatinib 40 bcr-abl mutant nm | Reference Offset: [2966-3266', 24677-24890', 21295-21574'] | Reference Text: suggests treatment mutation potential abl clinically second-line clear present kinase patient identification imatinib domain active resistance bcr-abl inhibitor mutant therapy nilotinib resistant ap24534 mutants dasatinib imatinib resistance bcr-abl mutant screen compound single resistant ap24534 subsequent mutation kinase confirmed domain resistance bcr-abl mutant nm profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 11 | Citation Text: oct4 fraction actively h3k4me3 genes determine transcribed nanog presence examined chip-seq nucleosomes published bound | Reference Offset: [30012-30425', 6228-6460', 6462-6750'] | Reference Text: oct4 reveal pluripotent genes set differentiated protein-coding states mirnas polycomb sets key silenced serve actively facilitate maintenance tcf3 promoters nanog sox2 regulated group es sites transcript oct4 reveal mirna tcf3 nanog transcriptional sox2 start transcripts highly method occupancy chromatin based mouse oct4 revealed tcf3 embryonic promoters sequencing nanog mirnas short sox2 transcripts fibroblasts quantitative es | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 6 | Citation Text: k-ras plasma exclusively dependent mechanism thought polybasic mitochondria membrane domain endomembrane golgi reticulum phosphorylation endoplasmic compartments | Reference Offset: [747-1019', 4249-4421', 16887-16973'] | Reference Text: region promotes k-ras membranes association bcl-xl show interacts rapid mitochondria polybasic kinase outer membrane pm intracellular phosphorylation membranes k-ras pkc rapid apparatus induced pm translocation golgi included intracellular reticulum endoplasmic promotes mitochondria k-ras pm translocation golgi phosphorylation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_EVAL | Citance Number: 10 | Citation Text: necroptosis metabolism cd40 induced glutathione jun pathways receptors toll-like spp1 kinases | Reference Offset: [14100-14425', 17635-17802', 571-813'] | Reference Text: genes interestingly cd40 spp1 network extensive surrounding pathways screen pathway immune innate jun signaling components necroptosis screen identification insights induced mechanism pathways molecular termed activates death dependent rip1 receptors type apoptotic conditions necroptosis stimulation kinase necrotic | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1410_TRAIN | Citance Number: 8 | Citation Text: reports revealed tissue upregulation tumor sequencing point qrt-pcr repression approach microarray | Reference Offset: [457-696', 1257-1336', 1338-1652'] | Reference Text: species mirna sequencing mirnas abundant rna mir-21 library mir-24 small caski suggests differentiation mirna tissue normal mirna mir-155 mirnas downregulation tissues mir-126 mir-145 mir-143 upregulation northern mir-146a cervical combination analyses significantly cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 9 | Citation Text: first-line mutations nilotinib resistant inhibitors treatment second-line cml dasatinib response tyrosine kinase approved respond imatinib sensitive shows bcr-abl | Reference Offset: [866-1118', 5363-5704', 1861-2026'] | Reference Text: nilotinib mutations attributable inhibition chronic lead switch second-line induces dasatinib kinase patients relapse imatinib leukemia domain resistance myeloid bcr-abl therapy range mutations abl disease cml bcr-ablt315i kinase enzyme approved level domain potent capable matching native bcr-abl inhibitor inhibitors chronic strategy disease effective sustained tyrosine kinase leukemia target myeloid bcr-abl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1428_EVAL | Citance Number: 3 | Citation Text: guanine phosphatidylinositol nucleotide pathogenesis ras mice and/or activated primary effectors multiple exchange pathway samples lacking implicated factors raf/mek/erk | Reference Offset: [1348-1508', 6472-6710', 364-526'] | Reference Text: guanine nucleotide ras phosphoinositide-3 kinases gtpases factors ral effectors raf small multiple exchange rac cellular deficient guanine nucleotide ralgds transformation investigate response mice critical factors generated ral oncogenic exchange regulate deficient gtpase activates guanine nucleotide factor ralgds investigate mice signaling ral generated small exchange | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 15 | Citation Text: suppresses events metastatic mirna pleiotropically distinct invasion multiple note regulators metastasis steps invasion-metastasis colonization breast cascade mir-31 local early cancer | Reference Offset: [14197-14359', 19695-19883', 1201-1487'] | Reference Text: affects events metastatic effects influences colonization size mir-31 invasion local early affects mir-31 events metastatic ectopic invasion extended local demonstrating early colonization site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1405_TRAIN | Citance Number: 11 | Citation Text: transcriptional networks mouse regulating pluripotency mesenchymal es self-renewal | Reference Offset: [802-1086', 2960-3147', 1779-2078'] | Reference Text: networks facilitate oct4 repressing lineage genes differentiation maintain recent transcriptional dual regulatory description pluripotency required self-renewal activation networks mouse differentiation poorly molecular transcriptional remain mechanisms self-renewal formation regulate structure oct4 genes differentiation state lead regulating experiments respond roles pluripotency consistent chromatin self-renewal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 14 | Citation Text: necroptosis form rip1 phosphorylated rip3 inhibited caspase-8 | Reference Offset: [10330-10444', 13831-14025', 18176-18380'] | Reference Text: rip1 regulated activities rip3 caspase-8 kinase complex additional fadd recruitment binding rip1 abolished inhibited rip3 inhibitor tnf rip1 rip3 inhibited production contrast l929 autocrine recently necrosis silencing | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 6 | Citation Text: mimetic defined apoptosis inhibition bh3 abt-737 sufficient bcl-2 family release | Reference Offset: [23641-23830', 31472-31746', 23082-23300'] | Reference Text: bcl-2 mitochondria upstream oligomerization apoptosis bax inhibition bh3 bad abt-737 untreated apoptosis induce peptide inhibition bh3 12 sufficient clear peptides mcl-1 release cytochrome induce inhibition sufficient mitochondria bcl-2 peptides release note cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_EVAL | Citance Number: 1 | Citation Text: short constructs oligonucleotides generated rna vector hairpin psuper | Reference Offset: [520-651', 1026-1154', 3023-3065'] | Reference Text: system vector mammalian report rnas psuper interfering synthesis small analyze system vector mammalian psuper types variety vector psuper | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1429_EVAL | Citance Number: 14 | Citation Text: work present outer exclusively membrane determined published mitochondrial | Reference Offset: [4423-4576', 17140-17200', 16334-16494'] | Reference Text: surprisingly k-ras membranes outer membrane bcl-xl phosphorylated included mitochondrial localization outer membrane shows mitochondrial mitochondria red pattern outer localization membrane suggested mitochondrial | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 18 | Citation Text: vertebrates sites strategies drosophila profiling promoters differences contrast undifferentiated 30% examined rest types es genome-wide reflect | Reference Offset: [933-1241', 2016-2296', 5452-5924'] | Reference Text: genes circuitry protein-coding mirna promoters sequencing transcriptional short regulatory identification transcripts describe chip-seq quantitative types es multiple based marson state mirna promoters sequencing short factors promote identification program transcripts describe chip-seq quantitative types es multiple key transcription additionally genes differentiated circuitry mirna factor transcriptional mrna regulation examined core types occupancy es transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 7 | Citation Text: point markers undifferentiated examined nanog es well-known | Reference Offset: [11083-11232', 16270-16429', 1040-1174'] | Reference Text: independently pathway undifferentiated state demonstrated nanog es retinoic confirmed staining acid treatment undifferentiated repressed nanog es independently encoding capable nanog es maintaining self-renewal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 19 | Citation Text: fact apoptosis expressing 2b4 dexamethasone-induced abt-737 | Reference Offset: [23641-23830', 28597-28723', 1045-1171'] | Reference Text: bcl-2 mitochondria upstream oligomerization apoptosis bax inhibition bh3 bad abt-737 contrast bcl-2 apoptosis 2b4 dexamethasone-induced abt-737 sensitive bcl-2 sensitivity priming molecules activator bh3-only abt-737 related | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1407_EVAL | Citance Number: 8 | Citation Text: functions constructed vector identify approach mirna retroviral mirnas | Reference Offset: [10037-10311', 894-1079', 2250-2458'] | Reference Text: termed reverse host mirna retroviral stable process vector primary copy transcription commitment identify lineage hematopoietic show regulated mirnas early specifically hematopoiesis functions lineages development conservation mammalian mirnas based animal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_TRAIN | Citance Number: 1 | Citation Text: necroptosis defense host virus infection part | Reference Offset: [826-966', 1226-1303', 4164-4417'] | Reference Text: screen tnf crucial rna programmed induced infection virus activator interference necrosis rip3 complex induced virus infection defense ablation host resulted rip1 physiological genetic roles programmed lethality mediator necrosis | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_TRAIN | Citance Number: 7 | Citation Text: cellular differentiation modifications epithelial interfering affect transformation regulating rest mechanisms | Reference Offset: [15641-15800', 25452-25609', 29162-29367'] | Reference Text: implicated potent regulating proliferation pathway vitro oncogenic epithelial inhibitor transformation suppression support epithelial tumor rest suppressing transformation suggests functions rest-fs shrnas epithelial endogenous transformation transforming rest mutant ability | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1427_EVAL | Citance Number: 5 | Citation Text: obtained mimetic peptide induce bh3 tumor bad abt-737 considered subset bcl-2 mitochondria bind release cytochrome | Reference Offset: [24548-24702', 11150-11315', 15440-15697'] | Reference Text: bh3 bad wt induces 12 mitochondria bcl-2 presence grown combination release cytochrome termed unable induce domains domain bik bh3 class bad release cytochrome treatment bh3 bad combination peptides puma bind release antiapoptotics cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_EVAL | Citance Number: 15 | Citation Text: lats2 cycle lats1 proliferation unable 36 effects affect mutants g2/m kinase require g1/s | Reference Offset: [6130-6297', 26590-26857', 1976-2141'] | Reference Text: g2/m controls lats2 lats1 regulating negatively proliferation interestingly transition g1/s cyclin lats2 cycle transition cyclins affect kinase e/cdk2 ectopic g1/s affecting downregulation regulators cycle lats2 model lats1 proliferation finally regulating negatively propose mammalian combination | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 6 | Citation Text: genomic location sequence recently mirna utilized | Reference Offset: [6952-7314', 13894-14090', 23123-23248'] | Reference Text: sites mouse provide location mirna factor sequencing mirnas fate transcriptional regulatory start program primary quantitative types es mechanisms transcription oct4 species location conserved determine mirna promoters factor occupancy es genome-wide transcription short provide sequence rnas mirna quantitative es transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 9 | Citation Text: promotes work pre-rc degradation degraded prevents extended show apc recently cdk2 cdc6 g1 early apccdh1 formation | Reference Offset: [17461-17605', 35887-36027', 4100-4235'] | Reference Text: degradation ligase destruction rxxl n-terminal mediate apc cdc6 g1 motifs early g2/m cycle degraded cdc6 g1 phase end early mediated recognition apc late g1 required activation substrate | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_EVAL | Citance Number: 3 | Citation Text: ros matrix indicating production mitochondrial expected red led increase decrease | Reference Offset: [20554-20840', 3121-3398', 12437-12664'] | Reference Text: sensitivity oxidative damage production mitochondrial mitochondria leads led dna initial increase cellular evaluate ros oxidative stress production mitochondrial response major ros oxidative production mitochondria chain increase approach phosphorylation based cytochrome | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1411_EVAL | Citance Number: 16 | Citation Text: binds p53 suppressor tumor pathways activities lt central transformation retinoblastoma | Reference Offset: [1687-1824', 4659-4886', 1826-2032'] | Reference Text: p53 prb genetic suppressor tumor pathways alterations cancers model technology individual pathway neoplastic genes suppressor tumor transformation p53 p16ink4a prb rna combination contribution interference directly p14arf mutations genes tumor frequent cancers p53 prb pathways inactivated types members intact | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 7 | Citation Text: lats2 constructs pcr pgl3 luciferase cloned genomic dna downstream amplified | Reference Offset: [42195-42329', 33047-33183', 42488-42578'] | Reference Text: promoter cmv mir-vec mirna pcr cloned genomic dna sequence downstream amplified cloned direct lats2 target downstream luciferase cloned lats2 pretrosuper constructs knockdown | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 8 | Citation Text: suppression rna translational mismatches small end | Reference Offset: [7755-7907', 9010-9221', 13362-13489'] | Reference Text: additional seed mirna mismatches sites duplexes seed predicted structures matches red rna involving target position positions mirna negative positive relative end | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 1 | Citation Text: mouse endoderm essential importantly visceral rt-pcr trophectoderm nanog rat northern rex1 marker lines ectoderm es | Reference Offset: [19789-19986', 31667-31805', 4551-4718'] | Reference Text: endoderm markers visceral rt-pcr nanog showed northern factors analyses null transcription endoderm differentiation trophectoderm require derived prevent nanog es primitive mouse lines required es self-renewal | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_EVAL | Citance Number: 2 | Citation Text: pluripotent state differentiate embryo embryonic nanog maintaining network mass factors regulation unclear capacity core derived stem types mechanisms ability regulate transcription | Reference Offset: [1491-1722', 433-559', 19789-19986'] | Reference Text: rapidly differentiate embryonic maintaining mass grow mammalian pluripotency derived stem types ability mass grow pluripotency derived stem embryonic maintaining endoderm markers visceral rt-pcr nanog showed northern factors analyses null transcription | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_TRAIN | Citance Number: 12 | Citation Text: tel-aml1-positive strategies cases set classified selection probe t-all hyperdiploid accuracy | Reference Offset: [19188-19541', 26214-26408', 11251-11396'] | Reference Text: genes classified chimeric subset mll characterized cases lineage t-all hyperdiploid presence classification bcr-abl t-all hyperdiploid cases relapse subgroups profiles accuracy defined cases genes distinct mll t-all hyperdiploid bcr-abl | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 13 | Citation Text: ras arf leads arrest oncogenic primary fibroblasts senescence rodent premature growth inducing | Reference Offset: [30597-30804', 33090-33236', 570-681'] | Reference Text: mutations induction ras transform program oncogenic primary senescence rodent premature demonstrate p53 association oncogenic primary senescence induction rodent ras premature arrest oncogenic primary g1 show rodent ras | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1422_EVAL | Citance Number: 2 | Citation Text: sites resulted deletion pml pods fusion disrupted major apl pod formation | Reference Offset: [6760-7052', 7950-8670', 979-1108'] | Reference Text: suggests patterns localization treatment differentiation normal rara pml presence oncogenic fusion reversed atra therapy apl remains revealed leukemic pml replication dna rna utilized apl sites functions rara factor transcriptional nuclear transcripts small pattern disrupted apl pod | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1409_EVAL | Citance Number: 17 | Citation Text: functions apoptosis genes inhibitors suppressor demonstrated downregulated upregulated tumor cancers contrast encoding molecules adhesion included chemokines | Reference Offset: [1429-1694', 1717-1978', 21133-21201'] | Reference Text: fraction lower majority suppressor finally tumor inpp4b cancers breast basal-like patient ovarian correlated suggesting locus survival find cellular aberrant proliferation progression apoptosis genes suppressor epithelial tumor tumors resulting oncogenes alterations generation multiple present functions evidence suppressor inpp4b tumor | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 15 | Citation Text: t315i point oral multi-targeted mutations ap24534 effective | Reference Offset: [2726-2843', 3529-3710', 866-1118'] | Reference Text: kinase point involves mutations imatinib domain resistance binding bcr-abl inhibitor inhibitors effective response patients oral leading bcr-abl availability drug nilotinib mutations attributable inhibition chronic lead switch second-line induces dasatinib kinase patients relapse imatinib leukemia domain resistance myeloid bcr-abl therapy | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 13 | Citation Text: oncogenic suppressor overexpression tumors tumor downregulation mirnas | Reference Offset: [935-1177', 1316-1547', 4194-4352'] | Reference Text: cellular screen harbor proliferation tumorigenesis ras mirnas transformation mir-373 p53 oncogenes oncogenic primary wild-type active mir-372 provide development pathway evidence germ potential tumors mirnas testicular p53 presence oncogenes wild-type tumorigenic growth neoplastic uncover genes recently suppressor tumor assays transformation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1417_TRAIN | Citance Number: 4 | Citation Text: pocket nucleotide-binding switch regions gefs | Reference Offset: [6833-7052', 9398-9528', 10287-10432'] | Reference Text: released site decreased subsequently nucleotide-binding nucleotide gefs affinity magnesium loop interact switch regions structure largely conformational loop binding switch regions induces | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1419_EVAL | Citance Number: 9 | Citation Text: conditions cycle progression genes inhibiting hypophosphorylated transcription rb | Reference Offset: [2954-3200', 4357-4467', 4251-4355'] | Reference Text: level regulation suggesting promoters transcription rb cycle events state rb cycle relative appeared rb | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1406_TRAIN | Citance Number: 6 | Citation Text: activate transmit kras mutations pik3ca pathways survival signals | Reference Offset: [9646-9802', 12148-12335', 12707-12953'] | Reference Text: transmit extracellular matrix switch receptors types express cancer signals direct kinase interaction survival ras growth signals transmit extracellular spectrum apoptosis differentiation ras signals signaling mediate component circuits growth | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1424_EVAL | Citance Number: 9 | Citation Text: functions immune cd2ap cd2 interacting response t-cell membrane antigen-presenting adhesion facilitates killer natural | Reference Offset: [3442-3613', 774-937', 3816-3977'] | Reference Text: surface lymphocytes cd2 kda t-cell process analyze membrane killer natural 50 process demonstrate cytoskeletal cd2 ligand adhesion molecule engagement clustering binds ligands area range cd2 adhesion participate molecule contact formation | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1402_EVAL | Citance Number: 5 | Citation Text: obtained plasmids | Reference Offset: [15518-15630', 22363-22459', 46387-46478'] | Reference Text: obtained normal ikbke sample representative obtained days infection shrna breast obtained tumor lines cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_EVAL | Citance Number: 1 | Citation Text: protects residues ubiquitination degradation cdc6 stability serine cdks phosphorylation n-terminal | Reference Offset: [1255-1349', 4974-5305', 6890-6994'] | Reference Text: inhibition cdc6 destruction serine phosphorylation triggered cyclin sites degradation subsequent potential cdk2 cdc6 wild-type proposed translocation phosphorylation phase nucleus based mutated led loss resulted cdc6 serine proteolysis phosphorylation apccdh1 | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1403_TRAIN | Citance Number: 4 | Citation Text: vectors retroviral pwzl-hygro | Reference Offset: [6328-6479', 35868-36048', 34574-34727'] | Reference Text: vectors allowed days retroviral selection hr plated retroviral 20 10 transfected incubated cyclin d1 receptor ecotropic retroviral express | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1416_EVAL | Citance Number: 10 | Citation Text: potent selective nilotinib imatinib bcr-abl inhibitor | Reference Offset: [1307-1497', 35030-35312', 6504-6591'] | Reference Text: potent selective describe imatinib active bcr-abl imatinib-resistant significantly inhibitor mutants potent proliferation dependent block express cml transfected patients imatinib lines bcr-abl derived inhibitor ability assessed superior vitro potency imatinib bcr-abl inhibitor vivo | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_EVAL | Citance Number: 13 | Citation Text: transcriptional h3k4me3 mes genes markers determined classified state active chip-seq | Reference Offset: [933-1241', 2016-2296', 703-931'] | Reference Text: genes circuitry protein-coding mirna promoters sequencing transcriptional short regulatory identification transcripts describe chip-seq quantitative types es multiple based marson state mirna promoters sequencing short factors promote identification program transcripts describe chip-seq quantitative types es multiple key transcription cellular crucial normal differentiation controlled mirna established embryonic transcriptional micrornas stem es self-renewal key regulators | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1412_EVAL | Citance Number: 2 | Citation Text: drivers ptpn12 lost therapeutic percentage molecular breast tyrosine subtype phosphatase cancer large targets find heterogeneous | Reference Offset: [1956-2297', 54634-54710', 54711-54829'] | Reference Text: ptpn12 suppresses inhibitors egfr tyrosine kinase oncogenic treated inactivated multiple frequently her2 tumorigenesis metastasis transformation kinases breast inhibits phosphatase negative cancer breast tyrosine ptpn12 suppressor phosphatase tumor cancer breast tyrosine ptpn12 demonstrate potent suppressor phosphatase tumor cancer | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1418_EVAL | Citance Number: 3 | Citation Text: sensitivity expressing mutation assays ba/f3 figure vitro determined bcr-abl mutated | Reference Offset: [10017-10194', 44373-44478', 10196-10292'] | Reference Text: cellular single mutations range proliferation expressing assays kinase ba/f3 native domain bcr-abl ba/f3 figure native expressing inhibition bcr-abl phosphorylation bcr-ablt315i ba/f3 proliferation native expressing ap24534 bcr-abl inhibited | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1401_TRAIN | Citance Number: 1 | Citation Text: allowed inactivation causing development death functional damage mechanism partial rapid p53 tgcts context induced | Reference Offset: [21704-21974', 21976-22172', 35674-35909'] | Reference Text: allowed ir cycle rasv12 mirnas suppression expected p53 presence replication arrest dna induced inactivation cellular remains damage confer response p53 dna senescence manner intact inactivation allowed p53 cases neoplastic majority active require transformation occur | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 10 | Citation Text: stem/progenitor regulating proliferation vitro tet2 differentiation myeloid suggested approaches recent | Reference Offset: [43625-43903', 1693-1890', 1904-2225'] | Reference Text: normal inhibition differentiation effects idh2 mutants stem/progenitor tet2 myeloid increase hematopoietic reduction stem/progenitor impaired marker tet2 differentiation idh1/2 hematopoietic suggesting finally mutant depletion hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1415_TRAIN | Citance Number: 2 | Citation Text: essential nsclc recently | Reference Offset: [891-964', 43428-43725', 47619-47854'] | Reference Text: c-raf essential nsclc onset k-ras potent melanoma partial disease nsclc patients recently active lines inhibitor mek allowed mouse pathway therapeutic synthetic lethal tumor models nsclc cdk4 identification recently k-ras-driven approaches targets | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 2 | Citation Text: mrna aml significantly research cancer samples database profile | Reference Offset: [9602-9714', 10630-10750', 10752-10968'] | Reference Text: genetic aml parameters clinical samples patients mutations aml significantly idh2 idh1 mutation samples idh2 idh1 12 patients aml specifically presented | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1430_EVAL | Citance Number: 19 | Citation Text: kras remains expressing maintenance pdac tumor recent setting lose vitro oncogenic pancreatic advanced oncogene lines mutant relevant vivo | Reference Offset: [11325-11564', 522-707', 1360-1480'] | Reference Text: suppressor regulator tumor related striking signaling pancreatic akt lines negative cancer pten k-ras shrnas mutations maintain lung viability pancreatic lines require cancer solid k-ras potent activated oncogene tumors tumor mutated frequently | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 7 | Citation Text: reports sequences translational mirna demonstrated recent positions introduced target repression correlate mismatches nucleotides end | Reference Offset: [13362-13489', 21515-21901', 51656-52251'] | Reference Text: position positions mirna negative positive relative end residues recognition seed mirna mirnas positions target consistent end mirna real matches free order end antisense seed sequences predicted dataset generated energy duplex | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1414_EVAL | Citance Number: 13 | Citation Text: strategies acts absence metastasis demonstrated mirna effects tumor influences pleiotropically achieved mir-31 loss-of-function primary suppress | Reference Offset: [37739-37848', 1201-1487', 3895-4285'] | Reference Text: contrast development mir-31 primary metastasis tumor influences site development attributable metastatic metastasis inhibition distant tumor steps influences colonization phenotypes initial primary invasion local survival extravasation specifically proliferation development remains apoptosis metastasis tumor influences mirnas affect exert potentially extent and/or primary unclear specifically | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1408_TRAIN | Citance Number: 4 | Citation Text: methods sites predicted targetscan regions comparison mrnas target | Reference Offset: [38233-38458', 15273-15562', 37030-37353'] | Reference Text: sites set genes targetscan predicted regions mammalian target vertebrates sites cases genes conserved predicted targetscan utrs involving target detected sites cases status revealed predicted utrs regions assays reporter target | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1404_TRAIN | Citance Number: 8 | Citation Text: kinase cycle p53 arrest apoptosis induction | Reference Offset: [304-393', 982-1224', 3999-4240'] | Reference Text: stabilization p53 arrest leading dna induction damage g1 cyclin maintenance induction damage stability proteolysis p53-independent resulting response d1 p53 arrest dna mediated g1 initiation radiation apoptosis damage ionizing prior response p53 arrest dna g1 required phase | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1413_TRAIN | Citance Number: 12 | Citation Text: 5% mutations tet2 3% specifically coding exon | Reference Offset: [30719-30823', 1349-1571', 1904-2225'] | Reference Text: patient single mutations concurrent tet2 identify idh2 specifically idh1 mutations exclusive epigenetic defects mutants enzyme mutually loss-of-function tet2 idh1/2 aml hypermethylation loss mutations global differentiation idh2 induces mutants dna tet2 idh1/2 increase myeloid inhibit mutant profile | Discourse Facet: | Run ID: BLLIP 1
Topic ID: D1426_EVAL | Citance Number: 5 | Citation Text: toxin mediated transduction cx3cr1 signal inhibited | Reference Offset: [3352-3455', 11370-11541', 31705-31888'] | Reference Text: toxin mediated effects pathways frequently transduction abolished signal indicating machinery transfected t